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1.1. Caries Experience and Prevalence 
   Caries experience is commonly expressed as “DMF-T/-S”. This so called caries 
index was first introduced by Klein and co-workers in 1938 [Klein et al., 1938]. It 
was a criterion to validate an individual’s experience with dental decay. The index 
is composed by three factors; D standing for dental decay, M standing for teeth 
missing due to caries and F standing for filled teeth. Further, DMF can be 
expressed on tooth (-T) and on surface (-S) level. This index, which is however 
worldwide used, is currently under discussion. Especially factor F, which should 
give an idea of the extend of the experienced decay, is being questioned. The size 
of a dental restoration is in many cases determined by the dentist and not by the 
extend of the carious lesion itself. As amalgam used to be the only material of 
choice for the dentist in the past, the same dentist nowadays has many other 
possibilities to treat an active carious lesion, with less substance loss for the tooth. 
Therefore, it is also difficult to compare DMF data from different time eras. 
Nevertheless, the index remains widely used as it provides a reasonably accurate 
historical account of changes in the prevalence of caries, as well as in incidence 
[Vanobbergen, 2001]. 
   Caries prevalence in children, which is epidemiologically determined in cross-
sectional and longitudinal studies, has declined the past twenty to thirty years in the 
Western world [Glass, 1982; Marthaler, 1990; Truin et al., 1994; Elderton, 1994; 
Marthaler et al., 1996; Petersson and Bratthall, 1996; Vanobbergen et al., 2001a; 
Vanobbergen, 2001]. It is however striking, that about 10 to 15% of all children 
now experience 50% of all carious lesions. Figure 1.1. illustrates the skewed 
distribution to the left. The latter means that these subjects should be regarded as 
“high caries risk individuals”. This was also found in the Belgian Signal-
Tandmobiel
®
 Project, in which this skewed distribution was also observed in 4351 
Flemish 7 year olds. Fourty four percent of the 7 year olds in this study were caries 
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free and 50% of all caries lesions was confined to 15.2% of the children 
[Vanobbergen, 2001].  
 
Figure 1.1.  : Distribution of dental caries (DMF-T) in 7 year olds in Flanders  
                       [J. Vanobbergen, thesis, Ghent 2001] 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
   The WHO goals for the year 2000, a maximum mean DMF-T score of 3 for 12 
year olds and a target of 50% of children caries free at the age of 5, have apparently 
been reached in many West-European countries [Petterson and Bratthall, 1996]. 
The main reason, being assumed responsible, for this decline of the overall caries 
prevalence, is the abundant availability of fluorides, more explicitely in toothpaste. 
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Not only the number of decayed, missing and filled teeth (DMF-T) did decline over 
the years, but also the extensiveness of dental decay (D-S) did become smaller. The 
latter can be derived from the extensiveness of the dental restorations (F-S). This 
can be attributed to two aspects; first of all the better oral hygiene in combination 
with fluoride containing toothpastes and secondly the less tooth-tissue-destructive 
restoration techniques in dentistry nowadays (e.g. composites and other adhesive 
restorative materials) [Cameron and Widmer, 1998; Vanobbergen, 2001].  
   The above mentioned 15.2% of children who “carry” all caries in Flemish 7 year 
olds should be the target group in dental prevention. Therefore methods to identify 
and to reach  these “high risk groups” are being explored. From the same study it 
was observed that the children at high risk for developing dental decay generally 
may come, on the one hand, from a socio-economically deprived environment (e.g. 
mother and father unemployed, parents without diploma) and that self esteem plays 
an important role in a child’s caries experience [Vanobbergen et al., 2001]. On the 
other hand certain groups of medically compromised and disabled children should 
not be forgotten as potential high risk individuals; although very few studies are 
known [Dahllöff and Martens, 2001]. The latter group is assumed to be more prone 
for dental decay, in part due to the type of their medication intake (e.g. syrups, 
inhalers, sugar containing medication). In table 1.1. the incidence or prevalence of 
chronic health conditions in childhood per number of live-births are presented. This 
table clearly shows that chronic health conditions in children are not rare and that 
the chance to come across such a patient in a general dental practice is quite large. 
Literature about the impact of the medical conditions on oral health is rather sparse. 
   From a study in the south of Sweden it was observed that 8.4% of children aged 
between 0 and 15 years old suffered from chronic health conditions [Westbom and 
Kornfält R, 1987]. Among these children, 70% suffered from one condition, while 
21% was even affected by two chronic health conditions and in 9% at least 3  
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Table 1.1. : Incidence of chronic health conditions in childhood [MJ Light, 2001a] 
        Disease                                                                 Incidence in number of live births 
Mental Retardation                     1 to 2 / 100 
Asthma     2 to 15 per 100 children 
Obstructive Sleep Apnea Syndrome  2 per 100 (4 to 5 year olds) 
Attention Deficit Disorder   3 to 5 / 100 
Anxiety Disorders    7 to 15 / 100 
Sickle Cell Anaemia    1 / 600 African-Americans 
Down Syndrome    1 / 660 
Klinefelter Syndrome    1 / 850 
Diabetes type 1    2 per 1000 children (< 18 year olds) 
Congenital Heart Disease   4 to 10 / 1000 
Fragile X     1 / 1250 (males); 1 / 2500 (females) 
Cystic Fibrosis    1 to 2500 Caucasians 
Turner Syndrome    1 / 2500 
Congenital Hypothyroidism   1 / 4000 
Haemophilia    1 / 7500 (males) 
Autism     4 to 5 / 10000 
Achondroplasia    1 / 15000 
Phenylketonuria    1 / 10000 to 1 / 15000 
Immotile Cilia Syndrome   1 / 16000 
Kartagener’s Syndrome   1 / 32000 
Galactosaemia    1 / 50000 
Acute Lymphoblastic Leukaemia  4 / 100000 Caucasians 
     2.4 / 100000 African-Americans 
Crohn’s Disease    1 to 7 / 100000 
Glycogen Storage Disease   1 / 100000 to 1 / 400000 
Chronic Renal Failure   18 / 1000000 
End-stage Renal Disease    3 to 6 / 1000000 
 
chronic health conditions were diagnosed.  As these children, nowadays, are not 
always institutionalised, general dentists and especially paediatric dentists are more 
often confronted with this group of paediatric patients.  Moreover, the last two 
decades, children with a chronic health condition have a great chance to survive 
their twenties. As a result up-to-date knowledge and know-how of chronic health 
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conditions has become an important aspect of paediatric dental care. More research 
is needed to provide more knowledge about the oral health consequences of 
chronical illnesses. Briefly, chronic health conditions in children can be devided 
into 5 different patterns [Dahllöff and Martens, 2001] as the expression of the 
condition may be variable as is the relative consistency or permanence of 
symptoms or consequences with time (table 1.2.).  
 
Table 1.2. : Five different patterns of chronic health conditions in children [Dahllöf 
                    and Martens, 2001] 
The pattern is ;                            Per Definition;                                                              Example; 
 
Permanent   consistent and unchanging consequences  cerebral palsy 
Recoverable  gradual improvement of sequelae as well  asthma, epilepsy,  
   as in intensity as in duration   long-term remission 
        leukaemia 
Deteriorating  deterioration of the condition   cystic fibrosis, 
   can take several years (decades)   muscular dystrophy, 
        aplastic anaemia 
Episodic   alternating periods of disease and  juvenile rheumatoid 
   relative good health    arthritis 
No clinical symptoms  no expression of disease   HIV, hypercholesterolaemia 
 
   Besides the side-effects of the (chronic) illness, compassionate parents could 
spoil their medically compromised or disabled child more with sweets and be less 
strict and demanding in their raising. The latter can also be partly held responsible 
for children with medically compromised conditions to experience more dental 
decay than others. These aspects should never be forgotten and once again indicate 
that caries is a multifactorial disease, which is among many factors also 
environmentally influenced. Therefore, it is obvious that the prevention of dental 
caries should be of utmost importance for children and adolescents with medical 
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compromised conditions, as simple dental problems may severly compromise their 
medical management [Cameron and Widmer, 1998; Dahllöf and Martens, 2001].  
   Among medical conditions, currently under discussion and in the sphere of 
interest of many researchers, are the respiratory disorders. 
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Chapter 2 
 
Respiratory disorders and oral health 
 
 
 
 
 
 
 
 
 
 
Part of this chapter was published as : 
L.C. Martens, J.K.M. Aps, G.O.G. Van Maele. Is oral health at risk in people with 
cystic fibrosis?  
European Journal of Paediatric Dentistry 2001;2:21-27. 
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2.1 Asthma 
2.1.1. Prevalence  and definition 
   As the number of children with chronic health conditions has increased 
significantly the last decades, respiratory disorders have gained more and more 
interest among clinical researchers. Asthma is the most common paediatric chronic 
respiratory disorder and is defined as a condition associated with reactive airways 
and reversible airway obstructions which are associated with inflammation. 
Apparently, till puberty, asthma is more common in boys than in girls, but after 
puberty the incidence is equal. Geographical differences have also been reported.  
   The contemporary incidence (table 1.1., chapter 1) of asthma is about 2 to 15% in 
children. The observed increase in prevalence in the last decades, can not only be 
explained by environmental conditions and yet the exact cause remains unclear 
[Light MJ, 2001b]. On the other hand it should be emphasized that this increase in 
observations can also be caused by a hightened awareness of making the diagnosis 
and collecting data among physicians.  
 
2.1.2. Oral health and asthma 
   The oral health consequences for asthma patients, who are under constant aerosol 
medication, have been studied recently. It is however interesting that both in the 
north of Europe (Finland and UK) [Mc Derra et al., 1998; Kankaala et al., 1998] as 
well as in the south (Turkey) [Kargül et al., 1998] asthma studies have been carried 
out. These studies reported that children with asthma had a significant increased 
incidence of dental decay, particularly in the permanent dentition. Dental calculus, 
gingivitis and dental erosions were reported to be significantly more present in this 
group of children. These features were attributed to their frequent medication 
intake (aerosols and liquids). Aerosol powders predominantly contain lactose and 
other sugars as “carriers” for the beta-2-agonists, and as a consequence they may 
attribute to the observed increased dental decay incidence. A side effect of beta-2-
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agonists is a decreased salivary secretion rate, which in its turn may also play a role 
in the development of dental decay [Ryberg et al., 1987; Ryberg et al., 1990]. 
Moreover, about up to 80% of the inhaled aerosol medication is retained in the 
mouth. This figure, however, decreases eightfold when another type of inhaler is 
used. It needs no further explanation that aerosols taken at night bear a potential 
caries risk. Furthermore, mouth breathing habits may be held responsible for the 
increased incidence of gingivitis, while dental calculus was thought to be 
influenced by increased salivary phosphorus and calcium concentrations in asthma 
patients.  
   More recently, the findings of the above mentioned studies were contradicted. A 
cohort study in New Zealand showed that there was no significant difference 
between asthmatic children and healthy controls [Meldrum et al., 2001]. The 
authors agree that certain oral physiological changes may occur due to the disease 
and the medication, but they emphasize correctly that if a substantial association 
between asthma and caries would exist, the chances of finding it in their large 
cohort study were high. Another study, carried out in the USA [Shulman et al., 
2001] did not find any differences in caries experience either between asthmatic 
children and controls. However, when they divided their sample into agecategories, 
the severe asthmatics, aged 4 to 10, had a significant lower caries experience than 
healthy controls of the same agecategory. A similar finding was reported recently 
in a Belgian survey, carried out at the Ghent University [Eloot et al., 2002].  
   From the above it is clear that results are rather controversial, nevertheless the 
question remains; “Are patients, who are affected with respiratory problems and 
obligatory have to take a lot of aerosols, potentially at high risk to develop dental 
caries?” Besides asthma patients, individuals suffering from cystic fibrosis are also 
taking lots of aerosols and as a consequence also could run a high caries risk. 
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2.2.  Cystic Fibrosis  
2.2.1. What is Cystic Fibrosis ? 
2.1.1.a. History of the name 
 “Woe to that child which when kissed on the forehead tastes salty. He is bewitched 
and soon must die!”[Lewis, 1997]. This quote dates from the seventeenth century 
and illustrates that cystic fibrosis (CF) is not new. It is believed that CF was 
brought to Europe several ten thousand years ago, when man was a hunter-
gatherer, living in the region of what is now called the Middle East. Ten thousand 
years ago, man migrated to Europe, to start up living as farmers. On their travelling 
to the North of Europe, they brought several genetic mutations along, which they 
mingled with local genes. Consequently today, these mutations can be found all 
over the world, although the frequency may vary from area to area. Probably, being 
a CF patient has an advantage in certain regions of the earth and it is believed that 
it provides a better condition in areas where diarrhoea could be a problem. 
Apparently CF patients would be less vulnerable to diarrhoea, as the thick mucus 
lining in their bowel prevents dehydration. 
   It wasn’t until the twentieth century that science began to unravel the secrets 
behind CF. Fanconi was the first to report on CF in 1936. Later in 1938, Anderson 
reported on children dying of lung disease, before their first birthday. She also 
discovered that not only the lungs were involved in this disease, but also the 
pancreas. Because of the fibrous scarring of the pancreas tissue the disease was 
first called “ cystic fibrosis of the pancreas”. She also postulated that this disorder 
was accompanied by not absorbing vitamin A.  
   In 1945, Farber introduced the name “mucoviscidosis”, as it was discovered that 
“all” mucus-producing glands were involved as well, causing obstructions in the 
ducts of these glands [Grundy et al., 1993; Lewis, 1997; Light, 2001b].  Very 
typical was the observation in New York, 1949, in the summer time, during a 
heatwave; several CF patients (children) were confronted with massive salt losses 
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due to sweating and developed a heat stroke.  As recently as 1960, CF patients 
rarely lived past ten years of age and the therapy for CF was simply dealing with 
the clinical features of the disease; steatorrhea, respiratory infections (mucous 
expectorates) and problems to gain body weight. Thanks to improved medical care 
and knowledge of the disease, CF patients are now able to survive longer than 40 
years ago (figure 2.1.) [Mulherin, 1991; FitzSimmons, 1993; Hodson, 1993; Vay 
Liang, 1993; Webb, 1993; Brewis, 1995; Hamer and Parker, 1996; Lewis, 1997]. 
Nowadays, the disease is called cystic fibrosis in the English-speaking literature, 
while in Dutch-,French- and German- speaking literature, it is called 
mucoviscidose. 
 
Figure 2.1. : Increase of survival in cystic fibrosis patients over the years 
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2.2.1.b. Genetics 
   Today, CF is known to be the most common lethal autosomal recessive inherited 
disease in Caucasians which affects both sexes equally and approximately 1 in 
every 2000 livebirths is a CF baby. About 5% of the Caucausian population is 
heterozygous for the CFTR (cystic fibrosis transmembrane regulator) gene. The 
disease is much less frequent in the Black population (1 in every 17,000 livebirths) 
or in the Asian population (1 in every 100,000 livebirths) [Kunitomo et al., 1991; 
Tsui et al., 1991; Harris et al., 1991; Aitkin and Fail, 1993; Vay Liang et al., 1993; 
Hilman, 1997]. As the disease requires two parental genes with the CFTR 
mutation, both parents are carrier of the disease. In 1988, however, Arthur Beaudet 
of the Baylor College of Medicine reported a uniparental disomy of CF. A CF 
patient was born out of a CFTR heterozygous mother and a non-carrier father. 
However, this exceptional meiosis phenomenon in which the child receives two 
copies of one parent’s CF bearing chromosome and none from the other parent, 
should not be forgotten, when examining CF patients [Lewis, 1997]. The 
responsible allelic sequence is located on the long arm of chromosome 7, at 
position 7q31. It encompasses a 250 kilobase segment of DNA consisting of 27 
axons. The CFTR protein is predicted to be 1480 amino acids long and to have a 
molecular weight of 160 to 170 kiloDalton. The most frequent CF mutation in 
Caucasians is a deletion of 3 nucleotides encoding phenylalanine at position 508 
(delta F508) in the amino acid sequence. The frequency of this mutation is 
approximately 70% in the USA and the north of Europe, less than 50% in the south 
of Europe and only 30% in Ashkenazic families.The highest allelic frequency of 
delta F508 is found around Denmark (86.6%) while the lowest is found in Turkey 
(27%) (figure 2.2.). This geographical distribution of the delta F508 mutation is 
illustrated in figure 2. In essence, the mutation causes a defective chloride channel 
transport in every exocrine gland of the body.  
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Figure 2.2. : Distribution of the cystic fibrosis transmembrane regulator genotype  
                     ‘delta  F508’ in different populations 
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2.2.2.  Clinical features of the disease 
   Fundamentally the disease is caused by a defective sodium and chloride 
reabsorption mechanism and as a consequence all exocrine glands are affected. The 
clinical manifestations of this single gene defect are both respiratory and digestive.  
   The current initial diagnostic tests are focused on the pilocarpine-sweat-test.  The 
higher salt excretion (> 60 mmol/L) when sweating in combination with the 
following 3 aspects, make the diagnosis of CF complete; (1) chronic obstructive 
pulmonary disease, (2) exocrine pancreatic insufficiency and (3) a family history of 
the disease. Finally, nowadays, a genetic diagnosis confirms the observations [Van 
Nieuw Amerongen, 1988b, Aitken and Fail, 1993; FitzSimmons, 1993; Vay Liang 
et al., 1993; Brewis et al., 1995].  
   CF patients are to be medically counselled carefully and an individualized 
medication programme is indispensable. The respiratory problems involve both 
upper and lower respiratory tracts. Nasal polyps are common in 10 to 15% of all 
CF patients [Brewis et al., 1995; Marks and Kissner, 1997]. Obstructive pulmonary 
disease, with recurrent respiratory infections, caused by Pseudomonas aeruginosa, 
Haemophilus influenzae and Staphylococcus aureus, and acute exacerbations are 
common in CF. The lower respiratory tract involvement accounts for well over 
90% of the morbidity and mortality in CF. Due to extreme mucoid secretions from 
the pulmonary secretion granules, evacuation of microorganisms is impaired. The 
latter obligates these patients to take antibiotics (I.V., per os, via aerosols), 
expectorantia and mucolytica on a regular basis [Bellon and Gilly, 1990; Foucaud 
et al., 1990; de Montalembert et al., 1991; Hoiby, 1991; Mulherin et al., 1991; 
Pascal et al., 1992; Wallace et al., 1993; Brewis et al., 1995; Frederiksen et al., 
1997]. In table 2.1. some types and names of currently used medication in CF 
patients are represented with their known side effects. The digestive problems, 
such as fat and protein malabsorption, result in steatorrhea and failure to thrive and 
consequently also in leanness. Pancreatic deficiency is the cause, which is in 90% 
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of all CF patients already present at birth [Herfindal et al., 1988; Aitken and Fail, 
1993; Hamer and Parker, 1996]. Pancreatic enzymes, such as Creon® (pancreatine) 
and Pancrease® (pancrelipasum), have to be taken with every meal and snack. 
   Sugar-rich in-between-meal snacks and drinks are necessary for the CF patient to 
gain bodyweight and body-energy. Most patients require supplemental vitamins 
(A-D-E) as fat malabsorption impaires their uptake via diet. Supplemental vitamin 
K is only required in cases where, secondary to the disease, liverpathology has 
developed and blood coagulation is impaired [Sokol et al., 1991; Vay Liang et al., 
1993; Durie, 1994 ; Beker et al., 1997]. 
      A social aspect of CF is that in most male CF patients the reproductive system 
is involved, frequently resulting in sterility, caused by congenital agenesis of the 
vas deferens. In CF females there is mainly a decrease in fertility [Harris et al., 
1991; Johannesson et al., 1997]. The latter could be interpreted as a disease-self-
limiting action by nature itself, in order to prevent spreading. Nevertheless, 
conception can always take place with or without help from modern current in vitro 
fertilisation techniques. 
 
2.2.3. Salivary glands and CF 
   Under healthy conditions, whole human saliva is a mixture of glandular saliva of 
3 pair of large glands (Glandula Submandibularis, Glandula Sublingualis and 
Glandula Parotis), several minor salivary glands on the palate, the cheeks and the 
mucosal side of the lips, crevicular fluid and a mixture of naso-oro-pharyngeal 
secretions. In case of CF, all exocrine glands are affected by the CFTR gene and 
inevitably the salivary glands are also involved. The glandula sublingualis, which 
is a pure mucous secreting salivary gland, is slightly enlarged under CF conditions. 
The glandula submandibularis (sero-mucous gland) and the glandula parotis (pure 
serous gland) are not affected by the disease. Under CF conditions, the salivary  
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Table 2.1. : Currently used medication (in alphabetical order) for airway  
                    obstructions (syrups and aerosols) in cystic fibrosis therapy [ Source: 
                    Compendium 2001 edited by the Associated Pharmaceutical Industry 
                    of Belgium] 
Trade name Type of medication/ indication  Oral side effects 
Atrovent®  anticholinergicum   dry mouth and rasping voice 
Bricanyl®  anti adrenergicum   pH = 3.5  , dry mouth 
Bromex®  mucolyticum   ! syrup without sugar ! 
Clarinase®  antihistaminicum   dry mouth 
Claritine®  antihistaminicum   dry mouth 
Duovent®  anticholinergicum   dry mouth 
Flixotide®   inhalation glucocorticoid  rasping voice + candidosis risk 
Lomudal®  antihistaminicum   dry mouth 
Lysomucil® mucolyticum / expectorantium  ? 
Lysox®   mucolyticum / expectorantium  ? 
Mistabron® mucolyticum / expectorantium  ? 
Mucomyst® mucolyticum / expectorantium  ? 
Mucosteine® mucolyticum / expectorantium  ? 
Oxivent®  anticholinergicum   syrup with sugar! dry mouth 
Pulmicort® anti allergicum   rasping voice and candidosis risk 
Pulmoclase® mucolyticum   syrup with sugar! 
Pulmozyme® mucolyticum   laryngitis 
Rhinathiol® antitussivum   syrup with sugar! pH =5 
Rhinofebryl® antihistaminicum   dry mouth 
Serevent®  beta-2-sympaticomimeticum  stimulation of viscous saliva 
Zaditen®  bronchodilatation   dry mouth 
 
 
consistency becomes more mucous as the percentage of mucous saliva will be 
higher than under healthy conditions. The composition (both organic and 
inorganic) of the CF patients’saliva is also reported  to be different than under 
normal conditions, but no clear data are known [Martinez, 1982; Kinirons, 1983; 
Van Nieuw Amerongen, 1988a,b,c; Fernald et al., 1990]. Most reports seem to be 
based on clinical observations and as a consequence should be interpreted with 
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care. CF patient’s saliva is claimed to have a higher buffer capacity and a higher 
calcium concentration than that of controls subjects. CF patients would 
consequently suffer more from calcium plugs resulting in obstructions of the 
salivary ducts. The increased salivary buffer capacity in combination with the 
higher salivary calcium concentration would make them more prone for developing 
calculus [Kinirons, 1983; Van Nieuw Amerongen, 1988a,b]. More recently, a study 
investigated salivary sodium and chlorine concentrations in CF children (n = 9, 
mean age 12 3.6 years) [Jiménez-Reyes and Sanchez-Aguirre, 1996] and claimed 
that they had significantly higher salivary sodium concentrations than healthy 
controls. They suggested that saliva could be useful in the confirmation of the CF 
diagnosis. In the mean time, since 1996, no further experiments with CF saliva as 
diagnostic tool have been published. Probably, because their findings were 
coincidental and only based on nine subjects with CF. Nevertheless, studies like 
these are necessary to gather more information on the phenotypic features of CF. 
They can be the basis for a new more profound study or for a diagnostic technique, 
which does not require invasive methods.  
 
2.2.4. Cystic fibrosis and oral health  
   As mentioned in chapter 1, little is known about the impact of disease on oral 
health in many medically compromised patient groups. Nevertheless, it is obvious 
that due to the better medical care and medical knowledge about these conditions, 
patients are surviving longer and are confronted with “new” aspects of their 
disease. The increased use of aerosols with mucolytica and expectorantia, the 
increased use of specific antibiotics, administered at the right moment and the 
correct use of dietary supplements and pancreas enzymes have made it possible for 
CF patients to survive into their twenties and thirties and some even longer 
[Mulherin et al., 1991; Webb, 1991; FitzSimmons, 1993; Vay Liang et al., 1993; 
Brewis et al., 1995; Hamer and Parker, 1996].  
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   Unfortunately, the effect of aerosols on teeth (see chapter 2, 1. Asthma) is being 
discussed in the literature and it is being considered as a potential high caries risk 
factor [Kargül et al., 1998; Kankaala et al., 1998; Mc Derra et al., 1998; Dahllöf 
and Martens, 2001]. The acidity of the aerosols in combination with the carrier 
(lactose or another sugar) could play an important role in the development of 
caries. On the other hand the inherent effect of this medication, a decreased 
salivary flow, should also be emphasized. Especially when the aerosols are used 
after toothbrushing before going to bed. No data are known for CF patients, but it 
can be assumed that only little difference in effect of this medication will exist 
between asthma and CF patients. Medication without sugar should be promoted in 
medicine in order to decrease the potential caries risk of medication (not only 
aerosols) intake. 
   The increased use of antibiotics over the past twenty years has indeed improved 
the general public’s health. But as every medal has two sides, the widespread use 
of antibiotics since the 1960s also caused a parallel increase in resistant 
microorganisms. Clinical resistance to penicillin was already reported in 1965 in 
Boston, USA. In 1967 the same phenomenon was reported in Australia and ten 
years later in Africa [Bellon and Gilly, 1990; Foucaud et al., 1990; Appelbaum, 
1992; Pascal et al., 1992; Hamer and Parker, 1996]. Factors influencing this 
emergence of resistance include indiscriminate use of antibiotics, prolonged 
hospitalizations, increasing numbers of immunocompromised patients and medical 
progress resulting in increased use of invasive procedures and devices. Resistance 
can be both obtained direct as well as indirect. “Direct” can be defined as 
resistance that is being developed to the agent that is used in the antimicrobial 
therapy, while “indirect” can be defined as resistance being developed through 
selection of resistant micro-organisms due to an antibiotic treatment or when the 
environment is “contaminated” with antibiotics (hospital), or via antibacterial 
agents in agriculture (food) and animal husbandry [Rubinstein, 1999]. The three 
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most common respiratory tract pathogens, Streptococcus pneumoniae, 
Haemophilus influenzae and Moraxella cattarrhalis, all exhibit high-level 
resistance to one or a number of agents, including penicillin, ampicillin, 
erythromycin, tetracyclin and first-generation cephalosporins. Pseudomonas 
aeruginosa and other gram negative bacilli have become increasingly resistant to 
beta-lactam antibiotics, including imipenem, as well as to fluoroquinolone  
[Chenoweth and Lynch, 1997; Jones, 1999]. Multidrug resistance, defined as lack 
of susceptibility to penicillin and at least two other non-ss-lactam classes of 
antimicrobial drugs, is observed with increasing prevalence in countries all over the 
world [Appelbaum, 1992; Levy, 1992; Kunin, 1993; Magee et al., 1999; Amyes, 
2000].   
   Dental literature reports that CF patients would gain profit from this abundant use 
of antibiotics, as it is not imaginary to assume that oral cariogenic microorganisms, 
such as Mutans streptococci and Lactobacilli, may virtually disappear from the oral 
cavity, resulting in less dental decay.  This theory was supported in the 1980s by 
Kinirons in his studies on the oral health of children with CF, in which he 
discussed the significant lower caries prevalence in CF patients than in healthy 
controls [Kinirons, 1983; Kinirons, 1985; Kinirons, 1989; Fernald et al., 1990].   
   On the other hand, it should be emphasized that, as mentioned above, when 
resistant oral cariogenic micro-organisms would develop, antibiotics would have an 
opposite effect and caries would still develop. It is clear that no straight answers 
can be provided, as no studies are available on oral cariogenic micro flora being 
affected by oral systemic antibiotics taken on a long term basis. 
   Recently in 1995, a case-report appeared on 3 adolescent CF homozygote males 
with a mean DMF-S of 28. The expected low caries incidence was clearly not 
always the case and this case report supported the hypothesis that CF patients may 
in time develop a kind of resistant oral microflora, which still can be as cariogenic 
as the original [Martens and Robberecht, 1995]. Similar findings in 60 children, 
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over 3 years old, with CF, attending a CF care centre in Manchester (UK) were 
reported to have a high caries experience [Clarkson and Sood, 1996].  
   The diet of a CF patient is focussed on the gaining of body energy from sucrose 
rich components, which are to be consumed in-between-meals (drinks and snacks) 
[Webb, 1991; Vay Liang et al., 1993; Bentur et al., 1996; Marelich and Cross, 
1996, Najera-Perez et al., 1997]. This implies that their frequency of eating is 
considerably high, which is commonly accepted in dentistry as a “high caries risk 
profile”. The number of sugar-rich-in-between-meal-snacks and drinks are 
modifying for the rate at which dental plaque and consequently caries will develop 
[Beck et al., 1988; Hunter, 1988; Mundorff-Shrestha et al., 1994; Van Loveren and 
van der Weijden, 1996a,b; Palenstein-Helderman et al., 1996; Jensen, 1999]. 
Consequently, CF patients potentially run a high caries risk. On the other hand, CF 
patients are also obliged to have extra pancreas supplements with every meal and 
snack, in order to be able to digest dietary fats. Many children with CF report to 
open the enzyme capsules and to mix the content in a yogurt drink, instead of 
swallowing the “large” capsules. The influence of these pancreas enzymes on the 
oral environment is not known. It may be possible that pancreas enzymes eliminate 
a large proportion of the oral micro-organisms, resulting in a lower caries 
experience among CF children [Van Nieuw Amerongen, 1988c]. Once the habit of 
opening the capsules (which is practised by most of the CF children) is left behind, 
the pancreas enzymes do not come into contact with the oral cavity any longer and 
caries experience may still increase. The latter could also explain the high caries 
incidence in the three adolescent CF patients reported by Martens and Robberecht 
in 1995. 
   From the above it can be concluded that CF patients may have a higher caries 
risk potential, than earlier described in the 1980s. Consequently there is a need for 
a thorough investigation on this issue. 
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2.2.5. Pilot study 
   In order to find out if oral health was really at risk in cystic fibrosis patients, a 
case-control pilot study was carried out. 
 
2.2.5.1. Material and methods 
   A sample of 37 CF patients and a similar number of age matched control subjects 
was selected. Control subjects were selected from the same street, community or 
school as the CF patients. In this way, socio-economic and demographic factors 
were matched. All CF patients were sampled from the Belgian Association for the 
Fight against CF (BAFCF). After mailing twice all CF patients associated with the 
BAFCF, 5% replied to be interested in participating in this project. The mean age 
of both groups was 16.3 +/- 8.3 years old.  The sample was devided into three age 
categories (AC): six to twelve year olds (AC-1) representing the primary school 
age children (15 pairs), thirteen to eighteen year olds (AC-2) representing the 
secondary school age adolescents (9 pairs) and the older than nineteen year olds 
(AC-3) representing the adult population (13 pairs). After a signed consent, all 
subjects were examined by the same trained paediatric dentist, using standardized 
and widely accepted criteria as recommended by the WHO report on oral health 
surveys [WHO, 1987] and based on the diagnostic criteria for caries prevalence 
surveys published by the Bristish Association for the Study of Community 
Dentistry, BASCD [Pitts et al., 1997]. The investigator (J.A.) was specifically 
trained at baseline and participated in an in vitro and a clinical calibration exercise 
according to the guidelines on training and calibration published by the BASCD        
[Pine et al., 1997].  
   All subjects were examined under the same conditions either at their homes or at 
the dental out-patient clinic. Teeth were scored using a WHO/CPITN type E probe, 
a white light source, cotton rolls and a dental mirror. Decay was recorded at the 
level of cavitation and the caries experience was expressed by means of the DMF-
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T and DMF-S index. The dental care index was expressed as F/D+F (T) and (S). 
Dental plaque was recorded when visible. This was recorded for every tooth and 
every surface. Bleeding of the gingiva was recorded when present on gentle 
probing. This was recorded for every tooth and every tooth surface. All data were 
immediately stored in a database on a Compac® Armada 1700 computer. The data 
entry program was prepared by the department of medical informatics and 
statistics. Appropriate statistical analyses (Wilcoxon matched-pairs signed ranks 
test and Kruskal-Wallis test) were performed and the level of significance was 
chosen at  = 0.05. The study was approved by the ethical committee of the 
Faculty of Medicine of the University of Ghent. 
 
2.2.5.2. Results 
   The investigator’s overall kappa values for both the in vitro and the clinical 
calibration exercise were respectively 0.84 and 0.76, both standing for an 
acceptable interreliability with an experienced examiner (L.M.) as benchmark 
[Bolin et al., 1995].  
   Thirty five percent of the CF patients (n = 13) had no caries experience (DMF = 
0) versus 21.6 % for controls (n = 8). This difference was not significant between 
both groups. From Table 2.2. it can be seen that there was no significant difference 
nor for caries experience (Fig. 2.3.), neither for the dental care index between both 
samples (Fig. 2.4.).  
   In Table 2.3. the mean values of the separate DMF factors for each AC are 
presented. Statistical analysis (Kruskal-Wallis test) of the separate mean DMF- 
factors between the 3 AC in each sample was conducted.  
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Table 2.2. : Caries Experience ( DMF-T and DMF-S ) and the Dental Care Index  
                ( F/D+F (T) and F/D+F (S) ) in Cystic Fibrosis patients versus Controls. 
                ( Wilcoxon matched-pairs signed ranks test ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
   For the CF group (Fig. 2.5.) a significant increase was found for mean DMF-T (P 
= 0.001) with increasing age. The mean  DMF-S was significantly lower in AC2 
than in both other AC (P = 0.004). The factor filled, was significantly different 
between the 3 age categories, both on tooth (P < 0.001) and on surface level (P = 
0.002) and increased also with ageing. The separate factors decay and missed 
between the age categories were not significantly different in the CF sample.  
   In the control sample (Fig. 2.6.), caries experience (DMF), both on tooth (P < 
0.001) and surface level (P < 0.001) also increased significantly with age. These 
significant differences were confirmed for the separate parameters M and F, as well 
on tooth level (P = 0.024  and    P < 0.001 respectively) as on surface level (P = 
0.024 and P < 0.001 respectively). Factor D, however, was significantly lower in 
AC2 than in both other AC, both on tooth level  (P = 0.031) and on surface level (P 
 
Index    Cystic Fibrosis  Control   P-value 
DMF-T  4.35 (5.57)  4.95 (5.04)  0.648 
D-T  0.32 (0.82)  0.54 (1.17)  0.375 
M-T  0.30 (0.94)  0.57 (1.37)  0.231 
F-T  3.78 (4.84)  3.95 (3.96)  0.905 
 
DMF-S  10.14 (16.96)  13.00 (17.42)  0.291 
D-S  0.43 (1.09)  1.30 (4.65)  0.303 
M-S  1.49 (4.69)  2.84 (6.83)  0.231 
F-S  8.22 (13.17)  8.86 (10.51)  0.583 
 
F/D+F (T) 0.85 (0.31)  0.86 (0.27)  0.139 
F/D+F (S)  0.86 (0.29)  0.87 (0.28)  0.169 
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= 0.030). With respect to the dental care index (Fig. 2) on tooth level, a significant 
difference was found with increasing age (P = 0.036) in the CF sample. 
 
Figure 2.3. : Caries index of the cystic fibrosis group (CF,n=37) versus the Control 
                      group (C,n=37) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   On surface level, this difference was  not significant (P = 0.055). This was not 
found for the control group. There was no significant difference between CF 
patients and controls for the number of teeth covered with dental plaque. The same 
was found, comparing the age categories in both groups. On average, CF patients 
have less gingival bleeding than controls; this was, however, not significant 
different (P = 0.067).  
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Figure 2.4. : Dental care index per age category (AC: AC1<13y, AC2 = 13-18y 
                      and AC3>18y) for the Cystic Fibrosis group (CF,n=37) and the 
                     Control group (C,n=37) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3. : Caries Experience (DMF-T and DMF-S) and Dental Care Index 
                    (F/D+F (T) and  F/D+F (S)) for each age category (AC : AC1 <13 y,  
                     13y  AC218y,   AC3 >18y) in the cystic fibrosis (CF-) and 
                    control (C -) group. (Wilcoxon matched-pairs signed ranks test) 
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  Figure 2.5. : Caries index (DMF-T/-S) for the Cystic Fibrosis group (CF,n=37) as  
                        a function of age category (AC: AC1<13y, AC2 = 13-18y and  
                        AC3>18y) 
 
 
 
 
 
Figure 2.6. : Caries index (DMF-T/-S) for the Control group (C,n=37) as a 
function of age  
                      category (AC: AC1<13y, AC2 = 13-18y and AC3>18y) 
 
 
 
 
 
  CF C P CF C P CF C P 
  AC1 AC1 value AC2 AC2 value AC3 AC3 value 
  N=15 N=15  N=9 N=9  N=13 N=13
 ------------------------------------------------------------------------------------------------------------------ 
DMF-T     1.80 1.53 0.928 2.22 3.56 0.309 8.77 9.85 0.753 
D-T  0.47 0.40 0.861 0.22 0.00 0.317 0.23 1.08 0.107 
M-T  0.13 0.00 0.655 0.11 0.22 0.655 0.62 1.38 0.155 
F-T  1.20 1.07 1.000 1.89 3.33 0.263 8.08 7.69 0.834 
 
DMF-S      3.87 3.33 0.694 3.78 6.44 0.312 21.77 28.69 0.388 
D-S            0.53 0.47 0.730 0.22 0.00 0.317 0.46 3.15 0.085 
M-S          0.67 0.33 0.655 0.56 1.11 0.655 3.08 6.92 0.155 
F-S  2.67 2.53 0.721 3.00 5.33 0.156 18.23 18.62 0.780 
 
F/D+F(T)  0.57 0.72  0.180 0.89 1.00 0.317 0.98 0.88 0.128 
F/D+F(S)         0.60 0.74  0.180 0.92 1.00 0.317 0.97 0.87 0.176 
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Figure 2.6. : Caries index (DMF-T/-S) for the Control group (C,n=37) as a 
                      function of age category (AC: AC1<13y, AC2 = 13-18y and  
                     AC3 > 18y) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.5.3. Discussion 
   This study shows that there are no statistical significant differences in caries 
experience between CF patients and age matched healthy controls, which is in 
contradiction with earlier findings [Kinirons, 1983; Kinirons, 1985; Van Nieuw 
Amerongen, 1988b; Kinirons, 1989; Fernald et al., 1990]. On the other hand it has 
to be stressed that the mean age of the total sample in the present study was 16.3 
+/- 8.3 years old, which is older compared to earlier studies. 
   Nevertheless, in the present AC1, being an age category comparable to these 
earlier studies, no significant difference was found regarding any parameter of the 
caries index.  
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   Due to the better medical care and better knowledge, CF patients are now able to 
survive into their thirties and even older, dependent of the phenotypic expression of 
their genetic mutation [Hughes and Griffith, 1984; Mulherin et al., 1991; Webb, 
1991; FitzSimmons, 1993; Hodson, 1993; Brewis et al., 1995; Hamer and Parker, 
1996]. As epidemiological data on oral health in CF adolescents and adults are 
lacking, the present report is the first of its kind. By dividing the samples in 3 age 
categories, we were able to compare CF patients from childhood, through 
adolescence into adulthood.  As no significant differences were found in caries 
experience between CF patients and controls and regarding the presence of 
potential caries risk factors, three hypotheses can be postulated. 
 
(i) As there are probably geographical differences, the earlier findings by 
Kinirons [Kinirons, 1983; Kinirons, 1985, Kinirons, 1989] are specifically 
representable for CF patients in Northern Ireland. Other environmental 
influences such as: drinking water fluoridation, social economical status 
differences and the availability of community dentistry centres where 
children are seen on a regular basis from age zero, will contribute to 
regional differences.  
(ii) As the reported DMF-T indices in young and adolescents subjects (Fig. 
2.4.) perfectly fit within the WHO objectives for the year 2000 [Nithila et 
al., 1998], it is possible that as a consequence of a broader use of 
antibiotics and aerosols, the “healthy” control subjects have become more 
similar to the CF population. The latter can explain why in none of the age 
categories significant differences in caries experience were found.   
(iii) A third hypothesis could be that medicine in a particular era plays an 
important role. In the nineteen eighties, the medical care for CF patients 
was different from today’s [Herfindal et al., 1988; Bellon and Gilly, 1990; 
Foucaud et al., 1990; Pascal et al., 1992;  Brewis et al., 1995; Hamer and 
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Parker, 1996; Marks and Kissner, 1997]. Due to this better medical 
attention and the individualized medication programmes, it could be 
assumed that CF patients also obtained better oral health than 20 years ago 
and subsequently became in a way more “similar” to control subjects. 
    
   When going into more detail, it is remarkable that the number of caries 
experience free individuals is not significant different between both groups. This 
means that CF patients do not seem to run a higher caries risk than controls. 
Neither of the age categories is significant different between CF patients and 
controls. This contradicts clearly earlier findings [Kinirons, 1983, Kinirons, 1985, 
Kinirons, 1989, Fernald et al., 1990]. The mean age of the caries experience free 
CF patients was 11.6 years old and for the controls 13.4 years old, which wasn’t 
significant different either.  
   DMF-T increased significantly with ageing in the CF sample. The same holds for 
the control group’s DMF-T and DMF-S. In the CF sample, DMF-S in AC2 was 
lower than in AC1 and AC3. This is due to the fact that in the CF group, factor 
“decay” and “missed” are lower in AC2 than in both other age categories, although 
not significantly different. Only the number of restored teeth and surfaces increased 
significantly with age. This implies that not only the number of restorations 
increase with age, but also the dimension of the restorations. This confirms the 
more recent findings [Martens and Robberecht, 1995] reporting a higher caries 
prevalence in 3 CF adolescents, with a mean DMF-S of 29. It was suggested that 
CF patients might have a lower caries experience at young age, but that the 
incidence of caries increased during ageing, due to intrinsic factors of the disease.  
   In the control sample both factors “missed and filled” increased significantly with 
ageing, while factor “decay” was significantly the lowest in AC2.  Actually no 
decay was present in AC2. This can probably be explained by the fact that the 
healthy controls at the time of examination all had a permanent dentition, which 
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had just erupted, or were in the middle of exfoliation of the deciduous canines and 
molars. The opportunity for caries to be present in this transitional period is rather 
low.   
   The dental care index, expressed as F/D+F (T) and (S), wasn’t significantly 
different between both samples. This means that both groups are equally “well 
cared for” dentally.  The dental care index in controls did not increase significantly 
with ageing, nor on tooth level, nor on surface level. In CF patients, dental care 
index increased significantly on tooth level, and only borderline not significantly 
on surface level. This means that control subjects seem to attend to dental visits at 
an earlier age than CF patients. This implies that controls in a certain way, maintain 
a “constant” dental care index, while in CF patients, dental visits are probably 
postponed as their parents are confronted with other “important aspects of their 
children’s health”. Dental care would probably be the last of their worries, as this is 
not considered as life-threatening. It is comprehensible that once CF patients 
survived their teenage years, their parents are less reluctant to attend to dental 
visits. Orthodontic problems could also be one of the main reasons why CF parents 
would suddenly submit their CF child to dental care, consequently resulting into 
better conservative and preventive dental care. 
   It remains however remarkable that although they seem to attend to dental visits 
later in life, they do not have a significant higher caries experience than controls. 
This supports the hypothesis [Kinirons, 1983; Kinirons, 1985; Kinirons, 1989] that 
CF patients are in a way protected, although they have frequent antibiotic (sugar-
containing) syrups, daily aerosols with mucolytica and expectorantia, an increased 
salivary viscosity and frequent in between-meal-snacks. All the latter are well 
known as caries risk factors, which should render CF patients more susceptible to 
dental decay. Probably there are intrinsic factors of the CF disease, which protect 
CF patients. As frequent antibiotics cause resistant micro-organisms, the earlier 
proposed hypothesis [Kinirons, 1985], that CF patients are protected by their 
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antibiotic treatments, should be disproved. Aerosols dry out the oral cavity and 
mostly have an acidic pH. This also bears a potential caries risk, which is recently 
shown in asthmatic patients [Kargül et al., 1998; Kankaala et al., 1998]. CF 
patients have to use this type of medication sometimes several times a day [Bellon 
and Gilly, 1990; Foucaud et al., 1990; Pascal et al., 1990; Brewis et al., 1995; 
Hamer and Parker, 1996; Marks and Kissner, 1997]. CF patients also need to have 
several in-between-meal-snacks, in order to provide them of the necessary body-
energy [Hughes and Griffith, 1984; Tsui, 1991; Grundy et al., 1993 ; Vay Liang et 
al., 1993; Bentur et al., 1996]. These are mainly sugar-rich snacks and drinks, as 
they are unable to digest fats. In combination with every meal or snack, CF patients 
also need to take additional pancreas enzymes. Sometimes as much as 80 capsules 
a day! Most of the small children reported to open the capsules and mix the content 
with a yoghurt or other drink. The effect of the enzymes in the oral cavity on the 
oral bacterial flora is not known. Once they get older, after the age of 11 or 12, 
most of them report to be able to swallow the large capsules. Opening the capsules 
probably destroys micro-organisms, and consequently bears a protective aspect 
with regard to dental decay.  
   With regard to the oral cleanliness, it is expected that brushing habits are 
disorganized, especially in the morning, as mucus is blocking their airways and 
gagflexes are stimulated. Similarly, during hospitalized antibiotic treatments and 
periods of severe health problems, oral cleanlines can also be expected to be 
impaired. No differences were found, however, between CF patients and controls 
for the amount of plaque. There wasn’t a significant difference between the age 
categories in both samples. CF patients had less, although not statistically 
significant for AC1 and AC2, gingival bleeding sites than controls. This could 
mean, in contrast to the above mentioned suggestion, that CF adults brush more 
carefully than healthy adults which is probably related to the fact that they are more 
conscious of their health and hygiene than controls or that that other intrinsic 
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protective mechanisms are involved . The fact that they survived into their twenties 
is probably for most CF patients an extra motivation to take good care of their 
health, as they are well aware of the potential lethal risks they run when 
encountering a bacterial infection.  
 
2.2.5.4. Conclusion 
   There are no significant differences in caries experience, dental care index and 
dental plaque between CF patients and healthy control subjects. CF adults have 
significantly less gingival bleeding sites than adult healthy controls. As a result of 
these findings, former literature [Kinirons, 1983; Kinirons, 1985; Kinirons, 1989; 
Fernald et al., 1990] on oral health and CF is contradicted and more recent 
suggestions [Martens and Robberecht, 1995; Clarkson and Sood, 1996] are 
confirmed. It is clear that still more refined analyses are necessary in order to 
declare the phenomenon of having a medically compromised group which is 
intrinsically at risk for caries development and which experiences no more caries 
than healthy controls. For this a large, perhaps multicentre study in depth regarding 
oral hygiene, dietary habits, salivary properties, medication intake etc. should be 
planned.   
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Chapter 3 
 
Aims of the study 
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3.1. Introduction 
   Up to now, no oro-dental data whatsoever were available on CF patients in 
Belgium. Moreover, within the international literature only data about North Irish 
children were reported. As a consequence a need was felt to investigate differences 
in oral health between CF patients, CF heterozygotes and healthy controls in 
Belgium and to define the determinants of oral health within the three groups.  
   As CF heterozygotes can now be distuinguished from the general population 
through genetic testing, they should be considered as a separate group and as a 
consequence they would not be mingled with control subjects as was inevitably 
done in the past.  
   The null hypothesis of this study is that CF patients are potentially at risk for 
oral health and that saliva can be used for its determination. 
 
3.2. Caries experience and oral cleanliness 
   As only data on caries experience in CF children were available in the literature 
[Kinirons, 1983; Kinirons 1985; Kinirons, 1989] a need was felt to examine 
Belgian CF children, as well as adolescents and adults. Both the latter groups were 
now “available”, compared to the 1980s when not that many CF children survived 
their teenage years.   
   Caries experience (figure 3.1.) is a valuable parameter for oral health as it reflects 
different factors which are of influence; oral hygiene habits, dietary habits, 
environmental factors, bacterial constitution of the oral cavity and host factors. The 
impact of every factor is, however, inter-individually different. Caries experience 
also provides a view into the past, already explained in chapter 1, while oral 
cleanliness on the other hand, another valuable parameter for oral health, being 
defined as presence or absence of plaque, calculus and gingival bleeding, are 
“actual” facts, tells something about the present attitudes of a subject.  
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Figure 3.1. : An updated scheme of the confounding factors which influence the 
                     development  of dental decay [Source : Van Loveren C. and Van der  
                     Weijden GA. Preventieve tandheelkunde ; op weg naar een  
                     doelmatige aanpak. 1996a,b] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3. Oral micro-organisms 
   Mutans streptococci and Lactobacillus are both oral micro-organisms, which 
belong to the commensal oral flora, but which are considered in the literature 
[Larmas, 1985; Loesche, 1986; De Soet et al., 1989; Van Houte, 1993; Van Houte, 
1994; Kohler et al., 1995; Loesche et al., 1995; Roeters et al., 1995] as indicative 
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for caries experience, if present in large amounts ( 10
5
 CFU/ml). Both micro-
organisms can be cultivated in laboratory environment on agar plates, but 
commercial, well described in literature, chair-side-tests are also available 
(Vivadent, CRT
® 
Bacteria and CRT
®
 Buffer) nowadays [Rogosa et al, 1951; 
Larmas, 1975; Kneist and Heinrich-Weltzien, 1997; Kneist et al., 1999a,b; Twetman 
et al., 1999]. Mutans streptococci are considered as the “initial” colonizers in caries 
active individuals, as they generally consume lots of sugars, while Lactobacilli are 
known to colonize the oral cavity at a later stage, when cavitation is present. 
Lactobacilli  apparently prefer niches to hide in and as a consequence, poorly 
fitting dental restorations can also be the reason for them to flourish [Marsh and 
Martin, 1999a,b]. 
   CF patients obligatory consume lots of sugar rich in-between-meal snacks and 
drinks, which could result in a high Mutans streptococci count, therefore an 
investigation to study the  differences in bacterial counts (Mutans streptococci and 
Lactobacilli) between CF homozygotes, CF heterzygotes and healthy controls was 
considered important and opportune. 
 
3.4. Medication influence 
   Certain types of medication are known to influence salivary composition and 
properties [Van Nieuw Amerongen, 1988c]. CF patients take expectorantia, 
mucolytica, antibiotics and pancreas enzymes on a daily basis (per os, I.V. and 
aerosol). The effect of the daily medication of CF patients, however, on their oro-
dental habitat is not known. Therefore a study was needed to investigate the effect 
on caries experience of opening the capsules with pancreas enzymes, while the 
effects of the different aerosol medications and antibiotics in CF therapy had to be 
investigated with oral cleanliness and caries experience as response variables 
within the CF patients in this study. 
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3.5. Dietary habits 
   Dietary habits can also provide a window at an individual’s caries experience and 
oral cleanliness, as it is well illustrated in literature that sugar rich foods and drinks 
can be responsible for large amounts of plaque and consequently for caries 
[Grindefjord et al., 1993; Holbrook et al., 1993; Leverett et al., 1993; Verrips et al., 
1993; Grindefjord et al., 1995; Grindefjord et al., 1996; Van Loveren and Van der 
Weijden, 1996b; Palenstein-Helderman et al., 1996; Al Ghanim et al., 1998].     
   Dietary habits in case of CF patients is even more interesting to investigate as CF 
patients obligatory consume many sugar rich in-between-meals and drinks. The 
latter implies that theoretically CF homozygotes potentially run a high caries risk. 
All the more, because literature on CF patients [Kinirons, 1983; Kinirons, 1985; 
Kinirons, 1989] claimed that CF children had significantly less caries experience 
than others, while they behaved like a group at high risk to develop caries, the 
study had to involve an investigation on the impact of this  determinant of oral 
health in the three groups. Differences in dietary habits could provide an 
explanation for possible differences in oral health. 
 
3.6.  Oral hygiene habits  
   A subject’s oral hygiene habits can determine in great extent that same 
individual’s oral cleanliness and caries experience [Van Loveren and Van der 
Weijden, 1996a; Vanobbergen et al., 2001b; Vanobbergen, 2001].  
   Therefore an investigation on the differences in oral hygiene habits, which could 
be held responsible for differences in oral cleanliness or caries experience between 
the three groups and within the groups was needed. It should however, be 
emphasized that oral hygiene habits can have changed in time. This implies that 
current oral hygiene habits will mainly reflect current oral health and oral 
cleanliness in particular, and to a lesser extent past caries experience. As a 
consequence, it can be expected that oral hygiene habits will correlate more with 
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presence or absence of plaque, calculus and gingival bleeding, than with          
DMF-T/-S. 
 
3.7. Salivary electrolytes 
   Calcium, bicarbonate, phosphate and sodium play an important role in re-and 
demineralization of dental enamel [Driessens and Verbeeck, 1990].  In the line of 
factors that determine oral health, salivary electrolytes should not be forgotten, 
although little cause-result evidence has been found between dental caries and 
salivary ions [Van Nieuw Amerongen, 1988a]. However, as CF is a disease 
characterized by a malfunction in sodium and chlorine exchange through cell 
membranes of exocrine glands, salivary electrolytes could play an important role in 
the expression of the different phenotypes of CF and in the prevalence of dental 
decay in this group of medically compromised [Van Nieuw Amerongen, 1988b]. 
Secondly, it is interesting to investigate whether differences in salivary electrolyte 
concentrations exist between CF heterozygotes and healthy controls. Perhaps CF 
heterozygotes can be identified through salivary electrolyte alterations.  
 
3.8. Salivary proteins 
   The altered salivary visco-elastic properties of patients with CF is caused by the 
increased proportion of saliva (viscous) excreted by the Glandula sublingualis; 
mucins (acidic) and other proteins, binding water molecules, can partly be held 
responsible. Total salivary protein concentration is reported to be twofold in CF 
homozygotes [Van Nieuw Amerongen, 1988a,b]. However, nothing is known about 
CF heterozygotes. Consequently, it can be of importance to determine differences 
in salivary protein composition and total salivary protein concentration between CF 
homozygotes, CF heterozygotes and healthy controls.  
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3.10. Aims of the study 
   According to the null hypothesis, which states that CF homozygotes are at risk 
for oral health, and that saliva can be used for its determination, the following aims 
of the study can be postulated ; 
 
1. Determination of the caries experience and oral cleanliness of CF 
homozygotes, CF heterozygotes and healthy controls. 
 
2. Quantification of the oral bacterial flora with respect to caries in CF 
homozygotes, CF heterozygotes and healthy control subjects. 
 
3. Assessment of the impact of medication, dietary habits and influence of oral 
hygiene habits on oral health in CF homozygotes, CF heterozygotes and 
control subjects. 
 
4. Evaluation of salivary electrolyte concentration differences and differences in 
salivary proteins among CF homozygotes and between CF homozygotes, CF 
heterozygotes and healthy individuals. 
 
 5. Assessing the posibility to use human saliva as a diagnostic tool for the 
determination of oral health. 
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Chapter 4 
 
Material and methods 
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4.1. Patient selection    
   CF patients and CF heterozygotes were selected via the Belgian Association for 
the Fight against Mucoviscidosis. From a mailing (anno 1998) to about 700 CF 
families, 7% replied to be interested to participate in this study. According to the 
mailing replies, the main reason for not willing to participate was the appropriate 
fear to get infected with Pseudomonas. The second most common excuse was 
“distance”, although it was suggested that investigations could be carried out at 
home if required. Finally, in 1999, visits were started, with three CF patients less 
than planned. Unfortunately, in the mean time, three people with CF had died from 
the disease. A total of 50 CF homozygotes were seen, either at their homes or in the 
dental out-patient clinic at the Ghent University Hospital. A drop out of 8 patients 
was observed due to insufficient volume of saliva sample or due to patient’s 
moving, resulting in a full documented study group of 42 CF homozygotes. Their 
mean age was 16.2 8.1 years. 
       A total of 48 CF heterozygotes were involved in the study. CF heterozygotes, 
were  defined as individuals which were genetically proven to be CF heterozygous 
for the CFTR gene, Consequently, they were all related to the CF homozygotes in 
this study and as this group consisted of parents, brothers and sisters of CF 
homozygotes, their mean age was considerably higher; 29.5 15.9 years.  
   Healthy individuals (n = 62), being people without cardiovascular, genito-
urinary, endocrine, hematological or infectious diseases, were recruited either from 
the CF homozygotes environment (e.g. school, street or village) or from the Ghent 
University Hospital dental out-patient clinic. The mean age of the control group 
was 19.9 11.5 years old.  
   Prior to participation, all participants signed an informed consent and the study 
was approved (20/03/1997, number 97/71) by the Ghent University Hospital’s 
ethical committee.    The study was financially supported by the Fund for Scientific 
Research Flanders (FWO grant: 3.0014.98).  
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4.2. Caries experience and oral cleanliness  
4.2.1. Caries experience 
   All subjects were examined by the same trained paediatric dentist (J.A.), using 
standardized and widely accepted criteria as recommended by the WHO report on 
oral health surveys [WHO, 1987 and WHO, 1997] and based on the diagnostic 
criteria for caries prevalence surveys published by the Bristish Association for the 
Study of Community Dentistry, BASCD [Pitts et al., 1997]. The investigator (J.A.) 
was specifically trained at baseline and participated both in an in vitro and in a 
clinical calibration exercise according to the guidelines on training and calibration 
published by the BASCD [Pine et al., 1997]. The investigator’s overall kappa 
scores for the in vitro and in vivo calibration exercise were respectively 0.84 and 
0.76. Both figures stand for an acceptable interreliability with an experienced 
examiner (L.M.) as benchmark [Bolin et al., 1995]. All subjects were examined 
under the same conditions either at their homes or at the Ghent University dental 
out-patient clinic. The home visits were necessary, as most CF patients were 
appropriately afraid to get infected with Pseudomonas aeruginosa. Teeth were 
scored using a WHO/CPITN type E probe, a white light source, cotton rolls and a 
dental mirror. Decay was recorded at the level of cavitation and the caries 
experience was expressed by means of the DMF-T and DMF-S index. The dental 
care index was expressed as F/D+F (T) and (S). No radiographs were taken. 
 
4.2.2.  Dental plaque and dental calculus 
   As the purpose of this study was to obtain data on the presence and not on the 
amount of dental plaque and calculus per tooth or per surface (with exception of 
the occlusal surface), and as in most cases subjects were examined at home, a fast 
and easy recording technique was considered most appropriate. In order to compare 
data from the literature, all teeth, except the third molars were involved. Visual 
presence of plaque and calculus were scored  1 and absence was scored as  0. 
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In case of doubt, a WHO/CPITN type E probe [http://www.whocollab.od.mah.se] 
was used for verification. Consequently the presence of dental plaque and calculus 
was recorded as a numerical value, both on tooth and on surface level.  
 
4.2.3.  Gingival bleeding  
   The gingival status was recorded after assessing caries experience, dental 
calculus and dental plaque. A simplified version of the Löe gingival index (GI) 
[Löe, 1967] was used; score 0 was absence of bleeding after gentle probing with 
a WHO/CPITN type E probe [http://www.whocollab.od.mah.se] and scores 1 to 3 
were converted into one score (score 1) corresponding to bleeding after gentle 
probing. This was recorded for every tooth present (apart from the third molars) 
and for the respective surfaces. For the reasons mentioned above, as it was not the 
aim of the study to investigate the ‘severeness’ of the gingival status, no extensive 
bleeding index notation was considered necessary.  
 
4.3.   Probing subject’s habits 
4.3.1. Interview 
   The technique of interviewing was preferred over a written questionnaire which 
was filled in by the participants themselves for two important reasons. Primo to 
avoid unanswered questions and secundo to avoid biassed information, which can 
be expected from the kind of questions asked in a survey. It is commonly accepted 
that a questionnaire, if not correctly assembled, can biass answers, as people 
unavoidedly change their answers.  The prejudice that for instance a dentist is 
asking questions about oral hygiene habits, might push subjects to give “false” 
answers, which do not stroke with their usual habits. 
    All interviews, about 30 minutes each, were taken by the same investigator 
(J.A.). Detailed information was obtained about every subject’s dietary habits, oral 
hygiene habits and medication use. The interview was based on a questionnaire, 
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which was used with success in previous studies and of which the validity was 
shown. Regarding reliability, the investigator considered it acceptable that possible 
‘noise’ could lead to an equal shift of the results, but as statistical models were 
used with a dichotomised outcome and explanatory variables, this was to be 
minimised. Moreover, the investigator had obtained experience in the past, 
working with this questionnaire, during a collaborative study (Children’s Dental 
Health in Europe, coordinated by Dr. A.K. Bolin) [ Rise et al., 1991a; Rise et al., 
1991b; Goldbohm et al., 1994; Osler and Heitman, 1996; Bolin et al., 1997a,b; 
Vanobbergen, 2001]. 
 
4.3.2. Oral hygiene habits  
 The following items on oral hygiene measures were discussed via an interview 
during which all answers were dichotomized as “yes” or “no”  
 
 I brush less than twice a day / I brush at least twice a day 
 I do not brush my teeth in the morning / I brush my teeth in the morning 
 I do not brush my teeth in the evening / I brush my teeth in the evening 
 I use at least a pea size of toothpaste / I use at least one centimetre of 
toothpaste 
 I do not use a fluoride containing toothpaste / I use a fluoride containing 
toothpaste 
 I use a regular toothbrush / I use an electrical toothbrush 
 I never use a fluoride containing mouthrinse / I use a fluoride containing 
mouthrinse 
 I never had fluoride supplements (drops or tablets) / I had fluoride supplements 
 I never use a chlorhexidine containing mouthrinse / I use a chlorhexidine 
containing mouthrinse 
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 I never use dental floss / I use dental floss 
 I never use toothpicks / I use toothpicks 
 
4.3.3.  Dietary habits 
    The composition of every meal and snack was recorded, the time of the day 
when was eaten and drunk and how and where this was carried out. The 
questionnaire consisted of questions which could be answered with yes or no (e.g. 
“do you have breakfast every day ?”) and questions which had to be answered 
more into detail (e.g. “ what do you drink with your breakfast ?”).  Subsequently 
the investigator (J.A.) listed the answers into categories. Drinks were divided into 4 
categories, being ; “no drinks, sweetened drinks (e.g. fruit juices, soft drinks, coffee 
with sugar), non sweetened drinks (e.g. black coffee, plain tea, water) and dairy 
drinks (e.g. milk, yogurt, coffee with milk)”. Foods were divided into 3 categories, 
being ; ”a hot meal, a sandwich-like meal with a sweet filling  (e.g. marmalade) 
and a non-sweet filling (e.g. meat, cheese, vegetables, salads)”.  The desserts were 
categorized into 4 groups, being ; “ no dessert, a sweet dessert (e.g.  pie, candy 
bar), fruit and a non-sweet dessert (e.g. cheese)”.  Snacks were divided into drinks 
and food, being ; “no drink, a sweetened drink (e.g. fruit juices, soft drinks, coffee 
with sugar),  a non-sweetened drink (e.g. plain tea or coffee), dairy drinks (milk, 
yogurt, tea with milk), a sweet snack (e.g. candy bar, cookies), fruit and non-sweet 
snacks (e.g. a cheese or ham sandwich)”. 
 
4.3.4.  Medication   
    Every subject was asked whether medication was used on a regular basis. This 
could  include anticonceptiva as well as expectorantia. The number of intakes per 
day, the way of taking medication (e.g. aerosol, syrup or intravenously) and the 
type of medication (e.g. antibiotics, mucolytica or anticholinergica) were recorded 
meticulously for every subject in this study.  For the CF homozygotes, separate 
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questions about how (e.g. open or closed capsules or opened in a yoghurt drink) 
pancreatic enzymes were taken, were also included in the interview. 
 
4.4. Saliva collection for analytical purposes 
   Paraffin stimulated whole saliva was collected in a sterile plastic receptacle. All 
subjects were in an up-right position at the time of collection. As salivary 
electrolytes concentrations vary during the day, due to the circadian rythm [Van 
Nieuw Amerongen, 1988a], samples were collected between 9 a.m. and 4 p.m. in 
the presence of the same investigator (J.A.). All samples were transported at room 
temperature almost immediately to the Ghent University Hospital, where their 
analysis took place and the volume of saliva was devided into several smaller 
recipients for further analysis. These samples were subsequently stored in a 
controlled freezer at  –17°C. 
  
4.5.  Mutans streptococci and Lactobacilli counts 
   CRT
®
 Bacteria (Vivadent
®
, Schaan, Liechtenstein) was chosen as a commercial 
bacterial colony counting test kit, as it is simple to perform and provides the 
opportunity to evaluate both Mutans streptococci (MS) and Lactobacilli (LB) on 
the same two-sided dip-slide [Rogosa et al., 1951; Gold et al., 1973; Larmas, 1975; 
Kneist et al., 1999a,b]. The CRT
®
 Bacteria test-results are expressed as a low (10
5
 
CFU) or a high ( 10
5 
CFU) bacterial count. Chair-side tests, such as CRT
®
 
Bacteria and Dentocult
® 
(Orion Diagnostica
®
, Finland) have been extensively 
described in literature as being reliable and easy to use clinically to assess caries 
risk in populations [Twetman et al., 1994; Kneist and Heinrich-Weltzien, 1997; 
Kneist et al., 1998; Kneist et al., 1999a,b; Twetman et al., 1999]. Dipslides were 
inoculated, incubated and evaluated according to the manufacturer’s guidelines.  
   The investigator (J.A.) was trained at baseline in evaluating the CRT Bacteria 
commercial test results. Subsequently the same investigator evaluated a total of 40 
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samples twice at an interval of 8 hours. This was necessary as no major changes of 
the agar plates was acceptable for intra-examiner reliability assessment. The kappa 
value was 0.71, standing for an acceptable intra-examiner reliability.  
 
4.6. Salivary electrolytes 
   Prior to chemical analysis, each sample was vortexed for at least 30 seconds and 
subsequently 3 milliliter was centrifuged for 10 minutes at 3000 rpm at 
roomtemperature. Subsequently the supernatant was used for chemical electrolyte 
analysis (respectively calcium, bicarbonate, phosphate, potassium, sodium and 
chloride concentrations). Salivary osmolarity was also determined.  
   Measurement of the total calcium concentration was performed by a colorimetric 
method and inorganic phosphate was quantified by means of a molybdate 
complexing reaction method. Both procedures were carried out by means of a 
testkit provided by Roche
®
 (Mannheim, Germany).  
   The bicarbonate concentration was determined enzymatically using commercial 
reagents from BioMérieux
®
 (Biomérieux, Marcy-les-Etoiles, France).  
   Potassium, sodium and chloride were automatically measured using indirect 
potentiometry on the Hitachi 747
®
 analyzer (model 100) (Tokyo, Japan).  
   Salivary osmolarity was measured with the “Advanced cryomatic osmometer®” 
(model 3C2, Advanced Instruments) (Needham Heights, Massachusetts, USA).  
 
4.7. Salivary proteins 
4.7.1.  Total protein concentration  
   Two milliliter of each well vortexed saliva sample was centrifuged at 3000 rpm 
for 10 minutes. Subsequently the supernatant was pipeted and the total protein 
content was determined automatically on a Hitachi
® 
911 automatic analyzer 
(Tokyo, Japan). This machine uses the pyrogallol-red molybdate complexing 
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method [Van Ingen, 1990]. Photospectrometry is carried out at a wavelength of 600 
nm. The result is expressed as gram total protein per litre saliva. 
 
4.7.2.  Sialic acid concentration 
   Sialic acid (nitrogen-acetylneuramine) was determined on a Hitachi
®
 911 
automatic analyzer (Tokyo, Japan) with help from a Roche
®
 test package. By 
means of neuraminidase, the sialic group was separated from its glycoprotein. 
Subsequently nitrogen-acetylneuraminic acid is converted into pyruvate and 
nitrogen-acetylmannosamine. In a third phase, pyruvate is oxydated respectively 
into carbondioxide, hydrogenperoxide and acetylphosphate. By means of the 
Roche
®
 test package the hydrogenperoxide finally is converted into a red 
pigmented fluid, which is subsequently measured by photospectrometry 
(wavelength 550 nm). The peroxide is a measure for the concentration of free 
nitrogen-acetylneuramine. The concentration is expressed as milligrams sialic acid 
per litre saliva. 
 
4.7.3.  Electrophoresis 
4.7.3.1.  Molecular mass differentiation 
   Electrophoresis, in general, is the movement of particles in an electrical field. It 
is one of the most efficient analytical tools in modern clinical biochemistry to 
separate the different monomers of a polymer. Saliva can be considered as a 
polymer and as a consequence, the individual monomers, the salivary proteins, can 
be identified on basis of their molecular mass (unit = Dalton) by means of “sodium 
dodecyl sulphate poly acrylamide gel electrophoresis” or SDS-PAGE for short.  
 
4.7.3.2.  SDS-PAGE procedure 
   Three millilitre of each saliva sample was ultracentrifuged (Beckman
®
 L-2) at 
13000 rpm for 30 minutes at 10°C. Then the supernatant was frozen at –17°C and 
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subsequently lyophilized at -70°C (Virtis
®
 Gardiner, NY 12525, USA) for at least 8 
hours until only powder was left in the glass bulb. The lyophilized saliva was 
thereupon diluted in 250 µL sample buffer (pH = 6.8; 3.8 ml distilled water, 1.0 ml 
0.5 M Tris-HCl, 1.6 ml 10% SDS, 0.8 ml glycerol, 0.4 ml 1% brominephenol blue 
(Merck
®
)) and vortexed. Only 50 µL of this solution was used for further procedure 
and 10 µL neuraminidase was added. The solution was incubated for 2 hours at 
37°C. The latter was necessary to separate the sialic acid groups from the salivary 
glycoproteins.  
   In the mean time the electrophoresis buffer solution (pH = 8.3; 9 g of Tris 
alkaline + 43.2 g of glycine + SDS + diluted with distilled water to a volume of 
600 ml) was prepared and stored at –4°C. SDS- PAGE 4-15% Tris-HCl-gradient 
gels (BIO-RAD
®
 Laboratories, 2000 Alfred Nobel Drive, Hercules CA 94547, 
USA), were mounted in the appropriate Mini-Protean II 
®
 electrophoresis cell 
(BIO-RAD
®
). 
   Prior to application of the samples in the gel indentations, the electrophoresis 
buffer solution is poured into the inner cooling core of the electrophoresis chamber 
and checked for leakage. Subsequently the outer core was filled and 10 µL samples 
were applicated in the indented application sites of the gradient gel. 
   SDS-PAGE was performed at a constant voltage of 200 Volts for 50 minutes. 
The progression of the electrophoresis was easy to follow because of the samples’ 
blue color. 
   After 50 minutes, the gels were removed from the electrophoresis chamber and  
put in a Coomassie  Brilliant Blue R250 solution (LKB Bromma
®
, a 1g/L dilution 
in 40% methanol and 10% acetic acid) for 30 minutes. Subsequently the gels were 
decolorized several times in a solution with 40% methanol and 10% acetic acid 
until only the blue and purple protein fractions were visible.  
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4.7.4.  Determination of the molecular masses and identification 
   By means of a standardized protein mix (SDS-PAGE Standards, broad 200 µl, 
order number 161-031 ), as provided by BIO-RAD
®
, the molecular masses of three 
particular protein fractions were determined via linear regression analysis.  
 
4.8. Data processing and statistics 
   All data from either the clinical examination or the interview were immediately 
stored in an automated database (Access file, 
©
 Microsoft Corporation) on a 
Compaq Armada 1700 computer. 
   Statistics were performed either by means of the MedCalc
®
 statistical programm 
for biomedical research (MedCalc, Mariakerke, Belgium) or by means of the SPSS 
programm at the Department of Medical Informatics and Stastistics, RAMIT 
(Research in Advanced Medical Informatics and Telematics) at the Ghent 
University Hospital, by Dr. Georges Van Maele.  
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Chapter 5 
 
Caries experience and oral cleanliness in cystic 
fibrosis homozygotes , heterozygotes  
and healthy controls 
 
 
 
 
 
 
 
This chapter was published as : 
Aps J.K.M., Van Maele G.O.G., Martens L.C. Caries experience and oral 
cleanliness in cystic fibrosis homozygotes, heterozygotes and healthy controls. 
Oral Surgury, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 
2002 ; 93:in press.  
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ABSTRACT 
   In the present study caries experience (DMF) and oral cleanliness (plaque, 
calculus and gingival bleeding) of CF homozygotes (n = 42), CF heterozygotes (n 
= 48) and healthy controls (n = 62) were recorded and statistically analysed. CF 
homozygotes showed a significant lower caries experience (DMF-T) than both 
controls (P < 0.001) and CF heterozygotes (P= 0.011). They also had significantly 
less gingival bleeding sites than controls (P = 0.014) and CF heterozygotes (P = 
0.019). CF heterozygotes showed significantly more extensive restorations than CF 
homozygotes (P = 0.015) and significantly more missing teeth than controls (P = 
0.008), while the latter had significantly more missing teeth than CF homozygotes 
(P < 0.001). Although CF homozygotes potentially run a high caries risk due to 
their essential sugar rich diet, they did not show a significantly higher caries 
experience. Their better gingival health and lower caries experience may be 
attributed to medication use (antibiotics) and certain still, as yet unidentified, 
intrinsic salivary mechanisms.  
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5.1. Introduction    
   Cystic fibrosis (CF) is the most common lethal recessive inherited disease in 
Caucasians. Around 1 in every 2000 live newborns has CF and about 4 to 5% of 
Caucasians are heterozygous for the cystic fibrosis transmembrane regulator 
(CFTR) gene. In essence, the deletion causes increased mucous secretions in every 
exocrine gland, including the salivary glands (the sublingual glands in particular). 
CF patients need many in-between-meal-snacks and sugar-rich drinks to provide 
them with the necessary body energy. This diet is thought to carry a high 
cariogenic potential. A more detailed description of the disease and useful 
references were published elsewhere [Martens et al., 2001]. 
   Literature on CF and oral health is rather scarce. Reports from the 1980’s stated 
that CF homozygotes (all children) had a lower caries experience than healthy 
controls and a higher tendency to form dental calculus [Kinirons, 1983 ; Kinirons, 
1985 ; Kinirons, 1989 ; Fernald et al., 1990]. While most studies deal with younger 
children, a recent study [Martens et al., 2001] compared the caries experience 
between CF homozygotes and controls, comprising a wider age range. This type of 
study only became possible as CF patients survived into their teenage years as a 
consequence of better medical care and knowledge [FitzSimmons, 1993]. It did, 
however, not confirm the lower caries experience in CF patients, as reported in the 
literature [Kinirons, 1983 ; Kinirons, 1985 ; Kinirons, 1989 ; Fernald et al., 1990]. 
A comparison of caries experience and Mutans Streptococci and Lactobacilli 
counts between CF homozygotes, heterozygotes and controls, revealed a 
significantly lower caries experience       (DMF-S) in CF homozygotes than in CF 
heterozygotes, but no significant difference between CF homozygotes and controls 
[Aps et al., 2001]. 
   The aim of the present study was to evaluate cross sectionally the caries 
experience (DMF) and oral cleanliness between CF homozygotes, CF 
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heterozygotes and healthy controls in Belgium, and to investigate potential 
correlations. 
 
5.2. Material and methods 
5.2.1. Patient selection 
   CF homozygotes (n = 42) were recruited from the Belgian Association for the 
Fight Against cystic Fibrosis (BAFCF). Their mean age was 16.2  8.1 years old. 
Genetically proven CF heterozygotes (n = 48) were also recruited via BAFCF. 
They were related (as parents or mostly older brother or sister) to the selected CF 
homozygotes in this study. Consequently their mean age was 29.5  15.9 years old. 
Healthy controls (n = 62), excluding subjects suffering from cardiovascular, genito-
urinary, endocrine, hematological or infectious diseases, were recruited from the 
Ghent University Dental out-patient clinic and from the CF patients’ and CF 
heterozygotes’ environment. CF patient family members were excluded as control 
subject. Their mean age was 19.9  11.5 years old. 
Prior to participation, all participants were informed about the aims of the study 
and all signed an informed consent. The study was approved by the Ghent 
University’s medical ethical committee. 
 
5.2.2. Caries experience 
   The investigator (J.A.) was trained at baseline and participated both in an in vitro 
and in vivo calibration exercise, of which details and results were published 
elsewhere [Martens et al., 2001]. Caries experience was recorded according to the 
WHO  [http://www.whocollab.od.mah.se] and the British Association for the Study 
of Community Dentistry (BASCD) guidelines [Pine et al., 1997 ; Pitts et al., 1997]. 
Caries was recorded at the level of cavitation and no radiographs were taken. All 
subjects were examined by the same investigator in a horizontal position and 
examinations were carried out at the Ghent University dental out-patient clinic or at 
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the subject’s home. The latter was necessary as not all participants were able to 
visit the clinic or because , in case of CF homozygotes, they were appropriately 
afraid to get infected by Pseudomonas aeruginosa, which gives a worse prognosis 
for CF patients. All data were immediately stored in an automated database on a 
Compaq
®
 Armada 1700 computer. 
 
5.2.3. Dental plaque and calculus 
   As the purpose of this study was to obtain data on the presence and not on the 
amount of dental plaque and calculus per tooth or per surface (with exception of 
the occlusal surface), and as in most cases subjects were examined at home, a fast 
and easy recording technique was considered most appropriate. In order to compare 
data from literature, all teeth, except the third molars were involved. Visual 
presence of plaque and calculus were scored  1 and absence was scored as  0 . 
In case of doubt, a CPI probe [http://www.whocollab.od.mah.se] was used for 
verification. Consequently the presence of dental plaque and calculus was recorded 
as a numerical value, both on tooth and on surface level. 
 
5.2.4. Bleeding index 
   The gingival status was recorded after assessing caries experience, dental 
calculus and dental plaque. A simplified version of the Löe gingival index (GI) 
[Löe, 1967] was used; score 0 was absence of bleeding after gentle probing with 
a CPI probe [http://www.whocollab.od.mah.se] and scores 1 to 3 were converted 
into one score (score 1) corresponding to bleeding after gentle probing. This was 
recorded for every tooth present (apart from the third molars) and for the respective 
surfaces. For the reasons mentioned above, as it was not the aim of the study to 
investigate the severeness of the gingival status, no extensive bleeding index 
notation was considered necessary. 
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5.3. Statistics 
   All data were immediately stored in an Access-database on a Compaq
®
 Armada 
1700 computer. Appropriate statistical analysis was performed using the Kruskal-
Wallis test to investigate differences for caries experience and oral cleanliness 
among the three groups, while the Mann-Whitney U-test was used to compare 
differences between two groups. The non-parametric Spearman rank correlation 
was used to investigate correlations between the caries experience data and the oral 
cleanliness data in every group. The level of significance was set at = 0.05.  
 
5.4. Results 
5.4.1. Caries experience 
   In table 5.1. caries experience data are shown with the respective composing 
factors, for both  tooth and surface level. This table also illustrates all P-values after 
statistical analyses. 
   We observed that the caries experience (DMF-T) was significantly different 
between the three groups (P = 0.001). CF homozygotes had a significantly lower 
caries experience than both CF heterozygotes (P = 0.011) and controls (P < 0.001). 
The difference between CF heterozygotes and controls was borderline not 
significant (P = 0.06). 
   Present decay was not significantly different between the three groups, while 
missing teeth due to caries, was (P < 0.001). CF heterozygotes had significantly 
more missing teeth than controls (P= 0.008) and the latter had significantly more 
missing teeth than CF homozygotes   (P < 0.001). 
   Considering the three groups, there seemed to be no significant difference for 
restored teeth, the restoration’s extensiveness, however, was (P = 0.046). CF 
homozygotes had significantly smaller restorations compared to CF heterozygotes 
(P = 0.015), while this was borderline significant  compared to healthy controls (P 
= 0.054). 
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Table 5.1. : Caries experience (DMF-T, D-T, M-T, F-T, DMF-S, D-S, M-S, F-S) 
                    and oral cleanliness (dental calculus, dental plaque and gingival 
                    bleeding both on tooth -T- and on surface -S- level) data with the 
                    results of the statistical analyses for CF homozygotes (n = 42), CF 
                    heterozygotes (n = 48) and healthy controls (n = 62) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CF Homoz. 
( A ) 
mean (SD) 
CF Heteroz. 
( B ) 
mean  (SD) 
Controls 
( C ) 
mean (SD) 
Kruskal-
Wallis test 
P-value 
 
Mann-Whitney U-test 
P- value 
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5.4.2. Oral cleanliness 
   No significant differences were observed between the three groups or between 
any two groups, for the number of teeth or surfaces covered with dental plaque or 
dental calculus (table 5.1.). On the other hand, the number of bleeding sites was 
significantly different between the three groups, both on tooth (P = 0.033) and on 
surface level (P = 0.026). A Mann-Whitney U-test revealed that CF homozygotes 
had significant less gingival bleeding sites than CF heterozygotes (P = 0.014 on 
tooth level and P = 0.011 on surface level) and controls  (P = 0.019 on tooth level 
and P = 0.017 on surface level). 
 
5.4.3. Correlations  
    No correlations in any group were found between caries experience and oral 
cleanliness. 
   Table 5.2. summarizes the correlation values between the oral cleanliness 
parameters on tooth level and their respective P-values. No correlations were found 
in CF homozygotes between any of the oral cleanliness parameters. In CF 
heterozygotes, however, positive significant correlations were found between 
dental calculus and plaque (r = 0.414 and P = 0.003) and between dental calculus 
and gingival bleeding (r = 0.470 and P = 0.001). In healthy controls, positive 
significant correlations were observed between gingival bleeding and dental 
calculus (r = 0.472 and P < 0.001) and between gingival bleeding and dental plaque 
(r = 0.316 and P = 0.012). Although the significancies were very pronounced             
(P  0.012), the correlations were rather weak (r < 0.5). 
 
5.5. Discussion 
   It should be emphasized that this study clearly made a difference between CF 
heterozygotes and control subjects. Nevertheless, statistically the control group 
could potentially contain 2 more CF heterozygotes. In the past [Kinirons, 1983 ; 
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Kinirons, 1985 ; Kinirons, 1989] this differentiation was not possible, as at that 
time the responsible chromosome and gene (7q31) was not yet determined. It was 
interesting, however, to notice that CF heterozygotes, who are unaffected by this 
disease and as such could be considered as healthy controls, had experienced 
significantly more extractions than the control group, and that they had 
significantly more and extensive restorations than CF homozygotes. This can partly  
 
Table 5.2. : Non-parametric Spearman rank correlations and their statistical  
                    significance between the oral cleanliness parameters on tooth level  
                    (dental calculus, dental plaque and gingival bleeding) for CF  
                    homozygotes (n = 42), CF heterozygotes (n = 48) and healthy controls  
                    (n = 62) 
Correlations 
Group 
Dental calculus 
versus 
Dental plaque 
Dental calculus 
versus 
Gingival bleeding 
Dental plaque 
versus 
Gingival bleeding 
CF homozygotes 
N = 42 
r = 0.167 
P = 0.290 
r = 0.118 
P = 0.458 
r = 0.289 
P = 0.063 
CF heterozygotes 
N = 48 
r = 0.414 
P = 0.003 
r = 0.470 
P = 0.001 
r = 0.159 
P = 0.282 
Healthy Controls 
N = 62 
r = 0.128 
P = 0.322 
r = 0.472 
P < 0.001 
r = 0.316 
P = 0.012 
 
be explained by the fact that the mean age of the CF heterozygote group 
individuals was substantially higher than in both other groups. The CF 
heterozygote group consisted of parents, brothers and sisters of the CF 
homozygotes, which automatically explains a higher mean age.  
   This study (figure 5.1.) confirmed that CF homozygotes had a significant lower 
caries experience than control subjects [Kinirons, 1985 ; Kinirons, 1989], 
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moreover, it became obvious that they also had a significant lower caries 
experience than CF heterozygotes. This group was never investigated in the past, 
except in a recent study in which bacterial counts were also involved [Aps et al., 
2001]. In the latter study, however, no significant differences were found between 
CF heterozygotes and CF homozygotes, which probably can be explained, in part, 
by the small sample used. 
   The earlier reported higher dental calculus incidence in CF homozygotes 
[Kinirons, 1983 ; Kinirons, 1985 ; Kinirons, 1989 ; Fernald et al., 1990] was not 
confirmed in this study. Moreover, no significant differences between the three 
groups were found for this parameter, nor for plaque. This is also illustrated in 
figure 5.1.  
   On the other hand, CF homozygotes showed significantly less gingival bleeding 
than both other groups, while no significant differences were observed between CF 
heterozygotes and controls (figure 5.1.). Both findings, a significantly lower caries 
experience and significantly less gingival bleeding sites, could be related to the 
lower, although not significant, sites with plaque, which probably contained a low 
pathogenic microflora. Alternatively, certain dietary components, such as dairy 
products, are more prominently present in a CF homozygote’s diet which is mostly 
sugar rich [Bentur et al., 1996]. Despite this caries risk behaviour, CF homozygotes 
showed a significantly lower caries experience. Moreover, certain intrinsic salivary 
processes could render them more protected against dental decay too.  It is also 
suggested in the literature that CF homozygotes have a significantly higher salivary 
buffer capacity and a higher salivary calcium concentration [Kinirons, 1983]. Both 
the latter and other salivary electrolytes could also contribute to this low caries 
profile. 
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Figure 5.1. : Illustration and brief summary of caries experience (DMF-T) and oral 
                     cleanliness (plaque, calculus and gingival bleeding) for CF 
                     homozygotes (n=42), CF heterozygotes (n=48) and healthy controls 
                     (n=62)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
   It should not be forgotten that CF homozygotes consume a lot of antibiotics, 
which could potentially reduce the oral bacterial cariogenic flora, resulting in a 
lower caries experience [Kinirons, 1985 ; Kinirons, 1989 ; Fernald et al., 1990]. 
Apparently this may also result in a lower plaque pathogenicity and may be explain 
their improved gingival health, as suggested in the present study.  
   Pointing to one particular aspect of oral hygiene behaviour or dietary habits as 
the responsible agent for dental decay, plaque, calculus and gingival bleeding 
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would be inappropriate. The weak, but nevertheless very significant correlations, 
support the concept that oral cleanliness (dental plaque, calculus and gingival 
bleeding) and caries experience are multifactorial conditions.  
 
5.6. Conclusion 
   From this study it is clear that CF heterozygotes can not be considered as another 
group of healthyindividuals as they apparently differ from healthy controls in 
caries experience. Despite the fact that CF homozygotes potentially run a high 
caries risk, they do not develop more carious lesions than healthy individuals. CF 
homozygotes had significantly less gingival bleeding than controls and CF 
heterozygotes. The latter could involve dietary and oral hygiene aspects, intrinsic 
salivary processes and/or medication use as agents responsible for lessening 
carious lesions or pathogenic plaque formation, both of which should be subject for 
further research.  
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Chapter 6 
 
Mutans streptococci, Lactobacilli and caries 
experience in cystic fibrosis homozygotes, 
heterozygotes and healthy controls 
 
 
 
 
 
 
 
 
This chapter has been published as : 
Aps J.K.M., Van Maele G.O.G., Claeys G., Martens L.C.  Mutans Streptococci, 
Lactobacilli and Caries Experience in Cystic Fibrosis Homozygotes, Heterozygotes 
and Healthy Controls 
Caries Research 2001 ;35 :407-411. 
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ABSTRACT 
   Mutans Streptococci (MS) and Lactobacillus (LB) counts (CRT® Bacteria chair 
side test) were compared and correlated with the respective caries experience 
(DMF) of cystic fibrosis (CF) homozygotes (n = 20), CF heterozygotes (n = 20) 
and healthy controls (n = 20). Each group of subjects was divided into two equal 
age groups; A<20y and B>20y. No significant differences were found regarding 
DMF between the three groups. CF heterozygotes had a significant higher DMF-S 
than CF homozygotes (P=0.040). This was also found in age group B (P<0.02), 
where it also counted for DMF-T (P<0.01). When in age group B, CF 
heterozygotes and controls were combined as one group, it was found that they had 
a significant higher DMF-T (P=0.031) and DMF-S (P=0.008) than CF 
homozygotes. No significant differences in LB counts between the three groups 
were observed. CF homozygotes and those in age group A, had significant (P= 
0.018 and P = 0.015) more low MS counts. LB and MS counts were positive and 
significantly correlated with DMF-T/-S in CF homozygotes and in the combined 
group of CF heterozygotes with controls (P  0.05 and P  0.001). No correlations 
between bacterial counts and DMF were observed in CF heterozygotes. It can be 
concluded that despite the fact that CF homozygotes behave as high caries risk 
individuals, they did not have significant more dental decay. More research is 
required in order to explore salivary, dietary and medication influences. 
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6.1. Introduction 
   Cystic fibrosis (CF) is the most common lethal autosomal recessive inherited 
disease in Caucasians, with a prevalence of 1 in every 2000 live-births. About 4% 
of the white Belgian population is heterozygous for the cystic fibrosis 
transmembrane regulator (CFTR) gene [Wauters et al, 1991]. The disease is 
characterized by an increased mucoid secretion by all exocrine glands, among 
which are the salivary glands [Hughes and Griffith, 1984 ; Bellon and Gilly, 1990 ; 
Tsui, 1991 ; Aitkin and Fail, 1993 ; Hodson, 1993 ; Sheppard and Ostegaard, 
1996 ; Hilman, 1997]. Salivary calcium and chlorine are altered under these 
circumstances [Jiménez-Reyes and Sanchez-Aguirre, 1996]. But it is, however, not 
known if this phenomenon in combination with an increased salivary viscosity has 
any effect on oral microflora and consequently on caries experience. For a long 
time it was suggested that young CF patients have significant lower caries 
experience than controls [Kinirons, 1983 ; Kinirons, 1985 ; Kinirons, 1989 ; 
Fernald et al., 1990]. The latter was, however, not confirmed in a recent age 
matched-control study [Martens et al., 2001] with a variety of young and older CF 
patients.  
   The present study aimed to evaluate mutual differences in Mutans Streptococci 
(MS) and Lactobacilli (LB)  counts between CF homozygotes, CF heterozygotes 
and healthy controls. In a second part, these data were correlated with caries 
experience.  
 
6.2. Material and methods 
6.2.1. Patient selection 
   CF homozygotes (n = 20) and CF heterozygotes (n = 20) were both recruited 
from the Belgian Association for the Fight against Cystic Fibrosis. All CF 
heterozygotes were related to the CF homozygotes and genetically proven to be 
heterozygous for the CFTR gene, which avoided expensive and unethical genetic 
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identification. Healthy controls (n = 20), excluding subjects suffering from 
cardiovascular, endocrine, hematological, infectious or genito-urinary diseases, 
were recruited from the Ghent University’s dental out-patient clinic. All three 
groups were subsequently divided into two age groups ; age group A < 20 years old 
and age group B > 20 years old (twice n = 10). For CF homozygotes, ages varied 
between 9 and 34, for CF heterozygotes between 7 and 60 and for controls between 
8 and 39. The study was approved by the University’s ethical committee and all 
participants signed an informed consent. 
 
6.2.2. Saliva sampling method and CRT
®
 
   CRT
®
 Bacteria (Vivadent, Liechtenstein) was chosen as a commercial bacterial 
colony counting test kit, as it is simple to perform and provides the opportunity to 
evaluate both  MS  and LB on the same two-sided dip-slide [Rogosa et al., 1951; 
Gold et al., 1973; Larmas, 1975; Kneist et al., 1999a,b]. The CRT
®
 Bacteria test-
results are expressed as a low (10
5
 CFU) or a high ( 10
5 
CFU) bacterial count. 
Chair-side tests, such as CRT
®
 Bacteria and Dentocult
® 
(Orion Diagnostica, 
Finland) have been extensively described in literature as being reliable and easy to 
use clinically to assess caries risk in populations [Twetman et al., 1994; Kneist and 
Heinrich-Weltzien, 1997; Kneist et al., 1998; Kneist et al., 1999a,b; Twetman et al., 
1999]. 
   Paraffin stimulated whole saliva was collected in a sterile plastic receptacle. 
Samples were collected between 9 a.m. and 4 p.m. in the presence of the same 
investigator (J.A.). Dipslides were inoculated, incubated and evaluated according 
to the manufacturer’s guidelines. All data (including the caries experience data) 
were immediately stored in an automated database (Excel file on a Compaq
®
 
Armada 1700) for further statistical analysis. 
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6.2.3. Investigator calibration , CRT
®
 evaluation and Caries experience data 
collection 
   Prior to the study, the investigator (J.A.) was trained in evaluating the CRT
®
 
Bacteria commercial test results. Subsequently the investigator evaluated a total of 
40 samples twice with an interval of 8 hours (to avoid major changes on the agar 
plates) to establish intra-examiner reliability, which was determined as kappa = 
0.71. The investigator was also trained [Martens et al., 2001] to evaluate caries 
experience (DMF-T/-S) [Klein et al., 1938] according to the British Association for 
the study of Community Dentistry (BASCD)  guidelines [Pine et al., 1997 ; Pitts et 
al., 1997]. Only a white light source, cotton rolls, a dental mirror and a CPI probe 
were used to examine the subjects [WHO, 1997]. Caries was detected at the level 
of cavitation without the use of X-rays.  
 
6.3. Statistics 
   The results of the CRT® Bacteria tests were dichotomized ( 10
5  
CFU versus  
10
5
 CFU). The Pearson Chi-Square test was performed to evaluate differences in 
MS and LB counts between the three groups, while differences in caries experience 
between the 3 groups were investigated by means of the Kruskal-Wallis test. A 
Mann-Whitney-U test was used to investigate numerical data between two (age) 
groups mutually. The non-parametric Spearman rank correlation was calculated 
between the DMF-index and CRT
®
 counts in the 3 groups. The level of 
significance was set at = 0.05.  
 
6.4. Results  
6.4.1. DMF data 
   The caries experience data, expressed as DMF-T/-S (mean, standard deviation 
and median), for all groups and their respective age groups, are summarized in 
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table 6.1. The respective P-values are also included in this table. No significant 
differences were observed between the three groups for DMF-T/-S. Comparing 
them in pairs, it was found that CF homozygotes had a significant lower DMF-S 
than CF heterozygotes (P = 0.040). Irrespective of the group, age group A 
individuals had significantly lower DMF-T/-S values than individuals from age 
group B. The respective p-values ranged between P < 0.001 and P = 0.011 (not 
included in table 6.1.). When only age group B individuals (> 20 y olds) were 
evaluated, it was observed that DMF-S was significantly lower (P = 0.022) in CF 
homozygotes than in CF heterozygotes and controls of age group B. Comparing the 
respective pairs, it was observed that this difference was only significant between 
CF homozygotes and CF heterozygotes and between CF homozygotes and all other 
subjects in age group B (P < 0.01). The latter was also true for DMF-T (P = 0.031).  
 
6.4.2. CRT® results  
   Table 6.2. comprizes the number of low and high MS and LB counts for every 
group and age group. No significant differences were found in LB counts nor 
between the 3 groups nor when the age groups were evaluated. Conversely, it was 
found that significantly more « low MS counts » were recorded in CF homozygotes 
(P = 0.018) than in CF heterozygotes or controls. When CF heterozygotes and 
controls were considered as one group, this difference was even more pronounced 
(P = 0.009).  
      CF homozygotes in age group A showed significant more « low MS counts » 
(P= 0.015) than their pairs of CF heterozygotes or controls. This difference was 
even more pronounced when CF heterozygotes and controls in age group A were 
considered as one group (P = 0.007).  
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Table 6.1.
               
               
               
               
89
 :  Mean , standard deviation and median caries experience data for CF 
                     homozygotes (n = 20), CF heterozygotes (n = 20), healthy controls 
                     (n=20) and their respective agegroups (agegroup A< 20y old and 
                     agegroup B> 20y old). Results of Kruskal-Wallis test and Mann- 
                     Whitney-U test are also included. Significancies are typed in bold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mann-Whitney-U-test  CF 
Homo-
zygotes 
“A” 
CF  
hetero- 
zygotes  
“B” 
Controls  
 
“C” 
Kruskal- 
Wallis test 
C  C C 
C 
DMF-T 
Mean (SD) 
median 

 
	


 


 
 
P = 0.212 
 
P = 0.081 
 
P = 0.431 
 
P = 0.361 
 
P = 0.135 
Agegroup A 
Mean SD) 
median 

 

 

 
 
P = 0.646 
 
P > 0.10 
 
P > 0.10 
 
P > 0.10 
 
P = 0.588 
Agegroup B 
Mean SD) 
median 

	
 

 
	


 
 
P = 0.063 
 
P < 0.02 
 
P > 0.10 
 
P > 0.10 
 
P = 0.031 
DMF-S 
Mean SD) 
median 
	
 

	
 
	
 
 
P = 0.126 
 
P = 0.040 
 
P = 0.261 
 
P = 0.465 
 
P = 0.061 
Agegroup A 
Mean SD) 
median 

0.5 
		
 


 
 
P = 0.627 
 
P > 0.10 
 
P > 0.10 
 
P > 0.10 
 
P = 0.397 
Agegroup B 
Mean SD) 
median 
	
 

 


 
 
P = 0.022 
 
P < 0.01 
 
P > 0.10 
 
P > 0.10 
 
P = 0.008 
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Table 6.2. : Distribution of high (	


CFUand low (< 10
5 
CFU) bacterial counts  
                    for CF homozygotes (n = 20 ), CF heterozygotes (n = 20), control  
                    subjects (n = 20 ) and the respective agegroups ( n = 10) (agegroup A  
                    < 20y old and agegroup B >20y old) 
 Lactobacillus 
Low counts 
Lactobacillus 
High counts 
Str. Mutans 
Low counts 
Str. Mutans 
High counts 
CF Homozygotes 
(n = 20) 
 
11 
 
9 
 
11 
 
9 
CF Homozygotes 
Agegroup A (n=10) 
 
7 
 
3 
 
8 
 
2 
CF Homozygotes 
Agegroup B (n = 10) 
 
4 
 
6 
 
3 
 
7 
CF Heterozygotes 
(n=20) 
 
7 
 
13 
 
3 
 
17 
CF Heterozygotes 
Agegroups A (n=10) 
 
5 
 
5 
 
2 
 
8 
CF Heterozygotes 
Agegroups B (n=10) 
 
2 
 
8 
 
1 
 
9 
Control subjects 
(n=20) 
 
7 
 
13 
 
5 
 
15 
Controls subjects 
Agegroup A  
(n= 10) 
 
4 
 
6 
 
3 
 
7 
Control subjects 
Agegroup B (n=10) 
 
3 
 
7 
 
2 
 
8 
 
6.4.3. CRT
®
 correlations 
   Positive significant correlations between MS count and LB count were only found 
in control subjects (r = 0.55, P = 0.013) and in the combined group of CF 
heterozygotes plus controls (r = 0.41, P = 0.008). 
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6.4.4. DMF and CRT
®
 Correlations 
   Table 6.3. shows the correlations, with their respective P-values, between CRT
®
 
counts and DMF data. The significant correlations between the caries experience 
data and the CRT
®
 Bacteria counts were all positive.  
   In CF homozygotes, MS counts and LB counts were both significantly correlated 
with DMF-T/-S. CF heterozygotes, showed no significant correlations, whatsoever, 
between caries experience and bacterial counts. Healthy controls, showed a 
significant correlation between MS counts and DMF-T/-S. In the combined group 
of CF heterozygotes with controls, both MS and LB counts showed a significant 
correlation with DMF-T/-S.  
 
Table 6.3. : Correlations with their respective significancies (* P 0.05and** P  
                     0.001between caries experience (DMF-T and DMF-S) and  
                     bacterial counts (Lactobacillus –LB- and Mutans Streptococci –MS-)  
                     for CF homozygotes (n=20), CF heterozygotes (n=20), healthy 
                     controls (n=20) and the combined group of CF heterozygotes and 
                     controls (n=40) 
 
 
 
 
 
 
 
 
 
Group Caries Experience SM counts LB counts 
DMF-T 0.47* 0.69** CF homozygotes 
DMF-S 0.49* 0.68** 
DMF-T 0.31 0.14 CF heterozygotes 
DMF-S 0.24 0.18 
DMF-T 0.52* 0.42 Healthy controls 
DMF-S 0.52* 0.39 
DMF-T 0.36* 0.31* CF heterozygotes 
+ healthy controls DMF-S 0.33* 0.34* 
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6.5. Discussion 
    Knowing that about 4 to 5% of the Caucasian population is heterozygous for the 
CFTR gene  [Wauters et al., 1991], implies that, in previous studies [Kinirons, 
1983; Kinirons, 1985; Kinirons, 1989; Martens et al., 2001], among control 
subjects, CF heterozygotes were always present. As a consequence the present 
study is different from others, as it differentiates between CF homozygotes, CF 
heterozygotes and “healthy controls”. It should be stressed, however, that the 
authors were well aware that therefore the “healthy control group” potentially and 
statistically contained at least 1 CF heterozygote.  
   In general, CF patients did not have a significant lower caries experience than 
controls, which was in agreement with a recent age-matched case control study on 
DMF in CF patients [Martens et al., 2001] and in disagreement with earlier reports 
[Kinirons, 1983; Kinirons, 1985; Kinirons, 1989]. The present analysis however, 
showed in contrast to the Martens study, that in age group B, CF homozygotes had 
a significant lower DMF-S than CF heterozygotes and controls. They also had a 
significant lower DMF-T and –S than the combined group of CF heterozygotes 
with controls in this age group. This should be interpreted with care, as each age 
group B only consisted of 10 individuals. CF heterozygotes did have a significant 
higher caries experience at surface level (DMF-S) compared to CF homozygotes, 
but not compared to controls.  
   This study indicated that CF homozygotes did not have a significant different 
caries experience than control subjects and CF heterozygotes together, irrespective 
of the fact that CF homozygotes, out of sheer necessity, consume many in-
between-meal-sugar-rich-snacks and that they are “chronic users” of aerosols, 
which are both considered as high risk factors for developing caries [Martens and 
Robberecht, 1995; Kankaala et al., 1998; Kargül et al., 1998].  
   There was only a significant difference in DMF-S between CF homozygotes and 
CF heterozygotes, from which can be concluded that CF homozygotes had less 
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extensive decay than CF heterozygotes. The latter is an unexpected, but interesting 
fact as it is in contrast with an earlier finding [Kankaala et al., 1998; Kargül et al., 
1998] on asthmatic patients, another respiratory disease, in which aerosols are also 
used on a regular basis. Under the above mentioned potential “ideal” 
circumstances, MS should flourish, but the opposite was found. Nevertheless, the 
significant lower MS count did not result in a significant lower caries experience 
for CF homozygotes in general. 
   It was postulated [Martens et al., 2001] that CF patients might have 
“compensatory salivary mechanisms”, which protect them from extensive dental 
decay, despite their potential high risk behaviour. The present study puts this 
statement into perspective, as certain dietary components, such as milk and sweets, 
and on the other hand the daily use of antibiotics probably play an important role in 
the development of caries in CF homozygotes. The latter clearly needs further 
investigation as one should, however, take into consideration that antibiotics may 
prevail over the use of frequent in-between-meals and drinks. 
   It is remarkable that no significant correlations between caries experience and 
CRT
®
, whatsoever, were observed in CF heterozygotes and no significant 
differences between CF heterozygotes and control subjects for DMF or CRT
®
 
results were observed either. As clinically, CF heterozygotes are not 
distinguishable from the general population, they are not affected by the CFTR 
mutation, and could therefore be considered as one group with controls versus CF 
homozygotes in the statistical analyses.  
 
6.6. Conclusion 
   Despite the fact that CF homozygotes could be expected to run a potential higher 
risk for dental decay, no significant differences were observed in caries experience 
between CF homozygotes and healthy controls. CF heterozygotes even had a 
significant higher DMF-S than CF homozygotes. CF homozygotes had 
93
  
94 
significantly more low MS counts than both other groups. Apparently CF 
homozygotes seem to be protected against high MS colonization by « salivary 
compensatory mechanisms » or dietary and medication influences, which 
apparently do not result in a significant lower caries experience, compared to 
healthy controls with low MS counts. A larger, multicentre study is recommended, 
to evaluate caries experience differences between these 3 groups. As dental decay 
is a multifactorial infectious disease, it is obvious that many factors may be of 
particular interest for further research in assessing differences in salivary 
composition (organic and inorganic) and salivary (intrinsic and extrinsic) 
biochemical processes in CF homozygotes. 
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Chapter 7 
 
 
The influence of medication and dietary habits on 
caries experience and oral cleanliness in cystic 
fibrosis homozygotes 
 
 
 
 
 
This chapter was submitted for publication as : 
Aps J.K.M., Van Maele G.O.G., Martens L.C. The influence of medication and 
dietary habits on caries experience and oral cleanliness in cystic fibrosis 
homozygotes. 
European Journal of Oral Sciences 2002 ; submitted January 2002 
Part of this chapter was rewarded with the Société Française d’Odontologie 
Pédiatrique-Vivadent award 2001 
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ABSTRACT 
   Cystic fibrosis (CF) homozygotes (n = 42), heterozygotes (n = 48) and healthy 
controls (n = 62) were examined to obtain data on caries experience (DMF) and 
oral cleanliness (dental calculus, dental plaque and gingival bleeding), oral hygiene 
habits and medication use (vitamins, aerosols, antibiotics and pancreas enzymes). 
Results : CF homozygotes had significantly less caries experience and gingival 
bleeding sites than both other groups, while CF heterozygotes had experienced 
significantly larger dental decay. Vitamin preparations, aersols and antibiotics did 
not affect caries experience or oral cleanliness in any of the three study groups. CF 
homozygotes who opened their pancreas enzyme capsules did experience less 
dental calculus than those who did not. CF homozygotes consumed significantly 
more dairy products than both other groups, which can partly explain their lower 
caries experience. It was concluded that the dairy substances in a CF patient’s diet 
played a significant role in the caries experience and gingival health of CF 
homozygotes,  while the role of antibiotics in general was not significant.  
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7.1. Introduction 
   Cystic fibrosis (CF) is the most common lethal autosomal recessive inherited 
disease in Caucasians. About 4 to 5% of the Belgian Caucasian population is 
heterozygous for the CFTR (cystic fibrosis transmembrane regulator) gene, which 
is located on the long arm of chromosome 7 (7q31). Although several hundreds of 
genetic mutations are known, the most common mutation in is Delta-F508. The 
prevalence of the disease is 1 in every 2000 live newborns. In essence, the disease 
affects all exocrine glands (including the salivary glands) and renders their 
respective secretions more viscous than under healthy conditions. CF patients 
consequently suffer from gastro-intestinal (due to pancreatic insufficiency) and 
respiratory problems. Due to this, they are compelled to have supplemental 
pancreas enzymes with every meal, drink and snack, if necessary supplemental 
vitamins (A,D,E and K), frequent antibiotics (per os and I.V.) and daily 
expectorantia and mucolytica (mostly via aerosols) [Hughes and Griffith, 1984 ; 
Tsui, 1991 ; Webb, 1991 ; Aitken, 1993 ; Hodson, 1993 ; Sheppard and Ostegaard, 
1996 ; Hilman, 1997].  
   Literature on CF and oral health is rather scarce. Study results published in the 
1980’s and the beginning of the 1990’s, claimed that CF youngsters (mean age 
7.01 years old) had significantly less caries experience than control subjects 
[Kinirons, 1983 ; Kinirons, 1985 ; Kinirons, 1989 ; Fernald et al., 1990]. This was 
attributed to their higher salivary buffer capacity, higher salivary calcium 
concentration and their frequent use of antibiotics. The latter findings were not 
confirmed in a recent, age matched control study, performed on a CF group with a 
wider age range (mean age 16.3 years old). There seemed to be no significant 
difference in caries experience between CF homozygotes and healthy controls 
[Martens et al., 2001].  
   More recently, CF homozygotes were compared with CF heterozygotes and 
healthy controls. From this study it became clear that CF homozygotes had 
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significantly less salivary Mutans streptococci  colonies, despite their many in-
between-meals and drinks. Further it was shown that CF homozygotes had a 
significant lower caries experience (DMF-T) than both CF heterozygotes and 
controls and that they experienced significantly less gingival bleeding than both 
other study groups [Aps et al., 2001 ; Aps et al., 2002a]. 
   The frequent use of antibiotics was reported to be responsible for a lower caries 
experience in CF patients. It was postulated, alhough not scientifically proven, that 
Mutans streptococci would decrease in number when antibiotics are taken on a 
frequent basis [Kinirons, 1985]. On the other hand several studies in medicine have 
shown a tremendous increase in bacterial resistance against several currently used 
antibiotics and that secondary infections may be the unfortunate result 
[Appelbaum, 1992 ; Levy, 1998 ; Jones, 1999 ; Magee et al., 1999 ; Marsh and 
Martin, 1999c ; Rubinstein, 1999 ; Ameyes, 2000 ; Virk and Steckelberg, 2000]. 
Therefore it can be expected that also in the oral cavity a shift in microflora is 
possible in subjects taking antibiotics on a frequent basis for years on end. The 
latter could explain why in a former study less Mutans streptococci were detected 
in CF homozygotes than in heterozygotes and healthy controls [Aps et al., 2001]. 
The exact effect of antibiotics on caries experience, however, is not known.  
   Further, one can also assume, as suggested in recent literature, that CF 
homozygotes potentially run a high caries risk due to their essential sucrose rich 
diet with many in-between-meal snacks and drinks [Martens and Robberecht, 
1995 ; Martens et al., 2001 ; Aps et al., 2001 ; Aps et al., 2002a] and their frequent 
use of aerosols, of which is also known that it bears a potential caries risk 
[Kankaala et al., 1998 ; Kargül et al., 1998 ; McDerra et al., 1998]. 
   The present study aimed to investigate the use of medication and the differences 
in dietary habits in CF homozygotes, heterozygotes and healthy controls, analysed 
against caries experience, dental plaque, dental calculus and sulcus bleeding as 
response variables.  
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7.2. Material and methods. 
7.2.1. Patient selection 
   CF homozygotes (n = 42) were recruited from the Belgian Association for the 
Fight Against Cystic Fibrosis. Their mean age was 16.2  8.1 years. Via the CF 
homozygotes, genetically proven CF heterozygotes (n = 48) were contacted. Due to 
ethical issues, no CFTR genetic identification could be performed on control 
subjects as permission was not granted by the Ghent University Hospital’s ethical 
committee. As a consquence CF heterozygotes were mainly older brothers or 
sisters and parents of the CF homozygotes, which automatically  resulted in a mean 
age of 29.5  15.9 years for this study group. Healthy controls (n = 62), excluding 
CF homozygote related persons, subjects suffering from cardiovascular, genito-
urinary, endocrine or infectious diseases, were recruited from the Ghent University 
Dental out-patient clinic and from the CF patients’ and CF heterozygotes’ 
environment. Their mean age was 19.9  11.5 years. 
   The study was approved by the Ghent University Hospital’s ethical committee 
and all participants signed an informed consent.  
 
 
7.2.2. Caries experience and oral cleanliness parameters 
   Prior to the study, the investigator (J.A.) was trained and calibrated at baseline 
according to the guidelines from the Bristish Association for the Study of 
Community Dentistry [Pine et al., 1997 ; Pitts et al., 1997]. The investigator’s over-
all kappa values for the in vitro and in vivo calibration exercise were 0.84 and 0.76 
respectively, both standing for an acceptable interreliabilty with an experienced 
examiner as benchmark [Martens et al., 2001]. All clinical examinations were 
carried out by the same investigator (J.A.), with the subjects in a horizontal 
position. A white light source, a WHO/CPITN-type E probe, cotton rolls and a 
dental mirror were the only tools used. No radiographs were taken. Most of the CF 
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homozygotes and heterozygotes were examined at home, as many CF homozygotes 
were appropriately afraid to become infected with Pseudomonas in a hospital 
environment. Caries experience was expressed as DMF-T and DMF-S. Caries was 
recorded at the level of cavitation. Oral cleanliness parameters, a recording of 
dental plaque, dental calculus and gingival bleeding, were collected from every 
participant. As the purpose of this study was to obtain data on the presence and not 
on the amount of dental plaque and calculus per tooth or per surface (with 
exception of the occlusal surface), and as in most cases subjects were examined at 
home, a fast and easy recording technique was considered most appropriate. In 
order to compare data from literature, all teeth, except the third molars were 
involved. Visual presence of plaque and calculus were scored  1 and absence was 
scored as  0 . In case of doubt, a CPI probe [WHO, 1997] was used for 
verification. Consequently the presence of dental plaque and calculus was recorded 
as a numerical value, both on tooth and on surface level [Aps et al., 2002a].  
   The gingival status was recorded after assessing caries experience, dental 
calculus and dental plaque. A simplified version of the Löe gingival index (GI) 
[Loë, 1967] was used; score 0 was absence of bleeding after gentle probing with 
a CPI probe [WHO, 1997] and scores 1 to 3 were converted into one score (score 
1) corresponding to bleeding after gentle probing. This was recorded for every 
tooth present (apart from the third molars) and for the respective surfaces. For the 
reasons mentioned above, as it was not the aim of the study to investigate the 
severeness of the gingival status, no extensive bleeding index notation was 
considered necessary [Aps et al., 2002a]. 
 
7.2.3. Medication inquiry 
   Every subject was asked to make a list of all medication they took on a regular 
basis or which they had been taking for a long period of time (= maintenance 
rations). The aim of this part of the study was to verify what kind of medication 
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had any influence on the caries experience and oral cleanliness of the subjects in 
this study. These data were subsequently catalogued into 3 categories; vitamin 
preparations, antibiotics, aerosols and others. The category of aerosols could 
contain mucolytica, expectorantia or antibiotics. The “others” category was not 
used for further statistical analysis, as it contained irrelevant data, such as 
anticonceptiva. 
   In case of CF patients, the number of pancreas enzyme capsules (Pancrease
®
 or 
Creon
®
) as well as the mode of intake (open or closed capsules) were recorded. The 
number of capsules per meal were dichotomized (< 10 capsules / meal and 10 
capsules / meal) as this was considered most appropriate for further statistical 
analysis.  
 
7.2.4. Dietary habits 
   The investigator (J.A.) interviewed every subject, to obtain information on their 
dietary habits. The interview was based on a questionnaire, which was used with 
success in the past and of which the validity was shown [Rise et al., 1991a; Rise te 
al., 1991b; Goldbohm et al., 1994; Osler and Heitman, 1996; Vanobbergen, 2001; 
Bolin et al., 1997a,b]. The authors had obtained experience, working with this 
questionnaire, during their collaboration with the “Children’s dental health in 
Europe” project [Bolin et al., 1997b]. It was accepted that possible noise would lead 
to an equal shift of the results, but as statistical analyses models were used with a 
dichotomised outcome and explanatory variables, this was to be minimised 
[Vanobbergen, 2001]. As the subjects were aware that the investigator was a 
dentist, specific questions about cariogenic food substances (e.g. sweets, soft drinks 
and fruitjuices) were banned from the interview. As a consequence, the investigator 
could filter biassed answers, which are usually difficult to distinguish in a written 
questionnaire filled in by the subjects themselves.  
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   The interviewer probed for the composition of every meal and snack as well as 
the time of the day when was eaten and drunk and how and where this was carried 
out. During the interview, the investigator immediately recorded all data in an 
Access
®
 data file (Microsoft
®
 Corporation). Some data were immediately 
dichotomized during input (e.g. “I have breakfast every day / I do not have 
breakfast every day”) and others were recorded more into detail (e.g. “I drink tea / 
coffee / tea with sugar / coffee with sugar / … at breakfast”). In order to facilitate 
the statistical analyses, answers were listed into categories.; 
   Drinks were divided into 4 categories, being ; “no drinks, sweetened drinks (e.g. 
fruit juices, soft drinks, coffee with sugar), non sweetened drinks (e.g. black coffee, 
plain tea, water) and dairy drinks (e.g. milk, yogurt, coffee with milk)”.  
   Foods were divided into 3 categories, being ; ”a hot meal, a sandwich-like meal 
with a sweet filling  (e.g. marmalade) and a non-sweet filling (e.g. meat, cheese, 
vegetables, salads)”.  The desserts were categorized into 4 groups, being ; “ no 
dessert, a sweet dessert (e.g.  pie, candy bar), fruit and a non-sweet dessert (e.g. 
cheese)”.  Snacks were divided into drinks and food, being ; “no drink, a sweetened 
drink (e.g. fruit juices, soft drinks, coffee with sugar),  a non-sweetened drink (e.g. 
plain tea or coffee), dairy drinks (milk, yogurt, tea with milk), a sweet snack (e.g. 
candy bar, cookies), fruit and non-sweet snacks (e.g. a cheese or ham sandwich)”. 
  
7.3. Statistical analysis 
 The statistical analysis was performed within specific categories (see Table 7.1.) 
by means of the SPSS program. Pearson chi-square tests were used to investigate 
differences in dietary habits between the three groups of subjects. The Mann-
Whitney U-test was used to investigate differences between dietary habits and 
medication use with caries experience and oral cleanliness as response variables. 
The level of significance was choosen at   0.05.  
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7.4. Results 
7.4.1. Caries experience and oral cleanliness 
   Table 7.1. shows the caries experience and oral cleanliness data for the three 
study groups. From this table it was clear that CF homozygotes had a significant 
lower caries experience than CF heterozygotes (P = 0.011) and controls (P < 
0.001). The extensiveness of the caries experience (DMF-S) was also significantly 
lower in CF homozygotes than in both other groups (P = 0.004 and P < 0.001 
respectively).  
 
Table 7.1. : Mean caries experience and oral cleanliness data for CF homozygotes 
                    (n = 42), CF heterozygotes (n = 48) and healthy controls (n = 62) and 
                    the results of the statistical analyses 
 
 
 
 
 
 
 
 
 
 
 
 
 
They also had significantly less gingival bleeding sites than CF heterozygotes (P = 
0.011) and control subjects (P = 0.017). There were no significant differences 
between the three groups for dental plaque and calculus. 
CF homoz. 
(A) 
CF heteroz. 
(B) 
Controls 
(C) 
Kruskal-
Wallis Test 
Mann-Whitney U-Test 
P-value 
 
N = 42 N = 48 N = 62 ABC AB AC BC 
DMF-T  		
 	 0.001 0.011 < 0.001 0.060 
DMF-S 	 	 		 < 0.001 0.004 < 0.001 0.058 
 
Surfaces with 
plaque 

	
 


 


 
 
0.649 
 
0.378 
 
0.804 
 
0.475 
 
Surfaces with 
calculus 


 

 


 
 
0.343 
 
0.202 
 
0.869 
 
0.215 
Surfaces with 
gingival 
bleeding 


 

 

		 
 
0.026 
 
0.011 
 
0.017 
 
0.577 
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7.4.2. Medication effects  
   Aerosols, vitamin preparations or antibiotics did not have a significant influence 
on caries experience or oral cleanliness in any of the three groups. Figure 7.1. 
shows the results for the CF homozygotes. It should be stressed that obviously, 
very few CF heterozygotes and control subjects used this kind of medications on a 
regular basis.  
Figure 7.1. : Mean caries experience (DMF-T and DMF-S) and oral cleanliness 
                     data (mean number of teeth with plaque, calculus and gingival 
                     bleeding) as a function of the type of medication in cystic fibrosis  
                     homozygotes (n = 42) 
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Sixty nine percent of CF homozygotes were under aerosol maintenance ration, 57% 
of them under vitamin preparation maintenance ration and 26% under antibiotics 
maintenance ration. The pancreas enzymes, which were obviously only recorded to 
be taken daily in the CF homozygote group, appeared to play a role in the 
occurrence of dental calculus (fig.7.2.). CF patients (18%) who opened their 
enzyme capsules had significantly less teeth with dental calculus than those who 
did not (P = 0.033). 
 
7.4.3. Dietary habits 
   From table 7.2., it can be concluded that significantly (P = 0.050) more CF 
homozygotes than CF heterozygotes had dairy drinks for breakfast. It was further 
shown that more CF homozygotes than controls had a drink with their forenoon 
snack. About 50% of control subjects had no drink whatsoever.  
   The type of drink, during the forenoon snack, was also significantly different (P = 
0.001) between the three groups. CF homozygotes had more dairy drinks and 
sweetened drinks (e.g. Coca Cola®) and less non-sweetened drinks than the others. 
The latter was confirmed (P < 0.001) when CF homozygotes were compared with 
controls.  
   There was a significant difference in lunch composition between the three groups               
(P = 0.042). CF homozygotes had significantly (P = 0.035) more often a hot meal 
for lunch than controls. The latter also held for CF heterozygotes (P = 0.035), when 
compared to control subjects. CF homozygotes also had significantly (P = 0.023) 
more often a sweetened dessert after lunch than controls.  
   The composition of the afternoon drinks was significantly different (P = 0.020) 
between the three groups. Significantly more (P = 0.013) CF homozygotes than 
controls subjects had a sweetened or dairy drink with their afternoon snack. 
Significantly fewer (P = 0.017) CF homozygotes had fruits as a snack in the 
afternoon than controls. 
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   Significantly (P = 0.044) more CF homozygotes had sweet fillings for diner than 
the others, while most controls seemed to have a hot meal for diner. Significantly 
more (P = 0.014) CF homozygotes than CF heterozygotes had a dairy drink during 
diner.  
   Significantly more (P = 0.019) CF homozygotes than controls had a late-night 
snack, which was in most cases non-sweetened (P = 0.021), in combination with   
(P = 0.016) dairy or sweetened drink .  
 
Figure 7.2. : Mean caries experience (DMF-T and DMF-S) and oral cleanliness 
                     data (mean number of teeth with plaque, calculus and gingival 
                     bleeding) as a function of the mode of pancreas enzyme intake in 
                     cystic fibrosis homozygotes (n = 42) 
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Table 7.2. : Descriptive data and statistical comparison of the dietary habits of CF 
                    homozygotes (-A-), CF heterozygotes(-B-) and healthy controls (-C-) 
                    (-Pearson Chi-square test - significant differences are  typed in bold) 
         
    -A- -B- -C-       A B C  A  B  A  C    B  C 
    N = 42 N = 48 N = 62 P P P P 
 
Breakfast ( yes )   86% 90% 90% 0.749     0.405        0.337          0.571 
No drink with breakfast  14% 10% 10% 
Sweetened drink with breakfast  26% 23% 31% 0.132     0.050        0.744          0.132 
Non sweetened drink with breakfast 21% 48% 27% 
Dairy drink with breakfast  38% 19% 32% 
Warm breakfast   19% 23% 23% 
Sweet breakfast   71% 56% 61% 0.581     0.245        0.508          0.800 
Non sweet breakfast   10% 21% 16% 
 
Forenoon snack or drink ( yes ) 71% 75% 68% 0.706     0.442        0.430          0.269 
No drink with the snack  26% 31% 52% 
Sweetened drink with the snack  43% 27% 15% 0.001     0.066     < 0.001          0.118 
Non-sweetened drink with the snack 10% 29% 27% 
Dairy drink with the snack  21% 13% 7% 
Sweet snack   31% 21% 16% 
Fruit for snack   2% 10% 11% 0.481     0.376       0.146          0.922 
Non-sweet snack   19% 21% 24% 
 
Lunch ( yes )   93% 98% 98% 0.256    0.259       0.179           0.685 
No drink with the lunch  14% 8% 8% 
Sweetened drink with the lunch  48% 38% 40% 0.256    0.058       0.471           0.308 
Non-sweetened drink with the lunch 31% 54% 45% 
Dairy drink with the lunch  7% 0% 7% 
Hot meal for lunch   50% 48% 26% 
Sweet filling for lunch  14% 6% 16% 0.042    0.363      0.035            0.035 
Non-sweet filling for lunch  36% 46% 58%  
No dessert after lunch  60% 69% 82% 
Sweet dessert after lunch  36% 23% 13% 0.065    0.247      0.023            0.255 
Fruit after lunch   2% 8% 5% 
Non-sweet dessert after lunch  2% 0% 0% 
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-A- -B- -C-       A B C  A  B  A  C    B  C 
    N = 42 N = 48 N = 62 P P P P 
  
Afternoon snack or drink ( yes ) 83% 71% 69% 0.244      0.125     0.082          0.518 
No drink with the snack  26% 38% 45% 
Sweetened drink with the snack  38% 19% 29% 0.020      0.062     0.013          0.144 
Non-sweetened drink with the snack 19% 35% 24% 
Dairy drink with the snack  17% 8% 2% 
Sweet snack    29% 25% 15% 
Fruit for snack   5% 10% 18% 0.090      0.392     0.017          0.393 
Non-sweet snack    36% 23% 19% 
 
Diner ( yes )   98% 100% 100% 0.268      0.467     0.404          1.000 
No drink with diner   7% 21% 18% 
Sweetened drink with diner  29% 21% 29% 0.086      0.014     0.372          0.130 
Non-sweetened drink with diner  50% 58% 45% 
Dairy drink with diner  14% 0% 8% 
Hot meal for diner   67% 65% 81% 
Sweet fillings with diner  17% 6% 3% 0.044      0.157     0.053          0.165 
Non-sweet fillings with diner  17% 29% 16% 
No dessert after diner   55% 63% 60% 
Sweet dessert after diner  41% 33% 32% 0.846     0.594      0.710          0.750 
Fruits after diner   5% 2% 7% 
Non-sweet desserts after diner  0% 2% 2% 
 
Late-night snack or drink  ( yes ) 83% 71% 63% 0.079     0.125      0.019          0.252 
No drink with late-night snack  29% 33% 42% 
Sweetened drink with late-night snack 36% 21% 29% 0.016     0.012      0.073          0.278 
Non-sweetened drink with late-night snack 14% 40% 23% 
Dairy drink with late-night snack 21% 6% 7% 
Sweet late-night snack  14% 6% 8% 
Fruit for late-night snack  5% 8% 8% 0.083     0.064      0.021          0.937 
Non-sweet late-night snack  57% 38% 32% 
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7.4.4. Correlations between dietary habits and caries experience and oral 
cleanliness 
   It was found that control subjects had a significant lower caries experience both 
on tooth (P = 0.008 ) as on surface (P = 0.019) level when they had dairy products 
for breakfast. They also had significant less dental calculus (P = 0.026) than 
controls having no dairy products for breakfast. Control subjects who had 
sweetened drinks with their lunch had significantly less dental plaque (P= 0.033) 
and calculus (P= 0.001) than those who had another drink.  
   When their lunch consisted of sweet fillings, it was found that these controls had 
significantly (P = 0.014) less dental calculus than those who had something else for 
lunch. 
   Control subjects, having a late-night snack, had a significantly (P = 0.043) higher 
DMF-S than those who did not have a late-night snack. For DMF-T this difference 
was bordeline not significant (P = 0.054). 
   CF heterozygotes who had breakfast, showed significantly more dental calculus 
(P = 0.018) than those who did not have breakfast at all. It was observed that those 
who had a breakfast, which was composed of sweetened substances, had 
significantly less dental calculus (P = 0.044) and a significant lower caries 
experience on tooth (P = 0.025) and on surface level (P = 0.016). CF heterozygotes 
who had a sweetened forenoon drink, had significantly less caries experience, both 
on tooth (P = 0.005) and on surface level (P = 0.007) than those who had 
something else to drink. The latter finding was confirmed for drinking a sweetened 
drink during lunch (P = 0.017 and P = 0.018 respectively). CF heterozygotes, who 
had a late-night snack or drink, had significantly more caries experience, both on 
tooth (P = 0.013) as on surface level (P = 0.031), than those who did not eat or 
drink late at night. 
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    CF homozygotes who had a sweet dessert after diner, had a significant lower 
caries experience, both on tooth (P = 0.014) as on surface level (P = 0.019), than 
CF homozygotes who did have a piece of fruit as dessert or no dessert at all.  
 
7.5. Discussion 
   This study showed that the influence of medication, such as aerosols and 
antibiotics, on oral cleanliness and caries experience in CF patients was rather 
moderate and insignificant. The latter is unexpected as in earlier reports on CF 
patients, it was postulated that the frequent use of antibiotics was partly responsible 
for a significant lower caries experience in CF homozygotes [Kinirons, 1985]. As 
the effect of pancreas enzyme capsules was never investigated before, it was 
surprising that CF homozygotes who opened their pancreas enzyme capsules had 
significantly less dental calculus than those who did not open them. Although no 
explanation can be found immediately for this finding, it deserves to be 
investigated into depth, whether certain constituents of these pancreas enzyme 
capsules could be potential anti-tartar agents. 
   Dietary habits were clearly different between the three groups, which, in turn, can 
be partly held responsible to explain the differences in caries experience. From this 
study it became clear that sweetened food substances are not necessarily 
cariogenic. The time of the day and the combination with other foodsubstances 
seemed to play a significant role. The latter supported recent reports on the 
cariogeneicity of foodsubstances [Duggal and Van Loveren, 2001; Van Loveren 
and Duggal, 2001].  
   CF homozygotes consumed significantly more dairy products than the others. 
The effects of milk and cheese on caries development have been described and 
investigated in the past [König, 1967; Edgar et al., 1975; Rugg-Gunn et al., 1978]. 
In particular calcium, phosphate, casein, IgA and fats were investigated and it was 
concluded that dairy products could be considered as being anticariogenic. 
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Therefore, it can be assumed that the more dairy products are consumed, the more 
frequent the oral environment is buffered, due to phosphate and calcium. As the 
latter is not the most favorite ecological environment, the number of Mutans 
Streptococci would decrease considerably. This can probably explain the earlier 
reported findings [Aps et al., 2001], showing that apparently CF homozygotes 
seemed to be protected against Mutans Streptococci attacks, which occur 
preferably in sucrose rich environments.  
   Casein, an enzyme, incorporated in cheese and milk [Reynolds et al., 1981; Van 
Loveren and Van der Weijden, 1996b] could also be the key to the low caries 
experience in CF homozygotes. If casein indeed enhanced enamel remineralization, 
it compensated the expected cariogenic effect of sucrose rich supplements, which 
CF homozygotes are obliged to take at regular moments of the day. If enhancement 
of enamel remineralization actually plays an important role, an increase of the 
mineral content (i.e. calcium phosphate) should be present in CF homozygotes. If 
so, the latter would imply that the above mentioned frequent intake of antibiotics is 
not the only extrinsic determining factor for their significant reduced caries 
experience as already suggested in earlier studies [Kinirons, 1983; Kinirons, 1985; 
Kinirons, 1989; Fernald et al., 1990].  
    It was interesting to find that the use of dairy products also resulted in caries 
experience and oral cleanliness differences in control subjects and CF 
heterozygotes. The use of dairy products seemed to result in a significant lower 
amount of dental calculus within both controls and CF heterozygotes, but not 
within CF homozygotes. The significant lower number of teeth covered with 
plaque and calculus in controls that consumed a sweetened drink during lunch, 
showed that sweetened drinks within a meal did not affect oral cleanliness 
negatively, as might be expected. In CF heterozygotes, breakfast seemed to have 
great impact on dental calculus and caries experience. It seemed, however, that the 
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importance of certain kinds of foods and drinks for the development of caries, 
plaque and calculus, should not be exagerated too much.  
   Moreover, it has to be further investigated if the better gingival status in CF 
homozygotes can be attributed to a better oral health care in this particular group of 
medically compromized patients or to particular salivary properties which protect 
them from gingival inflammation. 
   The fact that caries experience was significantly higher in CF heterozygotes than 
in CF homozygotes, can, however, not be explained by their dietary habits alone 
[Duggal and Van Loveren, 2001; Van Loveren and Duggal, 2001]. It has to strike 
one’s mind that CF heterozygotes in this study were all related to the CF 
homozygotes.        
   As such, they all lived in the same environment and had globally the same food, 
except less dairy products. Nevertheless, they had experienced more dental decay 
than their CF homozygote family members. Besides the higher mean age of the CF 
heterozygote group, which obviously was caused by the CF heterozygotes mainly 
being parents and older brothers and sisters of the CF homozygotes, the aspect of 
oral hygiene should be taken into account as well. Perhaps, CF heterozygotes are 
not that aware of their oral hygiene as are CF homozygotes, who are constantly 
remembered of microorganisms, threatening their live.  
   Finally it can be assumed that differences in salivary composition are responsible 
for CF heterozygotes experiencing more dental decay than both CF homozygotes 
and control subjects.  
 
7.6. Conclusion 
   It was concluded that dietary habits (increased intake of dairy products) can 
partly be held responsible for the differences in caries experience and oral 
cleanliness between CF homozygotes, CF heterozygotes and controls. The 
anticariogenic effect of dairy products during meals and in-between-meals can be 
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appointed as one of the compensatory mechanisms in the multicausal caries 
process. The supposed negative influence of regular use of aerosols or antibiotics 
on oral health was not confirmed in this study and therefore intrinsic salivary 
properties in CF homozygotes probably may also be held partly responsible for 
their significant better oral health.  
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ABSTRACT 
   Oral hygiene habits in cystic fibrosis (CF) homozygotes  (n = 42), heterozygotes 
(n = 48) and healthy controls (n = 62) were used in a multivariate analysis with 
caries experience (DMF-T) and oral cleanliness (dental plaque, calculus and 
gingival bleeding) as response variables.  
CF homozygotes had a significantly lower caries experience (P  0.001) and less 
gingival bleeding sites (P 0.02). Oral hygiene habits were not significantly 
different between the three groups, except for intake of fluoride supplements. 
Significantly more CF homozygotes had received fluoride supplements. Oral 
hygiene habits did affect caries experience or oral hygiene differently in each study 
group.  
No matter what oral hygiene habits were, CF homozygotes had an overall better 
oral health status. Apparently they seemed to possess intrinsic salivary 
compensatory mechanisms, as the significant higher use of fluoride supplements 
appeared not to be responsible for the better oral health. 
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8.1. Introduction 
   Cystic fibrosis (CF) is the most common lethal autosomal recessive inherited 
disease in Caucasians. About 4 to 5% of the Caucasian population is heterozygous 
for the CFTR (cystic fibrosis transmembrane regulator) gene, which is located on 
the long arm of chromosome 7 (7q31). Although several hundreds of genetic 
mutations are known, the most common mutation in Western Europe is Delta-
F508. The prevalence of the disease is 1 in every 2000 live newborns. In essence, 
the disease affects all exocrine glands (including the salivary glands) and renders 
their respective secretions more viscous than under healthy conditions. CF patients 
consequently suffer from gastro-intestinal (due to pancreatic insufficiency) and 
respiratory problems. Due to this, they are compelled to have supplemental 
pancreas enzymes with every meal, drink and snack, supplemental vitamins (A,D,E 
and K) if necessary, frequent antibiotics (per os, via aerosols and I.V.) and daily 
expectorantia and mucolytica (mostly via aerosols) [Hughes and Griffith, 1984 ; 
Tsui, 1991 ; Webb, 1991 ; Aitken, 1993 ; Grundy et al., 1993 ; Hodson, 1993 ; Vay 
Liang et al., 1993 ; Sheppard and Ostegaard, 1996 ; Hilman, 1997].  
   Literature published in the 1980’s and the beginning of the 1990’s, claimed that 
CF youngsters (mean age 7.0 years) had significantly less caries experience than 
control subjects [Kinirons, 1983 ; Kinirons, 1985 ; Kinirons, 1989 ; Fernald et al., 
1990]. This was attributed to their higher salivary buffer capacity, higher salivary 
calciumconcentration and their frequent use of antibiotics. A more recent age 
matched control study, performed on a CF group with a wider age range  (mean 
age 16.3 years) [Martens et al., 2001], reported no significant differences in caries 
experience between CF homozygotes and healthy controls. Due to lack of 
diagnostic tools, no information on CF heterozygotes was available in the 1980’s 
and as a consequence they were unavoidably included in the healthy control study 
groups.  
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   Recently a study [Aps et al., 2001] was published in which CF homozygotes, CF 
heterozygotes and healthy controls were compared. No significant differences in 
caries experience between these 3 groups, were found. CF homozygotes, 
nevertheless, had significantly less salivary Mutans Streptococci counts. In a 
continuing study [Aps et al., 2002a]
 
on a larger sample of CF homozygotes, CF 
heterozygotes and healthy controls it was shown that CF heterozygotes had 
significantly larger restorations than CF homozygotes, while the latter had also a 
significantly lower caries experience than healthy controls. CF homozygotes were 
also reported to have significant less bleeding gingival sites than CF heterozygotes 
and controls.  
   Several presumptions, dealing with compensatory salivary mechanisms, inherent 
to their disease, were mentioned in these reports, which could serve as an 
explanation for CF homozygotes experiencing less dental decay than others, 
despite the assumption them running a high caries risk (e.g. frequent in-between-
sucrose-rich-snacks and drinks and daily aerosols). From an analysis of their 
dietary habits [Aps et al., 2002b]
 
it was concluded that CF homozygotes may 
experience positive benefit from consuming lots of dairy products, whether 
sweetened or not. But as caries is a multifactorial infectious disease, other aspects 
of influence should be investigated also. 
   The present study, therefore, aimed to investigate oral hygiene habits in CF 
homozygotes, heterozygotes and healthy controls. Consecutively, these variables 
were used in a multivariate analysis with caries experience (DMF-T) and oral 
cleanliness (dental plaque, dental calculus and gingival bleeding) as response 
variables.  
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8.2. Material and methods 
8.2.1. Patient selection 
   Both CF homozygotes (n = 42, 16.2  8.1 years) and genetically proven CF 
heterozygotes (n = 48, 29.5  15.9 years) were recruted via the Belgian Association 
for the Fight Against Cystic Fibrosis. The high mean age of the CF heterozygotes 
can be explained by the fact that the CF heterozygote group consisted of parents 
and mainly older brothers and sisters of CF homozygotes. Healthy controls (n = 62, 
19.9  11.5 years), excluding subjects suffering from cardiovascular, genito-
urinary, neurological, endocrine or infectious diseases, were recruted from the 
Ghent University Dental out-patient clinic and from the CF patients’ and CF 
heterozygotes’ environment. The study was approved by the Ghent University’s 
medical ethical committee and for all subjects an informed consent was obtained.  
 
8.2.2. Caries experience and oral cleanliness 
   The methodology to record caries experience (DMF-T) and oral cleanliness 
(dental plaque, dental calculus and gingival bleeding) were already extensively 
described elsewhere [Martens et al., 2001 ; Aps et al., 2002a]. All teeth, except for 
the third molars, were included in the recording of the oral cleanliness parameters. 
Consequently the mean number of teeth with plaque, calculus and gingival 
bleeding in every study group was obtained. 
 
8.2.3. Patient questionnaire 
   To avoid misunderstandings, unanswered questions and biasses, every study 
subject was questioned by the same investigator (J.A.). By interviewing these 
subjects, the investigator was able to obtain objective information about their oral 
hygiene attitudes. All answers were dichotomized as “yes” or “no” immediately 
while entering the data in the database (Microsoft Access 2000, 
©
 Microsoft 
Corporation).  
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   Answers to the following items on oral hygiene measures were obtained after 
interviewing every subject; 
 I brush less than twice a day / I brush at least twice a day 
 I do not brush my teeth in the morning / I brush my teeth in the morning 
 I do not brush my teeth in the evening / I brush my teeth in the evening 
 I use at least a pea size of toothpaste / I use at least one centimetre of 
toothpaste 
 I do not use a fluoride containing toothpaste / I use a fluoride containing 
toothpaste 
 I use a regular toothbrush / I use an electrical toothbrush 
 I never use a fluoride containing mouthrinse / I use a fluoride containing 
mouthrinse 
 I never had fluoride supplements (drops or tablets) / I had fluoride supplements 
 I never use a chlorhexidine containing mouthrinse / I use a chlorhexidine 
containing mouthrinse 
 I never use dental floss / I use dental floss 
 I never use toothpicks / I use toothpicks 
    
8.3. Statistical analysis 
   Appropriate statistical analysis was performed by means of the SPSS program. A 
Kruskal-Wallis test was used to investigate differences in caries experience and 
oral cleanliness between the three groups of subjects. Subsequently a Mann-
Whitney U-test was used to investigate these data between two subject groups at a 
time. A Pearson Chi-square test was used to investigate differences in oral hygiene 
habits and oral health knowledge. Regression analysis with the oral hygiene habits 
as covariables and caries experience, dental plaque, dental calculus and gingival 
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bleeding as response variables was performed.  The level of significance was 
choosen at  = 0.05.  
 
8.4. Results 
8.4.1. Caries experience and oral cleanliness 
   It can be derived from table 8.1. that CF homozygotes had significantly less 
caries experience than CF heterozygotes (P < 0.001) and healthy controls (P = 
0.011) as well as significantly less gingival bleeding than CF heterozygotes (P = 
0.014) and healthy controls    (P = 0.019). 
   CF heterozygotes had experienced significantly more extractions and had 
significantly more restored teeth than CF homozygotes (P < 0.001 and P = 0.043 
respectively). They also had experienced more extractions than healthy controls (P 
= 0.008).  
 
Table 8.1. : Caries experience (DMF-T) and oral cleanliness (gingival bleeding,  
                    dental plaque and dental calculus on tooth level) in CF homozygotes 
                    (N = 42), CF heterozygotes (N= 48) and Healthy controls (N = 62) 
 
 
 
 
 
 
 
 
 
 
 
 CF homoz CF heteroz Control  Kruskal-Wallis       Mann-Whitney U -   
               Test   Test 
N = 42  N = 48  N = 62      P  -   v a l u e s  
 -A-  -B-  -C-  A C A  C B C 
DMF-T   		
 	      
D-T 0.31 (
 
	     

  
M-T 0.26 
	 	 	    	 
F-T 3.52 ( 

    
  	 
Plaque 3.62 (  

   
  
Calculus 1.93 ( 
     
 
Gingival 0.24 (	  
 

    	 
bleeding  
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8.4.2. Oral hygiene habits 
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   Table 8.2. shows that only the fact of having received any fluoride supplements 
was significantly different between the three groups (P = 0.037). Significantly 
more CF homozygotes than CF heterozygotes (P = 0.010) had used fluoride 
supplements (either drops or tablets).  
 
Table 8.2. : Descriptive data on oral hygiene habits in CF homozygotes (N = 42),  
                    CF heterozygotes (N = 48) and healthy controls (N = 62) and the  
                   appropriate statistical analyses results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   CF homoz CF heteroz Controls           Pearson Chi- Square Test   
   N = 42  N = 48  N = 62     P  -  v a l u e s  
   -A-  -B-  -C- A C A  C B C
 
 I brush 2/day  91%  90%  94%     0.736  0.341 0.413 0.341 
I never brush my teeth 0%  2%  5%     0.306  0.533 0.208 0.411 
I brush in the morning 76%  56%  69%     0.118  0.038  0.296 0.112 
I brush in the evening 71%  79%  87%     0.140  0.272 0.042 0.196 
I use pea size toothpaste 38%  50  50     0.434  0.378 0.160 0.518 
Fluoride toothpaste 100%  96%  97%     0.436  0.282 0.353 0.589 
Electrical toothbrush 24%  25%  18%     0.610  0.547 0.304 0.244 
Fluoride rinse  0%  6%  5%     0.283  0.147 0.280 0.532 
Fluoride supplements 64%  38%  47%     0.037  0.010 0.059 0.218 
Chlorhexidine rinse  5%  2%  5%     0.725  0.450 0.679 0.411 
I floss   10%  23%  18%     0.239  0.077 0.189 0.331 
I use toothpicks  14%  23%  24%     0.444  0.220 0.162 0.530 
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8.4.3. Effects of oral hygiene habits on caries experience 
   CF homozygotes who brushed their teeth in the morning (P = 0.009) as well as 
those who brushed in the evening (P = 0.016) or those who used toothpicks (P = 
0.002) had a significantly higher DMF-T. 
   Caries experience was significantly higher in CF heterozygotes who did not 
receive any fluoride supplements (P = 0.028) or who used dental floss (P = 0.002).  
   Healthy controls who used a fluoride containing toothpaste (P = 0.038), or those 
who never got fluoride supplements (P = 0.050) had a significant higher caries 
experience. The same was observed in control subjects who used dental floss (P = 
0.002) or toothpicks (P = 0.033). 
 
8.4.4. Effects of oral hygiene habits on oral cleanliness 
   CF homozygotes who used an electrical toothbrush experienced significantly 
more dental calculus (P = 0.042) than those who used a regular toothbrush.  
   CF heterozygotes who did not brush in the evening encountered significantly 
more dental calculus (P = 0.015), as did those who never received any fluoride 
supplements (P = 0.013) or never used toothpicks (P = 0.002). CF heterozygotes 
who did not get any fluoride supplements also experienced significantly more 
plaque (P = 0.047), as did those who used toothpicks (P = 0.036). Besides, using 
toothpicks also resulted in significantly more gingival bleeding (P = 0.018) in this 
group.  
   Healthy control subjects who brushed their teeth in the morning (P = 0.029), or 
who never received fluoride supplements (P = 0.019) or those who used toothpicks 
(P = 0.031) experienced significantly more dental calculus than those who did the 
opposite. Gingival bleeding was significantly higher in those healthy controls who 
brushed less than twice a day (P = 0.044) or never received any fluoride 
supplements (P = 0.004). 
 
123
  
124 
8.5. Discussion 
   It was interesting that CF homozygotes, a group of medically compromised 
individuals who could be supposed to run a high caries risk due to their dietary 
obligations and medication intake [Martens et al., 2001; Aps et al., 2001; Aps et al., 
2002a; Aps et al., 2002b], had a significantly lower caries experience than CF 
heterozygotes and healthy controls (table 8.1.). It was suggested in recent literature 
that CF homozygotes may in a way be protected against dental decay and that 
certain salivary mechanisms may be involved
 
[Martens et al., 2001; Aps et al., 
2001; Aps et al., 2002a; Aps et al., 2002b; Aps et al., 2002c].  
 
Figure 8.1a. : Schematical representation of the effect of NOT brushing in the 
                        morning or NOT brushing in the evening or NOT having had 
                        fluoride supplements or NOT using dental floss or toothpicks on 
                        caries experience (mean DMF-T) in CF homozygotes, CF 
                        heterozygotes and healthy controls 
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On the other hand, it was remarkable to notice that CF heterozygotes, who are not 
clinically affected by the CFTR gene, apparently ran a higher caries risk than 
healthy controls and CF homozygotes. They also had experienced significantly 
more extractions than the others and in a previous report [Aps et al., 2002a] it was 
also mentioned that the extensiveness of their restorations was significantly larger.  
   The number of teeth with hypertrofic and/or hyperaemic gingival margins was 
significantly lower in CF homozygotes than in CF heterozygotes. On the other 
hand it should be emphasized that the number of teeth covered with plaque was the 
highest in CF homozygotes, although the difference between the three groups was 
not significant.  
 
Figure 8.1b. : Schematical representation of the effect of brushing in the morning 
                       or brushing in the evening or having had fluoride supplements or 
                       using dental floss or toothpicks on caries experience (mean DMF-T) 
                       in CF homozygotes, CF heterozygotes and healthy controls 
 
 
 
 
 
 
 
 
 
 
 
   While plaque in general is expected to induce gingival inflammation, it was 
suggested earlier that dental plaque in CF homozygotes is probably composed of 
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other micro-organisms than in CF heterozygotes and control subjects [Aps et al., 
2001; Aps et al., 2002a], which could explain why they had significantly less 
bleeding sites than CF heterozygotes and controls. Perhaps this supposed less 
pathogenic plaque flora could also be responsible for CF homozygotes 
experiencing significantly less dental decay. 
   This study showed that very little differences can be found between these three 
groups regarding their oral hygiene habits. Only the fact of having received 
fluoride supplements of any kind (droplets or tablets) was significantly different. 
Sixty four percent of CF homozygotes against 38% CF heterozygotes and 48% 
healthy controls had received fluoride supplements.  
 
Figure 8.2a. : Schematical representation of the effect of NOT brushing in the 
                        morning or NOT brushing in the evening or NOT having had  
                        fluoride supplements or NOT using dental plaque or toothpicks on  
                       dental calculus (mean CI) in CF homozygotes, CF heterozygotes and  
                        healthy controls 
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Probably their pediatricians may have prescribed this “medication” additionally to 
their already extensive list of obligatory medications, inherent to their medical 
condition. This could be interpreted as a kind of “overtreatment” or reassurement 
of the patients’parents.  
   The effects of oral hygiene habits on caries experience and oral cleanliness in 
every study group were rather unexpected, sometimes unlogical and consequently, 
no clear conclusions could be drawn. It should not be forgotten that oral hygiene 
measurements are the result of certain oral cleanliness features. It is well possible 
that certain individuals had started using dental floss quite recently because their 
dentist had advised them to do so. Other oral hygiene habits, except use of fluoride 
supplements, may have been “influenced” in the same way.  Caries experience 
provides information about an individual’s past and present experience with dental 
decay, while an inquiry into oral hygiene attitudes reports only about the present 
habits. Consequently caries experience and current oral hygiene habits may be 
divergent. 
   In a pentagon, of which the surface area is a measure of the influence of brushing 
habits, fluoride supplements, use of dental floss and toothpicks, it can be visualized 
to what extend these parameters determine caries experience and oral cleanliness 
(figures 8.1. to 8.4.). When brushing habits, the use of fluoride supplements, dental 
floss and toothpicks were considered, whatever the oral hygiene habits of CF 
homozygotes were, they seemed to be of little influence on caries experience 
(figure 8.1a. and 8.1b.). The latter illustrated once more the  “intrinsic” 
compensatory mechanisms, mentioned before. The same held for dental calculus 
(figure 8.2a. and 8.2b.) and gingival bleeding (figure 8.3a. and 8.3b.). CF 
homozygotes seemed, however, to generate, although not significantly, more 
plaque than the other subjects (figure 8.4a. and 8.4b.), irrespective of their oral 
hygiene habits. 
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Figure 8.2b. : Schematical representation of the effect of brushing in the morning  
                        or brushing in the evening or having had fluoride supplements or 
                        using dental floss or toothpicks on dental calculus (mean CI) in CF 
                         homozygotes, CF heterozygotes and healthy controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Although the only significant difference in oral hygiene habits between the three 
groups was the fact of having had fluoride supplements, this did not seem to 
influence caries experience differences between the three groups (figure 8.5a. and 
8.5b.). These quadrangles show that whether CF homozygotes did receive fluoride 
supplements or not, did not affect their caries experience significantly. The fact that 
CF homozygotes who received fluoride supplements showed more, although not 
significantly, teeth with calculus, should be interpreted as coincidental. No 
correlations between fluorides and dental calculus have been reported before. 
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Figure 8.3a. : Schematical representation of the effect of NOT brushing in the  
                        morning or NOT brushing in the evening or NOT having had  
                        fluoride supplements or NOT using dental floss or toothpicks on  
                        gingival bleeding (mean BI) in CF homozygotes, CF heterozygotes 
                        and healthy controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   These findings reinforce once more the assumption that CF homozygotes may 
possess, not yet identified, intrinsic salivary compensatory mechanisms, which 
render them less vulnerable for a bad oral health status, as it did not seem to matter 
what oral hygiene habits they had. Fluoride supplements did not make the 
difference either between these three study groups. Nevertheless, it should always 
be remembered that caries is a multifactorial infectious disease and that many other 
factors, such as medication, which in CF patients in particular will play an 
important role, should be included in assessing caries risk in every population of 
medically compromised patients. 
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Figure 8.3b. : Schematical representation of the effect of brushing in the morning  
                        or brushing in the evening or having had fluoride supplements or 
                        using dental floss or toothpicks on gingival bleeding (mean BI) in 
                       CF homozygotes, CF heterozygotes and healthy controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.4a. : Schematical representation of the effect of NOT brushing in the 
morning or NOT brushing in the evening or NOT having had fluoride supplements 
or NOT using dental floss or toothpicks on dental plaque (mean PI) in CF 
homozygotes, CF heterozygotes and healthy controls 
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 Figure 8.4b. : Schematical representation of the effect of brushing in the morning 
                        or brushing in the evening or having had fluoride supplements or  
                        using dental floss or toothpicks on dental plaque (mean PI) in CF  
                        homozygotes, CF heterozygotes and healthy controls 
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Figure 8.4a.
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Figure 8.5a. : Effect of « I did NEVER receive fluoride supplements » on caries  
                        experience (mean DMF-T), gingival bleeding (mean BI), dental  
                        calculus (mean CI) and dental plaque (mean PI) in CF homozygotes,  
                        CF heterozygotes and healthy controls 
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Figure 8.5b. : Effect of « I DID receive fluoride supplements » on caries 
                        experience (mean DMF-T), gingival bleeding (mean BI), dental  
                        calculus (mean CI) and dental plaque (mean PI) in CF homozygotes,  
                        CF heterozygotes and healthy controls 
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Chapter 9 
 
 
Salivary Electrolyte Concentrations Are 
Compounded with 
Cystic Fibrosis Transmembrane Regulator 
Genotypes 
 
 
 
 
 
 
 
 
This chapter was published as : 
Aps J.K.M. , Delanghe J., Martens L.C. Salivary electrolyte concentrations are 
compounded with cystic fibrosis transmembrane regulator genotypes. 
Clinical Chemistry and Laboratory Medicine 2002;40(4):345-350.   
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ABSTRACT 
   It is estimated that about 1 in 24 Belgian Caucasians is a cystic fibrosis (CF) 
heterozygote. Until now, CF heterozygotes can only be identified by genetic 
decoding (e.g. Inno-Lipa CF2 test
®
), as they can not be phenotypically 
distinguished from the general population. The aim of this study was to evaluate 
differences in salivary electrolyte concentrations (calcium, bicarbonate, chloride, 
potassium, sodium and phosphate) and salivary osmolarity between CF 
homozygotes (n = 41), CF heterozygotes (n = 56) and healthy controls (n = 65). By 
means of non-parametric tests, differences between the three groups were 
investigated. Several significant differences between the three study groups and 
among as well as between the different Cystic Fibrosis Transmembrane Regulator 
(CFTR) genotypes were observed. Significant differences in salivary electrolyte 
concentrations between individuals with delta F508 mutation and those without 
and between CF homozygotes and heterozygotes were observed. Several salivary 
electrolyte concentrations and salivary osmolarity were significantly higher in 
CFTR genotype individuals. Differences in salivary electrolyte concentrations may 
partly explain differences in caries experience (DMF-T and DMF-S) between the 
three study groups. 
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9.1. Introduction 
   Cystic Fibrosis (CF) is the most common lethal autosomal recessive inherited 
disease in  Caucasians. The prevalence of CF homozygocity is about 1 in every 
2000 live births and about 4 to 5% of Caucasians is heterozygous for the Cystic 
Fibrosis Transmembrane Regulator (CFTR) gene, which is located on the long arm 
of chromosome 7 (7q31). The most common mutation is called delta-F508 and it 
occurs in about 74% of (Belgian) CF patients [Wauters et al., 1991; 
http://www.genet.sickids.on.ca/cftr/agreement.htm]. It is a deletion of three 
nucleotides encoding phenylalanine at position 508 in the amino acid sequence. 
This single gene mutation causes a defective sodium and chloride transport in 
every exocrine gland (respiratory and intestinal epithelium, as well as salivary 
glands), which subsequently results in increased mucous secretions. The expression 
of the disease is both inter-individually as well as inter-racially different [McColley 
et al., 1991]. Besides delta-F508, more than 950 other mutations are known to the 
Cystic Fibrosis Genetic Analysis Consortium. They are less frequent and in many 
cases specific for one family only or for a specific geographical area 
[http://www.genet.sickids.on.ca/cftr/agreement.htm].  
   As CF is a recessive inherited disease, CF heterozygotes can not be 
distuinguished phenotypically from the general population and clinical signs that 
might raise suspicion of being a CF heterozygote do not exist. As a consequence, 
most CF heterozygotes are therefore “incidentally” diagnosed when they become 
parents of or when they are closely related to a CF homozygote newborn. The only 
possible way of identifying CF heterozygotes is via genetical procedures. The 
(pilocarpine -) sweat-test, which is used in case of suspicion of an individual being 
a CF homozygote, is not useful to check for CFTR heterozygosy and no other 
available electrolyte test has been explored yet [Augarten et al., 1995; Gilbert et al., 
1995; ; Stewart et al., 1995; Veeze, 1995; Rosenstein, 1998; Lotem et al., 2000; 
Massie et al., 2000a; Massie et al., 2000b].  
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   Saliva, which is the most easy body fluid to collect [Mandel, 1990; Haeckel and 
Hanecke, 1993], could be used to investigate electrolyte concentration differences 
between CF homozygotes, heterozygotes and control subjects. Studies published 
on salivary composition of CF homozygotes versus control subjects did not 
differentiate between CF heterozygotes and controls [Kinirons, 1983; Kinirons, 
1985; Kinirons, 1989; Fernald et al., 1990; Jiménez-Reyes and Sànchez-Aguirre, 
1996].  
   Knowing that about 5% of the Caucasian population is heterozygous for the 
CFTR gene, implies that in these studies, CF heterozygotes were accidentally 
mixed with controls. This is understandable, as most of these studies date from 
before or around 1985, when the genetical information and techniques were not 
available.  
   It would be very convenient and clinically relevant to be able to identify CF 
heterozygotes by investigating their salivary chemical composition. Besides the 
low-cost aspect and the ease to collect saliva (a non-invasive method), 
identification of CF heterozygotes could be performed much faster (in infancy) and 
more adequate than today. A “suspicious” saliva test result could then be the 
motive to perform genetic identification of the CFTR gene.  Furthermore, saliva 
can be considered as a “model” fluid for studying the effect of the genetic 
heterogeneity of CF on the composition of secretions from exocrine glands. 
   The aim of the present study was to investigate differences in salivary electrolyte 
concentrations (bicarbonate, calcium, chloride, sodium, potassium, phosphate) and 
salivary osmolarity between CF homozygotes, CF heterozygotes and healthy 
control subjects. Secondly, it was investigated if any of  these analytes were linked 
to the CFTR genotypes. Additionally, a clinical oral parameter, the caries 
experience (DMF-T and DMF-S) of the individuals in this study, was also 
recorded. 
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9.2. Material and Methods 
9.2.1. Sample selection 
  The Belgian Association for the Fight against Cystic Fibrosis was explained the 
aims of this study, and 46 CF homozygotes agreed to participate. Their age varied 
from 6 to 38 years (17.2  7.8 years). Genetically confirmed CF heterozygotes (n = 
69), were enrolled in the study. Their age varied from 3 to 61 years old (31.2 
15.1 years). Control subjects (n = 64) were selected from the Ghent University’s 
dental out-patient clinic. Subjects suffering from cardiovascular, endocrine, 
hematological, neurological, infectious or genito-urinary diseases, were excluded 
as control subject. Their age varied between 5 and 51 years old (20.7 11.3 years). 
While the study as a whole was approved by the Ghent University Hospital’s 
ethical committee, no permission was granted to perform molecular genetics on the 
control subjects to avoid CF heterozygotes in this group. Consequently, statistically 
4 to 5% CF heterozygotes were unavoidably inclosed in the control group. All 
subjects involved in the study signed a letter of informed consent. 
 
9.2.2. Saliva collection 
   Paraffin stimulated whole human saliva was collected in a sterile plastic recipient 
between 9 a.m. and 4 p.m., while subjects were in an upright position. All subjects 
were instructed to chew a paraffin tablet, as provided in the Vivadent CRT
®
 
Bacteria and Buffer test kit (Schaan, Liechtenstein), for at least 3 minutes under the 
supervision of the investigator (J.A.). Saliva samples were subsequently 
transported to the laboratory, where they were analysed within 1 hour after 
collection. 
 
9.2.3. Salivary electrolytes 
   Prior to chemical analysis, each sample was vortexed for at least 30 seconds and 
subsequently 3 milliliter was centrifuged for 10 minutes at 1500 g at room 
139
  
140 
temperature. Subsequently the supernatant was used for chemical electrolyte 
analysis (respectively calcium, bicarbonate, phosphate, potassium, sodium and 
chloride concentrations). Salivary osmolarity was also determined.  
   Measurement of the total calcium concentration was performed by a colorimetric 
method and inorganic phosphate was quantified by means of a molybdate 
complexing reaction method. Both procedures were carried out by means of a 
testkit provided by Roche
®
 (Mannheim, Germany). The bicarbonate concentration 
was determined enzymatically using commercial reagents from BioMérieux
®
 
(Biomérieux, Marcy-les-Etoiles, France). Potassium, sodium and chloride were 
automatically measured using indirect potentiometry on the Hitachi 747
®
 analyzer 
(model 100) (Tokyo, Japan). Osmolarity was measured with the “Advanced 
cryomatic osmometer
®
” (model 3C2, Advanced Instruments) (Needham Heights, 
Massachusetts, USA).  
 
9.2.4. Genotypes 
   Both CF homozygotes and heterozygotes agreed, by a signed consent, to provide 
the investigators information on their CFTR genotype. Seven CF heterozygotes did 
not have the necessary information anymore and did not want it to be investigated. 
The data were obtained by the Inno-Lipa CF2
®
 test (Innogenetics, Ghent, Belgium) 
[http://www.innogenetics.com], which as a standard procedure investigates 8 
CFTR mutations; delta F508, G542X, N1303K, 1717-1G-A, W1282X, G551D, 
R553X and delta I 507 from genetic material collected by buccal mucosa swabs. 
These mutations cover about 85% of all CFTR mutations in Western Europe.  
   In case of equivocal results, another 21 less frequent CFTR mutations were 
investigated [http://www.innogenetics.com]. In this study, genotypes were divided 
into two subgroups. One subgroup consisted of individuals with delta F508 
genotype and the second subgroup of individuals with any other genotype than 
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delta F508 or heterozygotes of whom no information was available, but of whom it 
was certain that the mutation was not delta F508. 
 
9.2.5. Caries experience 
   Caries experience is widely expressed as “DMF-T and DMF-S” in dental 
literature. The index was first introduced by Klein and Palmer in 1938 [Klein and 
Palmer, 1938] and has been used ever since in cross-sectional and longitudinal 
studies on caries experience within populations. The index exists of three parts; 
“D” stands for actual dental decay, “M” stands for missing teeth due to extractions 
for reasons of extensive carious lesions which were considered too large to restore 
and “F” which stands for filled or restored. The second part of the index indicates 
whether it concerns the number of teeth (“T”) or the number of surfaces (“S”). All 
teeth, excluding the third molars are involved in the recording of the index. As a 
consequence, DMF-T can vary between 0 and 28 and DMF-S can vary from 0 to 
140.  
   The caries experience was recorded according to WHO guidelines 
[http://www.whocollab.od.mah.se] and the investigator (J.A.) was trained at 
baseline according to the guidelines published by the British Association for the 
Study of Community Dentistry in 1997 [Pine et al., 1997; Pitts et al., 1997]. The 
results of the calibration exercises were already published elsewhere [Martens et 
al., 2001]. 
 
9.3. Statistics 
   Statistical analysis was performed using the MedCalc
® 
software program 
(MedCalc, Mariakerke, Belgium). To investigate differences between the three 
samples (CF homozygotes, CF heterzogotes and healthy controls ), a Kruskal-
Wallis test was used.  The Mann-Whitney U-test was used to investigate statistical 
differences between two samples. The level of significance was chosen at   0.05.  
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9.4. Results 
  The different CFTR genotypes, were obtained after a signed consent from the CF 
patients and their family.  
   Sixty five point nine per cent were combinations with delta F508 and 34.1% did 
not have a delta F508 component. The following CFTR mutation combinations 
were involved in the CF homozygote group; delta F508 + delta F508 (n = 21), 
delta F508 + 394 del TT (n = 1), delta F508 + N1303K (n = 3), delta F508 + 
3849+10kb C-T (n = 1), delta F508 + G542X (n = 1), delta F508 + 3272-26AG 
(n = 1), delta F508 + unknown mutation (n = 1), G542X + G542X (n = 2) and delta 
I 507 + G542X (n = 1).  
   Fifty point seven percent of CF heterozygotes in this study had a delta F508 
mutation, 4.4% had an unknown mutation, 17.4% were other mutations and  27.5%  
did not know and did not want to know what mutation they had. The CF 
heterozygote group comprised the following (single) CFTR mutations; delta F508 
(n = 35), 2183 AAG (n = 1), 3849 10kb C T (n = 1), 394 del TT (n = 4), G542X 
(n = 4), N1303K (n = 2), 3 unknown CFTR mutations and 19 heterozygotes had no 
information on their mutation and did not want it to be investigated. 
   Table 9.1. summarizes the salivary electrolyte concentrations of CF 
homozygotes, CF heterozygotes and  healthy control subjects. Calcium and 
bicarbonate were excluded as these electrolytes were never significantly different 
between any of the three subject groups.       
   Salivary potassium (p = 0.005), sodium (p = 0.004) and phosphate (p = 0.0001) 
concentrations and salivary osmolarity (p = 0.033) showed to be significantly 
different between CF homozygotes, CF heterozygotes and controls. When, 
subsequently CF homozygotes and CF heterozygotes were compared, it was found 
that potassium (p = 0.002) and phosphate and (p < 0.0001) concentrations were 
both significantly higher in CF homozygotes. But when CF homozygotes were 
evaluated against healthy controls, salivary potassium (p = 0.046), sodium             
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(p = 0.002) and phosphate (p = 0.002) concentrations as well as salivary osmolarity 
(p = 0.019) were shown to be significantly higher in CF homozygotes.  
 
Table 9.1. : Descriptive data (mean standard deviation, median and interquartile  
                    range) of salivary electrolytes for CF homozygotes (n = 41), CF 
                    heterozygotes (n = 56) and healthy controls (n = 65) and the respective 
                    statistical analyses results (* p 0.05, ** p 0.01p 0.001 and 
                 N.S. = not significant ) 
 
 
 
Analytes 
CF Homoz 
 
 
n = 41 
CF heteroz 
 
  
n = 56 
Healthy 
controls 
 
n = 65 
Kruskal-
Wallis 
    test 
p-values 
 
Mann-Whitney U-test 
 
 
p-values  
 A  B C C  C C A
B+C 
C 
A+B 
Chloride 
(mmol / l) 
	


 
	


 
	

 
 
N.S. 
 
N.S. 
 
N.S. 
 
N.S. 
 
N.S. 
 
N.S. 
Potassium 
(mmol / l) 
	



 
	

 
	




 
 
** 
 
** 
 
* 
 
N.S. 
 
** 
 
N.S. 
Sodium 
(mmol / l) 
	


 

	

 
	


 
 
** 
 
N.S. 
 
** 
 
* 
 
* 
 
*** 
Phosphate 
(mg / l) 
	

 
	

 
	

 
 
*** 
 
*** 
 
** 
 
N.S. 
 
*** 
 
N.S. 
Osmolarity 
( Osmo / 
kgH2O ) 
	



 

	


 
	

 
 
* 
 
N.S. 
 
* 
 
* 
 
N.S. 
 
** 
 
143
  
144 
Only salivary sodium (p = 0.012) concentration and salivary osmolarity (p = 0.034) 
were significantly higher in CF heterozygotes than in healthy controls. The same 
two analytes were also significantly higher in all subjects with a CFTR mutation 
than in  healthy controls (p = 0.0009 and p = 0.009 respectively). 
  
Table 9.2. : Descriptive data (mean standard deviation, median and interquartile 
                    range) of both CF homozygotes and heterozygotes with (n = 30 and  
                    n = 35 respectively) and without (n = 11 and n = 21 respectively) 
                   genotype delta F508 and the respective statistical analyses  
                    (*p 0.05,** p 0.01,*** p 0.001 and N.S. = not significant ) 
F508  
CF heteroz 
N = 35 
Not F508 
CF heteroz 
N = 21 
F508 
CF homoz 
N = 30 
Not F508 
CF homoz 
N = 11 
Mann-Whitney U-Test 
 
p-values 
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   Comparing CF homozygotes with CF heterozygotes and healthy controls 
together, revealed a significant higher salivary potassium (p = 0.005), sodium (p = 
0.048) and phosphate (p < 0.0001) concentration in CF homozygotes. 
   In Table 9.2. comparisons between the two genotype subgroups are shown. 
Comparing the two genotypes (delta F508 and non-delta F508) within the CF 
heterozygotes (D versus E), showed a significantly higher salivary chloride (p = 
0.018) and sodium (p = 0.003) concentration in the delta F508 genotype subgroup. 
Within the CF homozygote group (F versus G), no significant differences in 
salivary electrolyte concentrations or salivary osmolarity, whatsoever, were found 
between the two genotype subgroups. 
   Comparisons within the delta F508 genotype individuals (D versus F), revealed a 
significant higher salivary potassium (p = 0.001) and phosphate (p = 0.003) 
concentration in CF homozygotes. Within the non-delta F508 CF homozygotes and 
heterozygotes (E versus G) significant higher salivary chloride (p = 0.045) and 
phosphate (p = 0.0009) concentrations were observed in CF homozygotes. 
   Caries experience (Table 9.3.) at surface level (DMF-S) was significantly lower 
in CF homozygotes than in healthy controls (p = 0.025). This significance was also 
shown when CF heterozygotes and control subjects were considered as one study 
group (p = 0.03).  
 
9.5.  Discussion 
   Saliva is the most accessable body fluid, next to urine, which can be collected 
without invasive techniques [Mandel, 1990; Haeckel and Hanecke, 1993]. 
Therefore, it can be collected from everyone, from infants to elderly, healthy or 
medically compromized, without being a psychological threat to the patient. In this 
study paraffin stimulated saliva was used in order to obtain whole human saliva 
and realistic electrolyte concentrations, such as they appear during mastication. 
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Table 9.3. : Descriptive data of caries experience (mean SD) for CF  
                    homozygotes (n = 49), CF heterozygotes (n  = 69) and healthy controls  
                    (n = 65) and the statistical analyses results (* P 0.05 and N.S. = not  
                    significant ) 
 
CF Homo- 
zygote 
A 
CF Hetero-
zygote 
B 
Healthy 
Controls 
C 
 
 
B + C 
Mann-Whitney U-test 
P-values 
Analytes 
N = 46 N = 69 N = 65 N = 134 A vs. B A vs. C B vs. C A vs.  
B + C 
DMF-T 	 	 
	
 
	 N.S. N.S. N.S. N.S. 
DMF-S 	 
	 	 	 N.S. * N.S. * 
 
In contradiction with earlier reports [Kinirons, 1983; Kinirons,1985; Kinirons, 
1989; Fernald et al., 1990; Jiménez-Reyes and Sànchez-Aguirre, 1996] on salivary 
electrolytes in CF, in this study no significant differences in bicarbonate or calcium 
concentrations were observed between CF homozygotes and healthy controls. The 
latter could be attributed to different techniques used to measure salivary 
electrolyte concentrations, to circadian rhythm of salivary secretion (different time 
of the day at which saliva was collected) or to the stimuli used to stimulate salivary 
secretion.  
   In the present study, salivary electrolytes of CF heterozygotes were intentionally 
investigated for the first time. The latter was not possible in the past, as no 
differentiation between the genotypes and no identification of CF heterozygotes 
was possible at that time. Nine different homozygote CFTR mutations were 
involved in this study. As in Western Europe delta F508 is the most common 
CFTR mutation, obviously delta F508 homozygotes made up for the largest part of 
this study group. Six known and three unknown or “unidentified” CFTR mutations 
in CF heterozygotes were involved in this study group.  This study is the first ever 
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to differentiate between CF heterozygotes and controls. Nevertheless, the authors 
are well aware of the fact that among the control subjects, statistically 4 to 5% CF 
heterozygotes may be included [Wauters et al., 1991]. On the other hand, this 
potential 4 to 5% accidental inclusions, did not seem to be bias, as several 
significant differences in salivary electrolytes were found between CF 
heterozygotes and healthy control subjects. 
   Salivary electrolyte concentration differences indeed exist between CF 
homozygotes and CF heterozygotes. Apparently they are linked to the respective 
genotypes. When either comparing them irrespective of their genotype or 
comparing delta F508 genotype individuals only, potassium and phosphate were 
always significantly higher in the CF homozygote group. Salivary phosphate was 
also considerable significantly higher in CF homozygotes when the not-delta F508 
individuals were compared. This significant higher salivary phosphate 
concentration in CF homozygotes may play an important role in their susceptibility 
for developing dental decay at a lower rate than other individuals. Phosphate in 
particular, plays an important role in de- and remineralisation of dental enamel 
[Driessens and Verbeeck, 1990]. 
   Within the CF homozygote group, no significant differences in salivary 
electrolyte concentrations or salivary osmolarity were found between the two 
subgroups of CFTR mutations. Within the CF heterozygote group, however, there 
were significant differences in salivary electrolyte concentrations. The latter could 
indicate that phenotypical varieties of CF heterozygotes do exist. Until now, only 
CF homozygotes were considered to have phenotypical varieties within their 
genotypes.   
   The fact that CF heterozygotes were reported to have a tendency of an apparently 
increased caries risk [Aps et al., 2001; Martens et al., 2001; Aps et al., 2002a; Aps 
et al., 2002b], could consequently be related to their specific salivary electrolyte 
concentrations. Although, this effect should not be exaggerated, as caries is a 
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multifactorial infectious disease, which means that besides host factors, oral micro-
organisms, dietary habits, oral hygiene habits and environmental factors play an 
important role as well in the development of dental decay.     
   Clinically, CF homozygotes show increased mucous salivary secretions 
[Kinirons, 1983; Kinirons,1985; Kinirons, 1989; Fernald et al., 1990; Jiménez-
Reyes and Sànchez-Aguirre, 1996]. Salivary viscosity can be attributed to either a 
decreased water content of saliva or to an increased concentration of organic and 
inorganic components. Besides a significant higher total salivary protein 
concentration [Aps et al., 1999], inorganic salivary inclusions may also influence 
salivary viscosity in CF homozygotes. The significant higher salivary osmolarity of 
CF homozygotes with respect to control subjects, illustrated the clinical 
observation that saliva of CF homozygotes was more viscous. However, no 
significant difference between CF homozygotes and CF heterozygotes (irrespective 
of the genotypes) concerning salivary osmolarity was observed. Moreover, also CF 
heterozygotes had a significant higher salivary osmolarity than healthy controls.  
   The observed differences in salivary ion composition between the different 
phenotypes might reflect differences in the composition of other body fluids (e.g. 
sweat and tears), since CF affects all exocrine glands. Consequently, further studies 
will be necessary to confirm the present findings in other body fluids. Future 
research will decide on whether saliva can be used as a diagnostic tool in 
investigating CF and other exocrine disorders. 
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Chapter 10 
 
SDS-PAGE of salivary proteins in cystic fibrosis ; 
preliminary results 
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ABSTRACT 
   Paraffin stimulated whole saliva samples of 36 Cystic Fibrosis (CF) 
homozygotes, 59 CF heterozygotes and 45 healthy control subjects were collected 
for protein examination purposes. The total protein concentration was determined 
and subsequently, every sample was examined by coomassie Brilliant R250 stained 
sodium-dodecyl-sulphate-poly-acryl-amide gel electrophoresis (SDS-PAGE), to 
investigate differences in salivary protein composition between the three subject 
groups. 
   It was found that CF homozygotes had a significant higher salivary protein 
concentration than CF heterozygotes and controls (P=0.008). The total salivary 
protein concentration showed to be a diagnostic aid to distinguish CF homozygotes 
from non-CF homozygotes. At a cut-off concentration of at least 0.86g/l, a 
sensitivity of 56.3% and a specificity of 89.6% was obtained. By means of linear 
regression analysis, three distinct salivary protein bands were recognized on the 
SDS-PAGE gradient (4-15%) gels. Their molecular weight was respectively 242 
kDa, 161.5 kDa and 68 kDa. The single band corresponding with 68 kDa was 
significantly more present in CF homozygote samples (P = 0.036). However, when 
this band appeared as a triplet, it was significantly more seen in CF heterozygote 
samples (P = 0.038). In a multiple regression model, with salivary protein 
concentration and the single band appearance of the 68 kDa protein on SDS-PAGE 
gel as independent variables and CF homozygotes as response variable, this model 
showed a predictibility of 39.5% and a multiple correlation coefficient of 0.63 to 
differentiate CF homozygotes from CF heterozygotes and healthy control subjects.  
   It was concluded that salivary proteins can be used to differentiate CF 
homozygotes and CF heterozygotes, but that identification of the distinctive 
proteins should be subject of further research. The relationship between these 
salivary properties and oral health should be investigated further into detail. 
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10.1. Introduction 
   Cystic Fibrosis (CF) is an autosomal recessive inherited disease and as a 
consequence CF heterozygotes can not be detected phenotypically in the general 
population. Thus, most CF heterozygotes are “incidentally” identified when they 
become parents of or when they are closely related to a CF homozygote newborn. 
Salivary studies about CF homozygotes and heterozygotes are sparce, as most 
literature on this issue focussed on bacterial aggregation in saliva and its 
repercussions on the CF patient’s general health. Especially the role of saliva and 
aggregation with Pseudomonas was investigated. The latter is logical, as CF 
patients who get infected with Pseudomonas will eventually die from this 
irreversible infection [Tumber-Saini et al., 1992; Armstrong et al., 1993].  
   It is reported in the literature that the total salivary protein concentration is higher 
in CF homozygotes than in healthy control subjects [Van Nieuw Amerongen, 
1988a,b], but nothing is known about the situation in CF heterozygotes. The latter 
can be understood as in the past CF heterzygotes could not be identified, while 
today this is possible by means of genetic decoding. 
   Therefore, the aims of this study were to evaluate differences in total salivary 
protein concentrations between CF homozygotes, CF heterozygotes and healthy 
controls. Secondly, it was investigated whether any distinct differences in salivary 
composition could be distinguished between these three groups. 
 
10.2. Material and methods 
10.2.1. Subject selection 
   CF homozygotes (n = 36) aged between 6 and 38 years old (16.5  8.0 years), 56 
CF heterozygotes aged between 3 and 61 years old (31.4  15.5 years) were 
recruited via the Belgian Association for the Fight Against Cystic Fibrosis. As the 
latter were mostly parents and older family members of CF homozygotes, their 
mean age was obviously higher than those of the CF homozygotes. A total of 45 
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individuals, aged between 5 and 40 years (19.6 10.5 years), were recruited from 
the Ghent University Dental Hospital out-patient clinic. Subjects suffering from 
cardiovascular, endocrine, hematological, infectious or genito-urinary diseases 
were excluded as control subject.  
   As obviously no permission was granted by the ethical committee to perform 
genetic verification of the control subjects, unavoidably 4 to 5% of these 
individuals were potential CF heterozygotes.  
   All subjects signed a letter of informed consent and the study was approved by 
the Ghent University Hospital’s ethical committee.  
 
10.2.2. Saliva collection 
   A paraffin stimulated saliva sample was collected from every subject. Saliva was 
collected in a sterile plastic recipient, subjects were in an upright position and the 
collections were made between 9 AM. and 4 PM, in the presence of the 
investigator (J.A.). Subsequently the samples were transported to the laboratory, 
where they were frozen in aliquots of 3 ml, at –17°C and stored for later 
investigation.  
 
10.2.3. Laboratory procedures 
10.2.3.1. Total protein concentration     
   Two milliliter saliva of a well vortexed sample was centrifuged at 1500g for 10 
minutes. Subsequently the supernatant was pipeted and the total protein content 
was determined automatically on a Hitachi
®
 911 automatic analyzer (Tokyo, 
Japan), which uses the pyrogallol-red molybdate complexing method [Van Ingen, 
1990]. The result is expressed as gram total protein per liter saliva. 
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10.2.3.2. Electrophoresis 
   Electrophoresis, in general, is the movement of particles in an electrical field. It 
is one of the most efficient analytical tools in modern clinical biochemistry to 
separate the different monomers of a polymer. Saliva can be considered as a 
polymer and as a consequence, the individual monomers, the salivary proteins, can 
be identified by means of sodium dodecyl sulphate poly-acrylamide gel 
electrophoresis (SDS-PAGE) based on their molecular mass. This technique was 
preferred over others, which are based on the principle of electrical charge of 
proteins [Frankel et al., 1970; Henry et al., 1974; Schultze and Heremans, 1966; 
Beeley, 1991; Beeley et al., 1991; Beeley et al., 1996]. 
   The gel can be considered being a sieve. The gels used in this study were 4-15% 
gradient gels, which means that at the top of the gel, large proteins (with a high 
molecular mass) are captured in the sieve, while near the bottom of the gel, the 
smaller proteins (with a low molecular mass) are retained. This results in distinct 
banding of proteins, which can be visualised by means of staining with several 
agents, such as Coomassie Brilliant Blue R250 or silver.  
 
10.2.3.3. SDS-PAGE procedure 
   Three milliliter saliva sample was ultracentrifuged (Beckman
®
 L-2 centrifuge) at 
13,000 rpm for 30 minutes at 10°C. The supernatant was then pipeted and frozen at 
–17°C. Subsequently it was lyophilized at -70°C (Virtis
®
 Gardiner, NY 12525, 
USA) for at least 8 hours, until only powder remained. Thereupon, the lyphilized 
saliva was diluted in 250 microlitre sample buffer (pH = 6.8; 3.8 ml distilled water, 
1.0 ml 0.5 M Tris-HCl, 1.6 ml 10% SDS, 0.8 ml glycerol, 0.4 ml 1% brominephenol 
blue (Merck®)) and well vortexed for at least 10 seconds. The sample colors 
immediately blue-purple. In order to separate the sialic acid groups from the 
salivary glycoproteins, 10 microlitre of neuraminidase was added to an aliquot of 
50 microlitre of this solution and incubated for 2 hours at 37°C.  
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   Subsequently the electrophoresis buffer solution (pH = 8.3; 9 g of Tris alkaline + 
43.2 g of glycine + SDS + diluted with distilled water to a volume of 600 ml) was 
prepared.  
   The SDS- PAGE 4-15% Tris-HCl-gradient gels (BIO-RAD
®
 Laboratories, 2000 
Alfred Nobel Drive, Hercules CA 94547, USA), were mounted in the respective 
Mini-Protean II
®
 electrophoresis cell (BIO-RAD
®
) and by means of a syringe, 10 
microlitre of salivary sample was injected into the indentations of the gel. 
    SDS-PAGE was performed at a constant voltage of 200 Volts for 50 minutes. 
The progression of the electrophoresis was easy to follow because of the samples’ 
blue color. 
   After 50 minutes, the gels were unmounted from the electrophoresis chamber and 
moved into a Petri dish and saturated with a Coomassie Brilliant Blue R250 
solution (LKB Bromma
®
, a 1g/l dilution in 40% methanol and 10% acetic acid) for 
30 minutes. Subsequently the gels were destained several times in a solution with 
40% methanol and 10% acetic acid until only distinct protein bands were visible as 
blue and purple horizontal lines.  
 
10.2.4. Determination of the molecular masses 
   By means of a standardized protein mix (SDS-PAGE Standards, broad 200 µl, 
order number 161-0317), as provided by Bio Rad
®
, the molecular masses can be 
derived, by means of linear regression analysis. The reference proteins (from high 
to low molecular mass) used in this study were myosine, bèta-galactosidase, 
fosforylase, serum albumine, oval albumine, carbonic anhydrase, trypsin inhibitor 
and lysozyme. 
   The gels were scored by two investigators (J.A. and KVDM) and immediately 
stored in an automated Excel file (Microsoft
®
 Corporation).  
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10.3. Statistical analysis 
   Statistical analysis was performed using of the MedCalc
®
 statistical program                 
(MedCalc
®
 Software, Broekstraat 52, B-9030 Mariakerke, Belgium, 
info@medcalc.be). Linear regression analysis was used to determine the molecular 
mass of the salivary protein bands on the SDS-PAGE gels. A one-way analysis of 
variance test was used to investigate differences in total salivary protein 
concentration between the three study groups. A Kruskal-Wallis test was used to 
investigate differences between the three groups, with regard to the appearance of 
the three protein bands on the SDS-PAGE gels. Multiple regression models were 
investigated with CF homozygotes as response variable and salivary protein 
concentration and protein bands as independent variables. 
   
10.5. Results 
10.5.1. Total salivary protein concentration 
   It was found that CF homozygotes had a significant higher total salivary protein 
concentration than CF heterozygotes and healthy control subjects (P=0.008). The 
mean total salivary protein concentrations were 0.53 g/l for control subjects, 0.67 
g/l for CF heterozygotes and 0.86 g/l for CF homozygotes, respectively. By means 
of a Receiver Operating Characteristic (ROC) curve, a ‘CF homozygote diagnostic’ 
cut-off point was established at a salivary protein concentration of at least 0.86 g/l. 
From figure 10.1, it can be observed that the sensitivity of this ‘test’ was 56%, 
while the specificity was 89%. The area under the curve was 0.775. 
 
10.5.2. SDS-PAGE results 
   Three distinct protein bands were considered relevant in this investigation. They 
were named band 1, 2 and 3. It was observed that bands 2 and 3 not only appeared 
as singlets, but also as doublets and triplets, depending on the study group (figure 
10.2.). The molecular mass of these three proteins bands (singlet bands only) was 
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determined by means of linear regression analysis, with a standardized protein mix 
as reference. 
 
Figure 10.1. : Receiver Operating Characteristic (ROC) curve with the total  
                        salivary protein concentration as a diagnostic tool to distinguish CF 
                        homozygotes from CF heterozygotes and healthy subjects 
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The respective molecular masses were 242 kDa (band 1), 161.5 kDa (band 2) and 
68 kDa (band 3).  
   There was no significant difference between the three groups, regarding protein 
bands 1 and 2. It was, however, found that band 3 (singlet appearance) was 
significantly more often observed in CF homozygotes than in both other groups (P 
= 0.036). When this band appeared as two separate lines, it was found to appear 
borderline insignificantly more often in control subjects (P = 0.055). When this 
band appeared as a triplet it was sigificantly more often found in CF heterozygotes 
(P = 0.038).  
 
Figure 10.2. : Coomassie Brilliant Blue R250 stained SDS-PAGE gel with the 
                        standardized protein mix (position 1) and salivary samples of CF 
                        homozygotes (positions 3,4,9 and 10), CF heterozygotes (positions   
                        5 and 6) and healthy control subjects ( positions 7 and 8) 
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Band 3 
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   A multiple regression analysis model, with CF homozygotes as dependent 
variable and total salivary protein concentration and protein band 3 (singlet) as 
independent variables, was obtained with a predictibility of 39.5% and a 
correlation coefficient of  0.63 (P = 0.009). 
 
  10.6. Discussion 
   The present investigation confirmed earlier studies reporting that CF 
homozygotes had a significant higher total salivary protein concentration [Van 
Nieuw Amerongen, 1988a,b] than CF heterozygotes and healthy controls. However, 
the differences between CF heterozygotes and healthy controls were never shown 
before. To the knowledge of the investigator, this was one of the first studies ever 
in which salivary proteins of both CF heterozygotes and healthy controls were 
compared. As phenotypically CF heterozygotes can not be distinguished from the 
general population, this technique offers new perspectives, which should be 
explored into detail in the future on a larger scale; preferably in a multi centre 
study in which also different genotypes should be investigated. 
   It was interesting to find differences in protein bands between CF homozygotes, 
CF heterozygotes and healthy controls. However, the identification of the protein 
bands is therefore necessary, in order to provide more information on the salivary 
mechanisms at play in oral health in CF homozygotes. Consequently, relevant 
salivary protein interactions could be studied. As pointed out before, dental decay 
is the result of a multifactorial process. The least understood confounding factor is 
probably saliva as it is a mixture of cellular, organic and inorganic components. 
   Although the number of samples was limited, the multiple regression model 
which was obtained also offered new possibilities for identification of CF 
homozygotes and CF heterozygotes. It remains to be proven whether this model 
still holds when larger populations are studied.  
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10.7. Conclusion    
  The total salivary protein concentration and in particular a low molecular mass 
protein of 68 kDa, can be used to distinguish CF homozygotes from others. The 
identification of this protein is necessary in order to obtain better knowledge on the 
salivary mechanisms at play in CF homozygotes and non-CF homozygotes. The 
latter could imply a new perception in the mechanisms that are important in the 
development of dental decay.  
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GENERAL DISCUSSION AND CONCLUSION 
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   Cystic fibrosis (CF) is the most common lethal autosomal recessive inherited 
disease in Caucasians. It has a prevalence of about 1 in every 2000 live births and it 
is estimated that about 4 to 5 percent of Caucasians is heterozygous for the cystic 
fibrosis transmembrane regulator gene (CFTR), which is located on the long arm of 
chromosome 7 at position q31.  
   This single gene defect affects all exocrine glands and as a consequence, these 
glands produce a thicker viscous secretion than under healthy conditions. CF 
patients suffer from pancreatic insufficiency and recurrent pulmonary 
exacerbations, which means that they have to use antibiotics, mucolytica and 
expectorantia regularly and pancreas enzymes on a daily basis. Because of their 
disease, they can be considered vulnerable to develop dental decay, as they have to 
consume many in-between-meal-snacks and drinks, which are sugar rich. On the 
other hand, the medication can also be considered potentially dangerous to develop 
caries, as sugar containing syrups and beta-2 agonist containing aerosols are in 
most cases used at night, before going to sleep. Both were described to enhance 
enamel demineralisation indirectly.  
 
   Since the 1980’s it was well known that children with CF had significantly lower 
caries experience than healthy control subjects. Recently, however, a report was 
published on CF adolescents with a high caries experience. As no studies were 
available since the 1980’s on CF and oral health, a need for an updated study was 
felt. The null hypothesis of this study was that CF homozygotes are potentially 
at risk for oral health and that saliva can be used for its determination.  
 
The aims of the study were :  
1. Determination of the caries experience and oral cleanliness of CF 
homozygotes, CF heterozygotes and healthy controls. 
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2. Quantification of the oral bacterial flora with respect to caries in CF 
homozygotes, CF heterozygotes and healthy control subjects. 
3. Assessment of the impact of medication, dietary habits and influence of oral 
hygiene habits on oral health in CF homozygotes, CF heterozygotes and 
control subjects. 
4. Evaluation of salivary electrolyte concentration differences and differences in 
salivary proteins among CF homozygotes and between CF homozygotes, CF 
heterozygotes and healthy individuals. 
5. Assessing the possibility to use human saliva as a diagnostic tool for the 
determination of oral health.  
 
   In a first approach (which corresponds with the first aim of this study), a matched 
case-control pilot study was carried out (chapter 2), in which the caries experience 
(DMF) of 37 healthy control subjects and 37 CF homozygotes was compared. 
There were no significant differences in caries experience found between these two 
groups. This was different from the results published in earlier literature on oral 
health and cystic fibrosis. Three hypotheses were brought forward, which could 
serve as possible explanation; geographical differences (e.g. environmental and 
genetical differences), the broader use of antibiotics (in the healthy control group 
also) and medical care differences (due to a better medical knowledge and 
understanding of the disease). Therefore the study needed to be enlarged and as 
today’s diagnostic tools have improved, CF heterozygotes were considered as a 
separate study group. The latter was never performed in the past. Moreover, CF 
heterozygotes were probably accidentally considered as healthy controls in the 
past.  
   A total number of 42 CF homozygotes, 48 CF heterozygotes and 62 healthy 
control subjects were studied in the further investigation. All CF heterozygotes 
were contacted via the CF homozygotes. Due to this way of subject selection, 
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confounding factors, such as socio-economical status, family, geographical spread 
and educational level, were excluded. It was obvious, however, that the mean age 
of the CF heterozygote group was considerably higher than that of the CF 
homozygote group. The latter implied that age remained the only confounding 
factor of influence. Consequently, it should be stressed that the results have to be 
interpreted with care. Additionally, the investigator is well aware of the rather 
small numbers of investigated subjects. However, this CF homozygote sample can 
be considered representative for the Belgian CF population, as it represents 7% of 
the total, which is in accordance with epidemiological standards. 
   In chapter 5 oral health (caries experience, dental plaque, calculus and gingival 
bleeding) was compared between 42 CF homozygotes, 48 CF heterozygotes and 62 
healthy controls. CF homozygotes had a significant lower caries experience and 
less gingival bleeding sites than healthy controls and CF heterozygotes. CF 
heterozygotes showed a significant worse caries experience than CF homozygotes 
and healthy controls. These results called for a deeper investigation (as suggested 
in the aims of the study) in the determining factors of oral health in these three 
study groups.  
   Chapter 6 focussed on the caries relevant oral microbial situation (Mutans 
streptococci and Lactobacilli) in CF homozygotes, heterozygotes and healthy 
controls, by means of commercially available chair sid tests. It was found that CF 
homozygotes had sigificantly less high Mutans streptococci counts than both other 
groups. This corresponded with and reflected the lower caries experience found in 
CF homozygotes (chapter 5). However, the cause of these observations was not 
clear, as oral health is determined by many  parameters, such as medication use, 
dietary habits, oral hygiene habits and salivary properties (organic and inorganic).  
   In chapter 7 medication and dietary habits were investigated (third aim). It 
became clear that medication (antibiotics, aerosols, pancreas enzymes and vitamins 
taken as maintenance ration) did not seem to play a major role in the caries 
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experience of CF homozygotes. It was found that CF homozygotes who opened 
their pancreas enzyme capsules, apparently did experience less dental calculus than 
those who did not. Dietary habits appeared to be only slightly different between the 
three groups in this study. Significantly more CF homozygotes consumed dairy 
products during meals and in between meals. Often in combination with a 
sweetened substance, which they need to provide them of the necessary body 
energy. This higher consumption of dairy products could partly serve as 
explanation for the lower caries experience (chapter 5) and the lower Mutans 
streptococci counts in CF homozygotes (chapter 6).  
   Subsequently, the oral hygiene habits and their impact on oral health of the three 
study groups were investigated (chapter 8). There were no differences in oral 
hygiene habits between the three study groups. Significantly more CF 
homozygotes than CF heterozygotes and healthy controls appeared to have 
received fluoride supplements. The latter was, however, not correlated with their 
lower caries experience.  
   None of the above mentioned parameters solely could sufficiently explain the 
lower caries experience in CF homozygotes. The latter once again supports the 
multifactorial aspects of the caries process. Subsequently, salivary electrolyte and 
protein concentrations were assessed (aims 4 and 5). 
   Primo, salivary electrolyte concentrations (sodium, potassium, chloride, 
bicarbonate, calcium and phosphate) were compared between the three study 
groups (chapter 9). Besides several differences between the several CFTR 
genotypes, major salivary electrolyte concentration differences were found 
between the three groups. It was shown that CF homozygotes and heterozygotes 
had a significant higher salivary sodium concentration than healthy controls. CF 
homozygotes also had a significant higher salivary phosphate concentration than 
CF heterozygotes and healthy controls. These findings could partly explain the 
lower caries experience in CF homozygotes, as the increased salivary sodium 
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concentration, which enhances enamel demineralisation, is possibly countered by 
an increased salivary phosphate concentration. The latter could also explain partly 
the higher caries experience in CF heterozygotes, as their increased salivary 
sodium concentration is not buffered by an increased salivary phosphate 
concentration. It was suggested that these distinct differences in salivary electrolyte 
concentrations may play an important role in the oral health status of any subject. 
   Secundo, the salivary protein composition (chapter 10) was investigated. The 
total salivary protein concentration was also significantly higher in CF 
homozygotes (0.86g/l) than in CF heterozygotes (0.67g/l) and healthy controls 
(0.56g/l). The use of the total salivary protein concentration as a diagnostic tool to 
differentiate CF homozygotes from the rest, was found to have a specificity of 89% 
and a sensitivity of 56%. It was concluded that this test might serve as additional 
test in the diagnosis of CF in newborns suspected of being CF patients.   
   It was also found that by means of sodium-dodecyl-sulphate poly acryl amide gel 
electrophoresis (SDS-PAGE) a 68 kDa salivary protein could be detected, which 
was representative for CF homozygotes. It remains to be explored whether this 
finding can be used as a diagnostic tool to detect CF homozygotes. Therefore 
further investigation is needed on a larger sample and to identify this protein (e.g. 
by amino acid sequencing, which is now possible as the human genome pattern 
was recently discovered). 
      It became clear from chapter 9 and 10 that saliva indeed can be used for 
diagnostic purposes. However, there is still one unidentified feature dealing with 
the typical clinically visible increased salivary viscosity in CF homozygotes. 
Salivary viscosity is caused both by salivary proteins and the cellular content of 
saliva (epithelial cells, erythrocytes, leukocytes). In order to study the salivary 
protein concentration, saliva had to be centrifuged, which means that “heavy” 
material is deposited at the bottom of the test tube (the greater the g-force, the more 
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particles will be deposited in the test tube), which in its turn results in a loss of 
viscosity, as the supernatant contains only little amounts of “large” particles.  
   In a further attempt to quantify viscosity, the cellular content of human saliva 
was measured by means of flow cytometry and reference values were established 
in healthy individuals (see Appendix). This spin-off investigation opened new 
possibilities and perspectives to use salivary flow cytometry to assess oro-
pharyngeal infections and to assess  cellular content changes in saliva. Actually 
reference values in healthy control subjects were established. Further investigation 
in medically compromised patients will show the possibilities of this innovative 
technique. 
 
   In conclusion it can be stated that, although CF patients were considered 
potentially to have a high risk caries profile, they had a significant lower caries 
experience than both CF heterozygotes and healthy controls. This was in 
disagreement with the null hypothesis. 
   On the other hand, the salivary composition, both inorganic (sodium and 
phosphate) and organic (proteins), was found to be significantly different between 
the three study groups. This means that the use of saliva, as a diagnostic tool, in 
the determination of oral health can be of significance.  
   It remains to be clarified, whether, CF homozygotes possess “intrinsic” (inherent 
to their disease) salivary compensatory mechanisms against dental decay. 
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Algemene discussie en conclusie  
(General discussion and conclusion in Dutch) 
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   Mucoviscidose (MV) is de meest voorkomende dodelijke recessief overerfbare 
aandoening in het blanke ras. Ongeveer 1 op elke 2000 levend geborenen is een 
MV patiëntje en 4 à 5 procent van de blanke bevolking zou drager zijn van het 
« cystic fibrosis transmembrane regulator » (CFTR) gen, welk gelokaliseerd is op 
de lange arm van chromosoom 7, op positie q31.  
   Deze aandoening treft alle exocriene klieren, welke een taaier secreet gaan 
vormen dan onder gezonde omstandigheden. MV patiënten lijden aan pancreas 
insufficiëntie en recurrente pulmonale ontstekingen. Hierdoor moeten zij 
regelmatig antibiotica, mucolytica, expectorantia en pancreas enzymes nemen. MV 
patiënten kunnen, omwille van hun ziekte,  beschouwd worden als personen met 
een verhoogd risico op cariës, omdat ze regelmatig suikerrijke tussendoortjes 
moeten verbruiken. Tegelijk kan ook de medicatie een belangrijke rol spelen in het 
ontstaan van cariës. Omdat suikerhoudende siropen en beta-2 agonisten in 
aerosolen in het bijzonder, meestal worden ingenomen ‘s avonds voor het slapen 
gaan, kunnen ze onrechtstreeks glazuurontkalking, en dus cariës, in de hand 
werken. 
 
   Studies uit de jaren 80 vermelden een lager cariës voorkomen bij kinderen met  
MV dan bij gezonde kinderen. Maar in een recente publicatie werd het 
tegenovergestelde gerapporteerd bij adolescenten met MV.  Bij gebrek aan recente 
studies (de recentste dateren van de jaren 80) over de orale gezondheid bij MV 
patiënten, werd de nood aangevoeld een « up-to-date » onderzoek op te starten. De 
nul hypothese van dit onderzoek was dat MV patiënten een potentieel risico 
lopen op een slechte orale gezondheid en dat speeksel kan gebruikt worden om 
dit te bepalen. 
 
De doelstellingen van het onderzoek waren; 
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1. Het bepalen van de status praesens van het cariës voorkomen en de orale 
gezondheid bij mucoviscidose patiënten, muco-heterozygoten en gezonde 
controlepersonen. 
2. Het kwantificeren van de orale cariogene bacteriële flora bij 
mucoviscidose patiënten, muco-heterozygoten en gezonde 
controlepersonen. 
3. Het bepalen van de impact van medicatie, dieetgewoonten en 
mondhygiëngewoonten op de orale gezondheid van mucoviscidose 
patiënten, muco-heterozygoten en gezonde controlepersonen. 
4. Het bepalen van verschillen in de concentratie van speeksel electrolieten en 
speekseleiwitten tussen mucoviscidose patiënten, muco-heterozygoten en 
gezonde controlepersonen. 
5. Het toetsen van de diagnostische mogelijkheden van speeksel in de 
bepaling van de orale gezondheid. 
 
   In eerste instantie werd een piloot studie opgestart met 37 MV patiënten en 37 
gezonde controle personen (hoofdstuk 2) bij dewelke het cariësvoorkomen (DMF) 
werd vergeleken (conform de eerste doelstelling van dit onderzoek). Er werden 
echter geen significante verschillen gevonden tussen beide groepen. Dit was 
opvallend verschillend met de bestaande literatuur over orale gezondheid en MV. 
Drie hypothesen werden naar voren geschoven als mogelijke verklaring voor deze 
vondst; geografische verschillen (bijv. omgevingsfactoren en genetische variaties), 
het veralgemeender gebruik van antibiotica (ook in de gezonde populatie) en een 
verschil in medische verzorging (dankzij de verbeterde inzichten en kennis van de 
ziekte). Daarom werd geopteerd om de studiegroep uit te breiden en daarenboven, 
werden, gezien de actuele diagnostiche mogelijkheden, de MV heterozygoten als 
een aparte groep te beschouwd. Waarschijnlijk zijn er zelfs , door onwetendheid, in 
het verleden MV heterozygoten als controlepersonen gebruikt geweest. 
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   In het totaal werden 42 MV patiënten, 48 MV dragers en 62 controlepersonen in 
het verdere onderzoek betrokken. Alle MV heterozygoten werden geselecteerd via 
de MV homozygoten. Op deze manier konden socio-economische status, familiale 
samenstelling, geografische spreiding en opleidingsniveau, worden uitgeschakeld 
als invloedrijke factoren. Het is dan ook vanzelfsprekend dat de gemiddelde leeftijd 
van de MV heterozygoten aanzienlijk hoger was dan die van de MV patiënten 
groep. Dit betekent wél dat leeftijd de enig invloedrijke factor blijft, die ervoor 
zorgt dat de resultaten van dit onderzoek met de nodige voorzichtigheid moeten 
geïnterpreteerd worden. Daarenboven wenst de auteur duidelijk te maken dat hij er 
zich van bewust is dat het om kleine onderzoeksgroepen gaat, maar dat de MV 
patiënten groep wel degelijk als representatief voor de Belgische MV populatie kan 
beschouwd worden, omdat ze 7% uitmaakt van het totaal, welke beantwoord aan 
epidemiologische criteria. 
   In hoofdstuk 5 werd de orale gezondheid (cariës voorkomen, tandplaque, 
tandsteen en gingivale bloedingen) van 42 MV homozygoten, 48 MV 
heterozygoten en 62 gezonde controlepersonen onderzocht. MV homozygoten 
hadden een significant lagere DMF (-T en -S) score en significant minder tanden 
met bloedend tandvlees dan MV heterozygoten en gezonde controlepersonen.  MV 
heterozygoten hadden significant meer tanden verloren dan controlepersonen. Hun 
DMF was net niet significant hoger dan die van de controlegroep. Deze resultaten 
eisten een dieper onderzoek naar de determinanten van de orale gezondheid in deze 
drie onderzoeksgroepen (zoals gesuggereerd in de doelstellingen). 
   In hoofdstuk 6 werd de cariës relevante orale microflora, door middel van 
commercieel verkrijgbare “chair-side testen”, bestudeerd  (Streptococcus mutans 
en Lactobacillen) tussen MV homozygoten, heterozygoten en controlepersonen. 
MV patiënten hadden significant minder Streptococcus mutans kolonies dan beide 
andere onderzoeksgroepen. Dit resultaat confirmeerde én weerspiegelde tevens het 
lagere cariës voorkomen bij MV patiënten (hoofdstuk 5). Het dient opgemerkt te 
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worden dat de oorzaak van deze bevindingen niet duidelijk is, omdat orale 
gezondheid door een waaier van parameters, zoals medicatie gebruik, 
voedingsgewoonten, mondhygiëne en speekselsamenstelling (organisch én 
anorganisch), wordt beïnvloed. 
    In hoofstuk 7 werden zowel de medicatie alsook de voedingsgewoonten (de 
derde doelstelling) bestudeerd. Medicatie (patiënten met een onderhoudsdosis van 
antibiotica, aërosolen, pancreas enzymes en vitaminepreparaten) bleek een minder 
belangrijke impact te hebben op de DMF score van MV homozygoten. Er werd 
vastgesteld dat de MV patiënten die hun pancreasenzyme capsules openden, 
significant minder tandsteen hadden dan diegenen die het niet deden.  Wat de 
dieetgewoonten betreft, werden slechts kleine verschillen aangetroffen tussen de 
drie onderzoeksgroepen. Significant meer MV patiënten gebruikten melkprodukten 
tijdens maaltijden en tussendoortjes, meestal zelfs in combinatie met suikerrijke 
bestanddelen, welke ze nodig hebben om zich dagelijks van de nodige 
lichaamsenergie te voorzien. Het aspect van de melkprodukten kan als 
gedeeltelijke verklaring dienen waarom MV patiënten significant lagere DMF 
scores hadden en significant minder Streptococcus mutans kolonies in hun speeksel 
vertoonden (hoofdstuk 6). 
    In hoofdstuk 8 werden de mondhygiënegewoonten bestudeerd tussen de drie 
onderzoeksgroepen, maar er bleken geen significante verschillen te zijn. Er waren 
wel significant meer MV homozygoten dan MV heterozygoten en 
controlepersonen die fluoridesupplementen hadden genomen. Dit bleek echter niet 
gecorreleerd te zijn met de DMF waarde bij MV patiënten.  
   Uit het voorgaande blijkt dat geen enkele van de hierboven onderzochte 
parameters de orale gezondheid van de drie onderzoeksgroepen kunnen verklaren. 
Dit bevestigd het multifactoriële aspect van het cariësproces. Vervolgens werden 
zowel de ionaire samenstelling alsook de eiwitsamenstelling van het speeksel 
onderzocht (doelstelling 4 en 5).  
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   In hoofdstuk 9 werden verschillen in speekselelectrolieten (natrium, kalium, 
chloor, bicarbonaat, calcium en fosfaat) tussen de drie onderzoeksgroepen 
bestudeerd. Naast het feit dat er verschillen in electrolietensamenstelling werden 
gevonden tussen de verschillende types van CFTR genotypes, bleken er ook twee 
duidelijk significante verschillen te bestaan tussen MV homozygoten en 
heterozygoten. MV homozygoten en heterozygoten hadden significant hogere 
natriumconcentraties in hun speeksel dan controlepersonen. Tegelijk hadden de 
MV patiënten ook een significant hogere fosfaatconcentratie in hun speeksel dan 
de MV heterozygoten en controlepersonen. Deze bevindingen kunnen op hun beurt 
deels verklaren waarom MV patiënten significant lagere DMF scores hadden; een 
hoge natriumconcentratie in het speeksel, die glazuur demineralisatie in de hand 
werkt, kan worden tegengewerkt door de hogere fosfaatconcentratie. Omdat ze 
geen compenserende (hogere) fosfaatconcentratie vertoonden in hun speeksel, kan 
dit tevens verklaren waarom MV heterozygoten méér tandbederf vertoonden. 
      Daarop volgend werden in hoofdstuk 10 verschillen in speekseleiwitten tussen 
de drie groepen bestudeerd. De totale speeksel eiwitconcentratie bij MV patiënten 
(0.86g/l) was significant hoger dan die van MV dragers (0.67g/l) en van 
controlepersonen (0.56g/l). Het gebruik van de totale speeksel eiwitconcentratie als 
diagnostisch criterium om MV homozygoten te kunnen onderscheiden van de rest, 
bleek een specificiteit te hebben van 89% en een sensitiviteit van 56%. Er werd 
besloten dat deze test eventueel als aanvullende test zou kunnen dienen bij de 
diagnose van MV bij pasgeborenen met een vermoeden van MV. 
Door middel van « sodium-dodecyl-sulphate-polyacryl amide gel electrophoresis» 
(SDS-PAGE) werd een eiwit met een molecuulgewicht van 68 kDa geïdentificeerd, 
dat representatief was voor MV patiënten. Of deze techniek kan gebruikt worden 
als diagnostische techniek moet nog verder onderzocht worden. Hiervoor is 
uiteraard verder onderzoek nodig op grotere schaal en is het ook noodzakelijk om 
het eiwit te identificeren (bijv. door eindstandige aminozuursequenties te gaan 
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bepalen, welke vandaag de dag mogelijk is, sinds de ontdekking van het menselijk 
genoom). 
      Het is duidelijk uit hoofdstukken 9 en 10 dat speeksel wel degelijk 
diagnostische eigenschappen heeft. Er blijft echter nog één aspect over, namelijk 
de klinisch waarneembare verhoogde speekselviscositeit van MV patiënten. 
Speekselviscositeit wordt bepaald door de eiwitten enerzijds en door de cellulaire 
inhoud (epitheelcellen, erythrocyten en leukocyten) van het speeksel anderzijds. 
Om de totale eiwitconcentratie te bepalen, moet speeksel gecentrifugeerd worden, 
wat betekent dat de “zware” deeltjes naar de bodem van de proefbuis zullen zinken 
(hoe groter de g-krachten, hoe meer partikels op de bodem van de proefbuis zullen 
neerdalen). Dit resulteert in een verlies van viscositeit omdat het supernatans bijna 
geen “grote” partikels zal bevatten.  
   In een poging om de viscositeit te kwantificeren, werd de cellulaire samenstelling 
van speeksel bestudeerd aan de hand van een flow cytometer en werden er 
referentiewaarden opgesteld van gezonde personen (zie Appendix). Dit spin-off 
onderzoek opende nieuwe mogelijkheden en perspectieven om speeksel flow 
cytometrie te gebruiken om oro-faryngeale infecties op te sporen en om de 
cellulaire inhoud van speeksel te gaan bepalen.Tot op heden werden enkel nog 
maar referentiewaarden voor gezonde personen opgesteld. Verder onderzoek bij 
medisch gecompromitteerde patiënten zal de mogelijkheden van deze nieuwe 
techniek bepalen.   
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Als algemene conclusie van dit proefschrift kan worden gesteld dat ondanks het feit 
dat MV patiënten kunnen beschouwd worden als individuen met een hoog cariës 
risico profiel, zij significant lagere DMF scores en een betere orale gezondheid 
bleken te hebben dan MV heterozygoten en gezonde controlepersonen. Dit was in 
tegenspraak met de nulhypothese. 
   Wat het speeksel betreft, bleek dat zowel de anorganische (natrium en fosfaat 
concentraties) als de organische (totale eiwitconcentratie) samenstelling 
significant verschillend waren tussen de drie onderzoeksgroepen. Hieruit kan 
besloten worden dat het gebruik van speeksel, als diagnostisch middel voor het 
bepalen van mondgezondheid, van betekenis kan zijn.  
   Het blijft echter onvoldoende bewezen of MV patiënten inderdaad beschikken 
over een soort van « intrinsiek » (inherent aan hun ziekte) compensatoir 
speekselmechanisme dat hen in zeker zin beschermt tegen tandbederf. Hiervoor is 
diepgaander vervolgonderzoek nodig. 
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APPENDIX 
 
 
Flow Cytometry as a New Method to  
Quantify the Cellular Content of  
Human Saliva and its Relation to Gingivitis 
 
 
 
 
 
 
 
 
This chapter was published as : 
Aps J.K.M., Van den Maagdenberg K., Delanghe J., Martens L.C. Flow cytometry 
as a new method to quantify the cellular content of human saliva and its relation to 
gingivitis. 
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PREFACE 
  During the clinical examinations, it was observed that very often CF homozygote 
saliva samples could be distinguished from CF heterozygote and control samples, 
due to their high viscosity. By means of capillary viscosimetry (PVS1 LAUDA
®
), 
an attempt was made to measure salivary viscosity. It was observed that clinically 
viscous saliva samples “lost” their viscosity when centrifuged and that the 
clinically visible difference disappeared [Van den Maagdenberg, 2000].  
   It should however be emphasized that saliva behaves like an emulsion and that 
the expression “viscosity” is not entirely correct, as Newton’s law is not applicable 
on these kind of biological fluids. Saliva should be considered as a gel, a colloidal 
system, which includes that by homogenizing the sample or by applying forces on 
the sample, the internal structure is ruptured. Consequently, the measured viscosity 
does not match the “actual” one. The latter implies that besides proteins, several 
particles, such as bacteria, epithelial cells, leukocytes and erythrocytes, strongly 
influence salivary rheology [Saunders, 1971; Blair, 1974; Van der Reijden, 1993; 
De Smedt, 1995; Glantz et al., 1995].  
   Due to the above mentioned considerations and especially the fact that 
rheological properties of saliva are influenced by the cellular content of the sample, 
which probably reflects oral health, the next study using flow cytometry was carried 
out to find out if this cellular content could be measured.     
   As this technique had never been used for saliva before, it was necessary, as 
recommended by the Internation Federation of Clinical Chemistry to establish 
reference values first from healthy individuals.  
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ABSTRACT 
   Determining the cellular content of saliva by means of conventional microscopy 
chamber counting is a very time consuming and operator sensitive procedure. This 
study concentrated on the use of flow cytometry to examine the cellular content of 
saliva. Erythrocytes, leukocytes, epithelial cells and bacteria were quantified and 
the results were compared with caries experience and the presence of gingivitis.  
Two hundred and fifty eight uncentrifuged vortexed paraffin stimulated saliva 
samples (112 males and 146 females) were analyzed with the UF-100
®
 flow 
cytometer. Salivary reference values were established for erythrocyte, leukocyte, 
epithelial cell and bacterial count. Caries experience (DMF) and the presence of 
gingivitis were recorded. 
Caries experience or caries risk could not be assessed with flow cytometry. 
However, salivary flow cytometry may be useful in determining an individual’s 
risk for gingivitis : a significant increase in salivary leukocytes was observed in 
individuals with gingivitis. At a cut-off level of 10
3
 leukocytes µL
-1
 saliva, a 
sensitivity of 76% and a specificity of 45% was obtained. Other analytes were not 
significantly different between individuals with and without gingivitis.  
Flow cytometry of paraffin stimulated human saliva seems a promising diagnostic 
or predictive tool and further investigations of diseases of the oro-pharyngeal loge, 
such as tonsillitis and periodontitis, should be carried out in the future.  
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A.1. Introduction 
   Whole human saliva is a complex exocrine secretion which contains proteins, 
ions, bacteria and cells derived from salivary glands, crevicular fluid, tonsils, the 
oral mucosa, bronchopulmonar and oropharyngeal secretions [Van Nieuw 
Amerongen, 1988a ; Edgar and O’Mullane, 1990 ; Mandel, 1990 ; Schonfeld, 
1992 ; Smith, 1992 ; Ten Cate, 1994 ; Schenkels et al., 1995 ; Burkitt et al., 1997 ; 
Marsh and Martin, 1999a,b]. Despite the fact that a lot of research has been carried 
out on the chemical composition of saliva, little is known about its cellular 
components.  
    Ongoing local inflammations can be investigated by means of flow cytometry of 
human body fluids. Flow cytometry allows a fast and accurate determination of 
epithelial cells, erythrocytes, leukocytes and bacteria in human secretions, such as 
urine [Ben-Ezra et al., 1998 ; Kouri et al., 1999 ; Langlois et al., 1999 ; Lun et al., 
1999], cerebrospinal fluid [Ziebig et al., 2000 ; Van Acker et al., 2001] and sperm 
[Muylaert et al., 2000].  
    Until now, no flow cytometry studies on saliva have been performed. Due to this 
the aims of the present study were both analytical and clinical. Quantification of 
erythrocytes, leukocytes, epithelial cells and bacteria in paraffin stimulated whole 
human saliva was carried out by means of flow cytometry. Investigation of the 
reproducibility of saliva flow cytometry was also performed. Furthermore 
reference values for these parameters in saliva were established. Next to these 
analytical aims, possibilities of using flow cytometry to trace gingival 
inflammation by a non-operator-sensitive technique, which avoids probing of the 
gingival tissues were explored. Finally assessment of caries experience (DMF) by 
means of saliva flow cytometry was also investigated.  
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A.2. Material and methods 
A.2.1 Patients 
   Subjects suffering from cardiovascular, endocrine, hematological, infectious or 
genito-urinary diseases were excluded from the study. A sample of 258 healthy 
volunteers (112 males and 146 females, mean age 33  13 years) was selected. 
Every subject signed an informed consent and the study was approved by the 
University of Ghent Hospital’s ethical committee.  
 
A.2.2. Oro-dental data  
   The investigator (J.A.) was specifically trained at baseline and participated both 
in an in vitro and in vivo calibration exercise, according to the British Association 
for the Study of Community Dentistry (BASCD) guidelines [Pine et al., 1997]. The 
investigator’s overall kappa values for both exercises were respectively 0.84 and 
0.76, both standing for an acceptable interreliability with an experienced examiner 
(L.M.) as a benchmark [Bolin et al., 1995]. The caries experience index (DMF-T 
and DMF-S) of 213 of the 258 volunteers (82.6%) was determined. This was 
performed according to the WHO report on oral health surveys (white light source, 
dental mirror, CPITN probe Type E and cotton rolls) 
[http://www.whocollab.od.mah.se] and based upon the diagnostic criteria for caries 
prevalence surveys, published by the BASCD [Pitts et al., 1997]. Caries was 
recorded at the level of cavitation. No X-rays were taken. The abbreviations « D, 
M and F » respectively stand for « decayed, missing (extracted due to decay) and 
filled » teeth (index –T) or surfaces (index –S). Gingivitis was recorded when at 
least one hypertrophic and hyperaemic gingival margin was present. As 
dichotomized data were preferable for statistical analysis, no specific index was 
used to express the severeness of gingivitis, as this was not relevant regarding the 
aims of  this study. 
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A.2.3. Saliva sampling 
   All subjects were asked to chew a paraffin tablet, as provided in the commercial 
available CRT® test kit (Vivadent
®
, Liechtenstein), for at least 3 minutes. The 
secreted saliva was collected in a sterile plastic recipient and transported to the 
laboratory at a temperature of 18°C. All subjects were in an upright position when 
saliva was collected and the collections were performed between 9 a.m. and 4 p.m. 
in the presence of the investigator. 
 
A.2.4. Saliva flow cytometry 
   The Sysmex UF100
®
 (TOA Medical Instruments Co, Kobe, Japan) was used to 
determine the cellular composition. The Sysmex UF100
®
 uses an argon laser to 
analyse the electrical impedance for volume, for forward light scatter and for size. 
DNA and membranes are analyzed, respectively with phenanthridine and 
carbocyanine, by fluorescent dyes. The pulse intensity and width of the forward 
scattered light and fluorescence light are measured. These data, combined with the 
impedance data of the formed elements, are categorized by multiparametric 
algorithms based upon their size [Sysmex UF-100 manual, 1995]. The instrument 
aspirates 800µL of the sample and the results are displayed as scatter grams and as 
counts per microliter. For this study saliva was not centrifuged, as it was the 
purpose to quantify the cellular content of saliva. Instead, it was vortexed for at 
least 20 seconds, before analysis with the Sysmex UF-100
®
 was performed. The 
analysis was performed at room temperature, within 1 hour after collection.  
 
A.2.5. Method  validation 
   As the presented technique was never performed on saliva, it was necessary to 
investigate the reproducibility and the influence of sample storage (temperature and 
time) on the analysis results.  
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A.2.5.a Reproducibility 
   Three adult healthy volunteers provided each a paraffin stimulated saliva sample, 
which was analysed 10 times in the UF-100® flow cytometer. The within run 
coefficient of variation (CV) was determined by means of the Medcalc
®
 (Medcalc
®
 
software – Mariakerke, Belgium) statistical software program. 
 
A.2.5.b Variation of cellular content during the day 
   Five healthy adult volunteers provided each at 4 different times of the day (9 
a.m., 11 a.m., 2 p.m. and 4 p.m.) a paraffin stimulated saliva sample. Immediately 
after collection the samples were analysed in the UF-100
®
. The latter was 
performed to obtain an impression of the intra- and interindividual fluctuations of 
the cellular content of saliva. Subsequently the between run coefficient of variation 
(CV) was determined, using the Medcalc
®
 program.   
 
A.2.5.c Influence of storage temperature and time 
   Six paraffin stimulated saliva samples were obtained from six healthy adult 
volunteers at 9 a.m . The samples were subsequently divided into 2 equal volumes 
and stored at 6 °C and at room temperature (20 °C). Every sample was 
subsequently measured in the UF-100
®
 flow cytometer at 9.30 a.m. (= baseline 
measurement), 11 a.m., 2 p.m. and 4 p.m.  
 
A.3. Statistics 
   All data were immediately stored in an automated database and appropriate 
statistical analysis was performed, using the Medcalc
®
 program (Medcalc
®
 
Software – Mariakerke, Belgium). Within-run imprecision and interindividual 
variations were expressed as coefficient of variation (CV). Reference values for the 
various parameters were calculated according to the IFCC (International Federation 
of Clinical Chemistry) guidelines [Sasse et al., 1995]. Statistical differences were 
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evaluated using the unpaired Wilcoxon test. A P-value < 0.05 was considered as 
statistically significant. The statistical differences between samples stored at 6°C 
and 20°C were calculated by means of a paired Wilcoxon signed ranks test. A Box-
and-Whisker plot (figure 1) and a ROC (Receiver Operating Characteristic) curve 
analysis (figure 2) were used to visualize the significant difference in leukocyte 
count between individuals with and without gingivitis [Metz, 1978] . 
 
A.4. Results 
A.4.1. Method validation 
A.4.1.a Reproducibility 
   Both the within-run as well as the between-run coefficient of variation (CV) of 
each analyte was carefully determined. The within-run CV for erythrocytes was 
27%, 29% for leukocytes and epithelial cells and 24% for bacterial count. The 
between-run CV for erythrocytes was 49%, 47% for leukocytes, 29% for epithelial 
cells and 50% for bacterial count.  The mean within-run CV and between-run CV 
were respectively 27 and 44%. This illustrates, with exception of epithelial cells,  
the broad range of cellular counts during the day. 
 
A.4.1.b Storage time and temperature influences 
    No significant differences were found between the UF-100
®
 erythrocyte and 
leukocyte readings for samples (n = 6) stored at room temperature (20°C) and 
refrigerator temperature  (6°C). On the contrary, it was observed that the epithelial 
cell count and the bacteria count were both significantly higher (P < 0.01) when 
samples were stored for 7 hours at room temperature.  
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A.4.1.c Experimental sample evaluation  
Clinical data 
   The prevalence of gingivitis in the study group was 25% (n = 54 ; 21 males and 
33  females). The mean DMF-T and DMF-S were respectively 7.8  6.7 and 23.1  
27.3.  
    Neither for gingivitis, nor for DMF, significant differences were observed 
between both sexes. 
 
Table A.1. : Reference values for salivary cells of paraffin stimulated saliva.  
                      Figures for the over- all sample and a comparison between males and  
                      females. ( ** P < 0.01, *** P < 0.001 ) 
Over-all 
( n = 258 ) 
Males 
( n = 112 ) 
Females 
( n = 146 ) 
 
Analytes 
Median, 
2.5th & 97.5th  
percentile ( µL-1 ) 
Median, 
2.5th & 97.5th  
percentile ( µL-1 ) 
Median, 
2.5th & 97.5th  
percentile ( µL-1 ) 
 
Erythrocytes 
 
716 ( 123 – 3388 ) 
 
918 *** ( 189 – 4244 ) 
 
580  ( 116 – 3269 ) 
 
Leukocytes 
 
1279 ( 257-5142 ) 
 
1239 ( 299 – 5016 ) 
 
1404 ( 237 -  5158 ) 
 
Epithelial cells 
 
935 ( 162 – 4191 ) 
 
1156 *** ( 244 – 4703 ) 
 
753  ( 136 – 2942 ) 
 
Bacteria 
 
 
11511 (3785 – 37249 ) 
 
12748** ( 4024 – 43810 ) 
 
10439 ( 3727 – 31465 ) 
 
Flow cytometer reference values 
   In table 1 the UF-100
®
 readings are shown for the study group (n = 258 ; 112 
males and 146 females). This table depicts a summary of the distribution of 
erythocytes, leukocytes, epithelial cells and bacteria for the over-all sample and 
according to gender. The numbers are presented as medians and 2.5th and 97.5th 
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percentiles. For all analytes studied, reference ranges are remarkably broad. For 
erythrocyte (P = 0.0002), epithelial (P = 0.0001) and bacterial cell counts (P = 
0.0026), significant higher counts were observed in males.  
 
Figure A.1. : A Box-and Whisker plot of the salivary leukocyte count (log 
                        leukocytes per microlitre) in the presence or absence of gingivitis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A.4.1.d Clinical data and saliva flow cytometry 
   A significant difference (P = 0.042) in salivary leukocyte count was observed 
between individuals with (1881 1349 cells µL
-1
) and without gingivitis (1399  
993 cells µL
-1
). A Box-and-Whisker plot shows the difference in leukocyte count 
(figure 11.1.).  
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    Salivary leukocyte count was considered to have a potential predictability for an 
individual to have gingivitis, therefore a ROC curve analysis was implemented. At 
a cut-off level of 10
3 
leukocytes per microliter, a sensitivity of 90% and a 
specificity of 49.1% was obtained (Figure 11.2.). This was not observed for 
epithelial cells or bacteria or for erythrocytes.  
    From analogue analyses, with caries experience as a response variable, no 
significant differences were found. 
 
Figure A.2. : A receiver operating characteristic (ROC) curve of the salivary  
                        leukocyte counts (log leukocytes per microlitre) in case of  
                        gingivitis, with a diagnostic cut-off point at 10
3
 leukocytes per 
                        microlitre whole saliva, standing for a sensitivity of 90% and a 
                        specificity of 49.1%  
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A.5. Discussion 
   The reproducibility of paraffin stimulated whole human saliva flow cytometry 
was acceptable. The CVs for erythrocyte, leukocyte and epithelial cell count were 
higher than for bacterial count. Compared with literature [Ben-Ezra et al., 1998] on 
the use of the UF-100
®
 instrument, these CVs are considerably higher than for 
urinalysis, which can be explained by the higher number of samples in the urine 
study and by the fact that the instrument is designed and calibrated to analyse urine 
and not saliva. The broad range in cellular counts was attributed to clustering of 
cells and to a broad range of inter-individual variation in salivary composition.  
    The broad range of flow cytometer counts during the day implicates that an 
individual’s flow cytometer saliva profile should not be based upon one 
measurement as large fluctuations occur during the day. The same holds for 
chemical analysis of saliva [Aguirre et al., 1993]. It is recommended that several 
salivary samples during the day should be taken for several consecutive days, to 
obtain an individual’s salivary flow cytometer profile. Analysis of only one sample 
is merely an instantaneous detection of an individual’s salivary cellular 
composition at a precise moment in time .  
    The significant higher bacterial count at room temperature was obviously caused 
by the higher bacterial activity and capacity to reproduce at room temperature, as 
food debris, epithelial cells and polysaccharide chains from salivary proteins serve 
as nutrients during storage [Van Nieuw Amerongen, 1988a; Rudney, 1995 ; 
Tenuvuo, 1998 ; Marsh and Martin, 1999a,b]. 
       The significant higher epithelial cell count at room temperature was attributed 
to unraveling of clusters of epithelial cells at this temperature. At 6°C epithelial 
cell clusters will less likely fall apart. When the sample is « fresh », epithelial cells 
will adhere and the flow cytometer will detect clusters of cells. The latter results 
apparently in a lower epithelial cell count. When the sample is stored at 20°C, the 
clusters may disintegrate, and as a consequence, the flow cytometer will 
188
  
189 
« identify » more individual cells. This explains the higher number at room 
temperature. A similar finding was reported on urinalysis, where at 20°C also a 
higher count was detected  in 1 of 16 specimens [Kouri et al., 1999]. 
    Obviously no significant differences were found for erythrocyte and leukocyte 
counts which is in concordance with other authors [Kouri et al., 1999].  
    It is recommended to analyse salivary samples in the flow cytometer as soon as 
possible after collection or to store them at low temperature, if analysis cannot be 
performed immediately after sample collection. This advise is endorsed by 
publications on chemical and bacterial analyses of saliva [Davis et al., 1991 ; 
Schonfeld, 1992 ; Smith, 1992 ; Bollen et al., 1999 ; Marsh and Martin, 1999a]. 
   Flow cytometry, by means of the Sysmex UF-100
® 
flow cytometer, is known as a 
fast and reliable technique to analyze the cellular composition of a biological fluid 
[Ben-Ezra et al., 1998 ; Kouri et al., 1999 ; Lun et al., 1999]. Moreover, it is not 
operator sensitive as is conventional chamber counting [Kouri et al., 1999]. 
Salivary flow cytometry is now clearly demonstrated to be among the possible 
applications of the Sysmex UF-100
®
. 
   The observed significant higher erythrocyte, epithelial and bacterial cell counts in 
males in 
 the experimental group were probably coincidental and should be interpreted with 
care. Gingivitis was associated with increased salivary leukocyte counts. Salivary 
leukocyte count may be useful as a biological marker for gingival inflammation. 
This is the first study that quantifies leukocytes in saliva to confirm the clinical 
presence of gingivitis. No literature data on salivary leukocyte counts and gingivitis 
are available.  
    As most of the salivary leukocytes are derived from the oropharyngeal area and 
from the crevicular sulcus [Ten Cate, 1994; Marsh and Martin, 1999a,b] , it should 
be emphasized that a high leukocyte count could also be related to other oro-
pharyngeal infections, such as tonsillitis [Kirstila et al., 1996; Brook et al., 1997]. 
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Although tonsillitis and other oropharyngeal infections were exclusion criteria in 
the present study, other causes of oropharyngeal inflammation could be considered 
as theoretical causes for an increased salivary leukocyte count. 
    No significant correlations between DMF-T or DMF-S and the flow cytometry 
data were observed. This can probably be explained by the fact that flow cytometry 
of saliva is a current recording of the cellular content of this secretion fluid on the 
one hand and that DMF is both a recording of the dental history (missed and filled 
teeth or surfaces) as well as a recording of the present dental situation (decayed 
teeth and surfaces) of an individual on the other hand.  
    It should also be emphasized that the UF-100
®
 cannot distinguish cariogenic 
bacteria from other commensals or periodontal pathogens. The number of bacteria 
(both viable and non- viable) only represents the amount of cells, this analyzer can 
categorize as such. Therefore the UF-100
® 
should not be used to assess an 
individual’s caries risk, by measuring the number of bacteria per microliter saliva. 
 
A.6. Conclusion 
   The use of the Sysmex UF-100
®
 flow cytometer is a fast and easy way to 
determine the cellular composition of saliva. Flow cytometry of saliva may be 
useful in assessing the presence of gingivitis in an individual. The salivary 
leukocyte count is a discriminative parameter for gingivitis.  
    Saliva flow cytometry should, however, not be used to evaluate the caries 
experience or to determine caries risk in individuals.  
    Further research is needed to determine and to evaluate other applications of 
salivary flow cytometry as a predictive and discriminative parameter for oral 
disease or infection, such as tonsillitis and periodontitis. 
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